Einrichtung von biologischen Testsystemen für metallisches Magnesium als neuartige Implantatmaterial und seine Wechselwirkung mit Bakterien, Zellen und Gewebe by Rahim, Muhammad Imran
 
 
 
 
 
 
Establishment of biological test systems for metallic 
magnesium as a novel implant material and its interaction 
with bacteria, cells and tissue 
 
 
 
 
Von der Fakultät für Lebenswissenschaften 
 
der Technischen Universität Carolo-Wilhelmina zu Braunschweig 
 
zur Erlangung des Grades eines 
 
Doktors der Naturwissenschaften 
 
(Dr. rer. nat.) 
 
genehmigte 
 
D i s s e r t a t i o n 
 
 
 
 
 
 
 
 
 
 
 
 
 
von Muhammad Imran Rahim 
aus Muzaffargarh / Pakistan 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1. Referent:  apl. Professor Dr. Peter Paul Mueller 
2. Referentin:  Professorin Dr. Susanne Engelmann 
eingereicht am:  01.06.2015 
mündliche Prüfung (Disputation) am: 27.08.2015 
 
Druckjahr 2015 
 
 
 
 
 
 
 
Vorveröffentlichungen der Dissertation  
 
Teilergebnisse aus dieser Arbeit wurden mit Genehmigung der Fakultät für 
Lebenswissenschaften, vertreten durch den Mentor der Arbeit,  
in folgenden Beiträgen vorab veröffentlicht: 
 
 
Publikationen 
Rahim M. I, Eifler R, Rais B, Mueller P.P. Alkalization is responsible for antibacterial 
effects of corroding magnesium. Journal of Biomedical Materials Research Part A. 
2015. doi: 10.1002/jbm.a.35503. 
Weizbauer A, Kieke M, Rahim M. I, Angrisani GL, Willbold E, Diekmann J, 
Floerkemeier T, Windhagen H, Mueller P. P, Behrens P, Bude S. Magnesium-
containing layered double hydroxides as orthopaedic implant coating materials-An in 
vitro and in vivo study. Journal of biomedical materials research Part B, Applied 
biomaterials. 2015. doi: 10.1002/jbm.b.33422. 
Badar M, Rahim M. I, Kieke M, Ebel T, Rohde M, Hauser H, Behrens P, Mueller P. P. 
Controlled drug release from antibiotic-loaded layered double hydroxide coatings on 
porous titanium implants in a mouse model. Journal of Biomedical Materials Research 
Part A. 2014. doi: 10.1002/jbm.a.35358. 
Badar M, Lunsdorf  H, Evertz F, Rahim M. I, Glasmacher B, Hauser H, Mueller P.  P. 
Formation of an organic coat and release of corrosion microparticles from metallic 
magnesium implants. doi: 10.1016/j.actbio.2013.03.012 Acta Biomater, 2013. 
Rais B, Rahim M. I, Lienenklaus S, Weiss S, Tolle C, Seitz J-M, Menzel H, Hauser H, 
Mueller P. P. Animal Test Models for Implant-Associated Inflammation and Infections, in 
Biomedical Technology, T. Lenarz and P. Wriggers, Editors. 2015, Springer 
International Publishing. p. 175-187. 
 
Tagungsbeiträge  
Rahim M. I, Rais B, Kieke M. D, Evertz F, Weizbauer A, Windhagen H, Willbold E, 
Kietzman M,Glasmacher B, Stiesch M,Hauser H, Behrens P, Mueller P.P: 
Characterization and optimization of antibacterial bacterial implants in vitro and 
validation in a small animal model (Oral presentation). 48th DGBMT Annual Conference 
Hannover (2014).  
Rahim M. I, Badar M, Hauser H and Mueller P. P: Cells and material interaction. (Oral 
presentation). 5th International PhD Symposium, Helmholtz Center for Infection 
Research, Braunschweig (2014). 
Rahim M. I, Hauser H and Mueller P. P: Establishment of different strategies to combat 
biomaterial associated infections (Oral presentation). 4th Annual Retreat, Goslar 
Hahnenklee (2014) 
 
 
 
 
Rahim M. I, Kieke M. D, Behrens P, Hauser H and Mueller P. P: Nanoparticles based 
slow drug release coatings to combat implant-associated infections (Oral presentation). 
4th Annual Retreat, Goslar Hahnenklee (2013). 
 
 
Posterbeiträge  
Rahim M. I, Badar M, Kieke M. D, Ebel T, Rohde M, Behrens P, Hauser H and Mueller 
P. P: Layered double hydroxide (LDH) based intrinsic and sustained drug delivery 
system to combat implant associated infections (Poster). Der Deutschen Gesellschaft 
fur Biomaterialien (DGBM), Dresden (2014). 
Rahim M. I, Rohde M, Lienenklaus S, Seitz J- M, Hauser H and Mueller P. P: 
Establishment of biofilm mouse model to understand implant-associated infections 
(Poster). 7th International Ph. D Symposium, Helmholtz Center for Infection Research, 
Braunschweig (2014). 
Rahim M. I, Evertz F, Kieke M. D, Weizbauer A, Windhagen H, Willbold E, Glasmacher 
B, Hauser H and Mueller P. P:. Protective coatings on metallic magnesium to limit 
hydrogen generation (Poster). 48th Annual Conference on Biomedical Technique, 
Hannover (2014).  
Rahim M. I, Badar M, Kieke M. D, Heemeier T, Ehlert N, Duda F, Behrens P, Hauser H 
and Mueller P. P: Establishing different strategies in the prevention of implant-
associated infections (Poster). 6th International Ph. D Symposium, Helmholtz Center for 
Infection Research, Braunschweig (2013). 
Rahim M. I, Mueller P. P, Rhode M and Hauser H: Evaluation and comparison of in 
vitro and in vivo degradation kinetics of magnesium (Poster). 47th Annual conference on 
Biomedical Technique, Graz, Austria (2013).  
Rahim M. I, Badar M, Mueller P. P, Kietzmann M, Weizbauer A, Glasmacher B and. 
Evertz F: Ex vivo measurement of pull out force for biodegradable magnesium wires in 
Tibia bones (Poster). Der Deutschen Gesellschaft fur Biomaterialien (DGBM), 
Handwerkskammer, Hamburg (2012).  
Rahim M. I, Badar M, Mueller P. P, Hauser H, Abraham W-R and Kietzmann M: 
Development of biological test systems for novel implant materials and interactions with 
bacteria, cells and tissues (Poster). Summer School on Infection Research, Hotel 
Aquamaris, Rugen (2012).  
 
 
 
 
 
 
 
 
Table of Contents 
ABSTRACT................................................................................................................................................... 1 
ZUSAMMENFASSUNG ................................................................................................................................ 2 
1 INTRODUCTION ................................................................................................................................... 3 
1.1 IMPLANT MATERIALS AND THEIR IMPORTANCE IN MEDICAL SCIENCE ..................................................... 3 
1.1.1 Magnesium as a potential biodegradable material ................................................................... 4 
1.1.2 Magnesium (Mg2+) as essential element for life ........................................................................ 5 
1.1.3 Magnesium as biomedical implant ............................................................................................ 7 
1.1.4 Cells and tissue response against magnesium ......................................................................... 8 
1.1.5 Major hindrances for clinical applications of magnesium .......................................................... 8 
1.2 IMPLANT-ASSOCIATED INFECTIONS ................................................................................................. 10 
1.2.1 Characteristics of bacteria within a biofilm matrix ................................................................... 12 
1.2.2 Biofilm formation by major pathogens involved in implant-related infections ......................... 13 
1.2.3 Strategies to combat biomaterial associated infections .......................................................... 15 
1.2.4 Different animal models for biofilm formation .......................................................................... 16 
1.3 AIM ............................................................................................................................................... 18 
2 MATERIAL AND METHODS .............................................................................................................. 19 
2.1 MATERIALS ................................................................................................................................... 19 
2.1.1 Implant materials ..................................................................................................................... 19 
2.1.2 Chemicals and antibiotics ....................................................................................................... 20 
2.1.3 Buffers, media and reagents ................................................................................................... 21 
2.1.4 Cell lines .................................................................................................................................. 21 
2.1.5 Bacteria ................................................................................................................................... 22 
2.1.6 Kits .......................................................................................................................................... 22 
2.1.7 Equipment ............................................................................................................................... 23 
2.1.8 Consumables .......................................................................................................................... 25 
2.1.9 Software .................................................................................................................................. 26 
2.1.10 Animals ................................................................................................................................ 26 
2.2 METHODS ..................................................................................................................................... 26 
2.2.1 In vitro and in vivo characterization of implant materials (Part A) ........................................... 26 
2.2.1.1 Sterilization .................................................................................................................................... 26 
2.2.1.2 Properties and dimensions of tested implant materials ................................................................. 27 
2.2.1.3 Corrosion media and in vitro incubation conditions ....................................................................... 27 
2.2.1.4 Determination of in vitro corrosion ................................................................................................. 28 
2.2.1.5 Biomechanical pull out tests .......................................................................................................... 29 
2.2.1.6 Phosphate coating procedure ........................................................................................................ 30 
2.2.1.7 Fluoride coating on magnesium ..................................................................................................... 30 
2.2.1.8 In vitro cell culture assays and conditions ..................................................................................... 31 
2.2.2 Implantation procedure in small animal model ........................................................................ 31 
2.2.2.1 Animal permission ......................................................................................................................... 31 
2.2.2.2 Animal housing .............................................................................................................................. 31 
2.2.2.3 Surgical process for implantation ................................................................................................... 32 
2.2.2.4 Measurement of hydrogen gas around subcutaneously implanted discs ...................................... 32 
2.2.2.5 Histology of tissue surrounding implants ....................................................................................... 33 
2.2.2.6 Energy Dispersive X-ray (EDX) spectroscopy ............................................................................... 33 
2.2.2.7 X-ray diffraction analysis of implant materials................................................................................ 33 
2.2.2.8 Scanning electron microscopy (SEM) ............................................................................................ 34 
 
 
 
 
2.2.3 Implant associated-infections (Part B) .................................................................................... 34 
2.2.3.1 Bacterial strains and their cultivation ............................................................................................. 34 
2.2.3.2 Initial inoculum to infect implant surfaces ...................................................................................... 34 
2.2.3.3 Determination of minimum bacterial inoculum capable of biofilm formation .................................. 35 
2.2.3.4 Non-invasive in vivo imaging of biofilm on implant surfaces .......................................................... 35 
2.2.3.5 Bioluminescent imaging of E. coli on implant surfaces .................................................................. 35 
2.2.3.6 Bioluminescent imaging of Salmonella on implant surfaces .......................................................... 36 
2.2.3.7 In vivo infection pattern by planktonic and biofilm cultures of P. aeruginosa ................................. 36 
2.2.3.8 Time-dependent antibiotic administration against P. aeruginosa biofilms ..................................... 36 
2.2.3.9 Dose-dependent antibiotic administration against P. aeruginosa biofilms ..................................... 36 
2.2.3.10 RNA isolation from in vitro cultures of P. aeruginosa ..................................................................... 37 
2.2.3.11 Electron microscopy of biofilm ....................................................................................................... 37 
2.2.3.12 Histology of biofilm ........................................................................................................................ 38 
2.2.3.13 In vivo imaging of IFN-beta response against biofilm .................................................................... 38 
2.2.3.14 Colony forming unit (CFU) of P. aeruginosa in biofilm and different organs .................................. 39 
2.2.3.15 RNA extraction from in vivo grown P. aeruginosa biofilm .............................................................. 39 
2.2.3.16 RNA clean up using DNase digestion kit ....................................................................................... 40 
2.2.3.17 Agarose gel electrophoresis .......................................................................................................... 40 
2.2.3.18 RNA sequencing ............................................................................................................................ 40 
2.2.3.19 General composition of media used .............................................................................................. 41 
3 RESULTS ............................................................................................................................................ 42 
3.1 CHARACTERIZATION OF IMPLANT MATERIALS (PART A) .................................................................... 42 
3.1.1 Effect of corrosion media on the weight of magnesium samples ............................................ 42 
3.1.2 Effect of magnesium degradation on local pH of corrosion media ......................................... 43 
3.1.3 Measurement of hydrogen generation .................................................................................... 45 
3.1.4 Surface properties of magnesium implants ............................................................................. 46 
3.1.5 In vivo implantation of wires in mouse model ......................................................................... 46 
3.1.6 In vivo compatibility of magnesium pins with the adjacent tissue ........................................... 47 
3.2 INTERLOCKING STRENGTH BETWEEN MAGNESIUM AND TIBIA BONES .................................................. 49 
3.2.1 Determination of interlocking force between magnesium and tibia bones ............................. 49 
3.2.2 Surface morphology of corrosion layers on magnesium ......................................................... 50 
3.2.3 Surface analysis of pulled out wires from tibia bones ............................................................. 51 
3.3 A PROTECTIVE COATING FOR MAGNESIUM TO LIMIT FAST DEGRADATION AND HYDROGEN GENERATION 53 
3.3.1 The selection of suitable phosphate solution as coating medium ........................................... 53 
3.3.2 Performance of phosphate coated implants in cell culture medium ....................................... 54 
3.3.3 Determination of appropriate time required for KH2PO4 coatings ........................................... 56 
3.3.4 Detailed analysis of KH2PO4 coated magnesium discs .......................................................... 57 
3.3.5 In vitro immersion tests for phosphate treated magnesium implants ...................................... 58 
3.3.6 Elemental composition of coated discs after short and long-term incubation ......................... 59 
3.3.7 Degradation kinetics of KH2PO4 treated magnesium in plasma and r-SBF ............................ 61 
3.3.8 Compatibility of phosphate coatings with mammalian cells .................................................... 63 
3.3.9 Cell viability and interleukin 8 (IL-8) response ........................................................................ 64 
3.3.10 Observation of gas cavities around subcutaneously implanted magnesium discs ............. 66 
3.3.11 Surface properties of discs after implantation ..................................................................... 68 
3.3.12 In vivo corrosion rate determined by weight loss ................................................................ 69 
3.3.13 Modest inflammatory response against implanted discs .................................................... 70 
3.4 MOUSE MODEL TO UNDERSTAND IMPLANT-ASSOCIATED INFECTIONS (PART B) .................................. 72 
3.4.1 Prolonged survival of P. aeruginosa on magnesium implants ................................................ 72 
3.4.2 Estimation of P. aeruginosa numbers required for infection ................................................... 76 
3.4.3 Characterization of persistent bacterial infections .................................................................. 77 
 
 
 
 
3.4.3.1 P. aeruginosa exhibit strong antibiotic resistance .......................................................................... 77 
3.4.3.2 Effect of system antibiotics on established P. aeruginosa biofilms ................................................ 81 
3.4.3.3 Biofilm-like morphology of P. aeruginosa on implants ................................................................... 83 
3.4.3.4 P. aeruginosa biofilms show strong inflammatory reaction ............................................................ 86 
3.4.3.5 P. aeruginosa biofilm matrix composed of exoplysacharide and protein ....................................... 87 
3.4.3.6 Immunohistology of P. aeruginosa biofilms ................................................................................... 88 
3.4.3.7 P. aeruginosa infections induce prolonged interferon production .................................................. 89 
3.4.3.8 Bacterial RNA isolation from in vivo grown biofilms ....................................................................... 90 
3.4.3.9 P. aeruginosa biofilms induce splenomegaly in mice .................................................................... 91 
3.4.4 P. aeruginosa remain mainly localized within the biofilm ........................................................ 92 
3.4.5 Contribution of magnesium corrosion products to prolonged infections ................................. 94 
3.4.6 Role of tissue-air interface in biofilm formation ....................................................................... 95 
3.4.7 Role of quorum sensing in persistent bacterial infection......................................................... 97 
3.4.8 Role of gas cavity formation and antibiotic treatments in prolonged infection ........................ 99 
3.4.9 Gram-positive Staphylococcus aureus can establish prolonged infections on Mg implants 101 
3.4.9.1 Characterization of S. aureus biofilms ......................................................................................... 102 
3.4.10 Prolonged survival of Salmonella on various implant surfaces ......................................... 103 
3.4.11 Infection by E. coli on implant surfaces ............................................................................. 104 
4 DISCUSSION .................................................................................................................................... 105 
4.1 ESTABLISHMENT OF IN VITRO CORROSION CONDITIONS TO UNDERSTAND IN VIVO MG   DEGRADATION 105 
4.2 INTERLOCKING BETWEEN CORRODING MAGNESIUM IMPLANTS AND SURROUNDING BONE IN VITRO..... 107 
4.3 CHARACTERIZATION OF SURFACE COATINGS TO PREVENT FAST DEGRADATION OFMAGNESIUM ......... 109 
4.4 ESTABLISHMENT OF PERSISTENT INFECTIONS AROUND METALLIC MAGNESIUM IMPLANTS ................. 111 
4.4.1 Characterization of prolonged infections on magnesium implants ....................................... 113 
4.4.2 Magnesium corrosion products responsible for prolonged implant infections ...................... 114 
4.5 PROPOSED MOUSE MODEL TO UNDERSTAND BIOFILM FORMATION ON IMPLANT SURFACES................ 115 
5 CONCLUSION .................................................................................................................................. 117 
6 OUTLOOK ........................................................................................................................................ 118 
7 REFERENCES .................................................................................................................................. 119 
8 APPENDIX ........................................................................................................................................ 135 
8.1 LIST OF ABBREVIATIONS ............................................................................................................... 135 
8.2 LIST OF FIGURES ......................................................................................................................... 139 
8.3 LIST OF TABLES ........................................................................................................................... 141 
ACKNOWLEDGEMENT ........................................................................................................................... 142 
Abstract/Zusammenfassung 
 
1 
 
Abstract 
Recently, magnesium based implants have gained increasing interest due to their 
degradability, biocompatibility and antibacterial properties. However, their clinical 
application is restricted due to unpredictable corrosion and the formation of gas cavities at 
the implantation site. The present study was aimed to identify efficiencies of magnesium as 
implant material and to find novel strategies to promote clinical applications. To identify 
relevant parameters and suitable degradation conditions, magnesium implants were 
incubated under various biological conditions. Magnesium is known to promote bone 
healing. We found that degradable magnesium interlocked with the bone in vitro in the 
absence of any cellular activity suggesting that at least in part this may be a purely physico-
chemical process rather than a biological phenomenon. Further, a novel biomimetic 
degradable magnesium implant coating was established which substantially diminished 
the corrosion and eliminated the formation of gas cavities at the site of implantation. This 
coating was biocompatible with murine fibroblasts and with soft tissue in animals. 
Magnesium is reported antibacterial in vitro; however the underlying mechanism has not 
been defined. Therefore, antibacterial properties of magnesium were investigated and it 
was found that alkalization was solely responsible for antimicrobial effects. To investigate 
these antibacterial properties in vivo, magnesium implants were infected with 
bioluminescent strains of P. aeruginosa and S. aureus in mice. Contrary to the in vitro 
situation, magnesium implants were susceptible to bacterial adherence and led to the 
prolonged survival of bacteria. Such infections were highly resistant to high doses of 
antibiotics and to the host immune system. This is indicative of bacterial biofilm formation. 
Electron microscopy and biofilm specific staining clearly revealed the formation of 
exopolysaccharide matrix around bacteria which is typical for biofilms. Causal factors for 
prolonged bacteria survival appeared to be magnesium corrosion products. Hence, 
precautions must be taken before its future clinical applications however magnesium could 
be used as model to study implant-associated infections in vivo. 
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Zusammenfassung 
Implantate auf Magnesiumbasis stoßen auf zunehmendes Interesse aufgrund ihrer 
Abbauarbeit, Biokompatibilität und antibakterielle Eigenschaften. Jedoch ist eine breite 
klinische Anwendung noch nicht möglich wegen unvorhersehbaren Korrosionseffekten 
und durch die Bildung von gasgefüllten Gewebehohlräumen an der Implantationsstelle. Die 
vorliegende Studie wurde durchgeführt um neue Strategien zu finden, welche die klinische 
Anwendung ermöglichen sollen. Um relevante Testparameter zu eruieren, wurden 
verschiedene Modelle untersucht. Magnesium ist zum Beispiel dafür bekannt, die 
Knochenheilung zu fördern. Wir fanden, dass solche Magnesiuminteraktionen mit dem 
Knochen auch in Abwesenheit von Zellen stattfinden, was darauf hindeutet, dass diese 
Interaktionen zumindest teilweise ein rein physikalisch-chemisches Phänomen sind. 
Außerdem wurde eine neuartige biomimetische und abbaubare Magnesiumbeschichtung 
gefunden, welche die anfängliche Korrosion beträchtlich verringert und die Bildung von 
Gashohlräumen im Gewebe eliminiert. Diese Beschichtung war biokompatibel mit murinen 
Fibroblastenkulturen und auch mit Weichgewebe in vivo. Weiter hat Magnesium 
antibakterielle Eigenschaften in vitro; wobei der zugrunde liegende Mechanismus bisher 
nicht bekannt war. Daher wurden antibakteriellen Eigenschaften von Magnesium 
untersucht und es wurde festgestellt, dass die Alkalisierung durch die Korrosion für 
sämtliche antimikrobiellen Wirkungen verantwortlich war. Um diese antibakteriellen 
Eigenschaften auch in vivo zu untersuchen, wurden Magnesiumimplantate in Mäusen 
infiziert mit lumineszent markierten P. aeruginosa und S. aureus Bakterien. Im Gegensatz 
zu den in vitro Resultaten waren Magnesiumimplantate anfällig für bakterielle Infektionen. 
Diese waren sehr widerstandsfähig gegenüber hohen Antibiotikadosen und auch 
gegenüber dem Immunsystem. Dies ist charakteristisch für bakterielle Biofilme. 
Elektronenmikroskopie und histologische Nachweismethoden zeigten die Bildung einer 
Exopolysaccharidmatrix, die für Biofilme typisch ist. Verantwortlich für das Überleben der 
Bakterien schienen Korrosionsprodukte zu sein. Daher müssen Vorsichtsmaßnahmen 
getroffen werden bevor Magnesiumimplantate für zukünftige klinische Anwendungen in 
Frage kommen. Andererseits könnten Magnesiumimplantate als Modell für die Erforschung 
von implantatassoziierten Infektionen dienen.  
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1 Introduction 
1.1 Implant materials and their importance in medical science 
An implant material is any foreign material that interacts with tissue and is primarily 
intended to substitute or restore the function of defect biological structure. These materials 
are helpful for millions of people worldwide after accidents or after suffering from chronic 
diseases [1-3]. Medical implants are then surgically inserted to restore the function or 
completely replace a missing body part [4]. These devices are artificially manufactured 
from biocompatible materials like stainless steel, chromium-cobalt alloys, titanium alloys, 
ceramic materials or polymeric materials [5-7]. For example, surgical sutures, needles, 
catheters, tooth fillings and bone plates are most frequently used [8,9]. Besides, 
biomaterials can also be made from proteins such as, glycoproteins, proteoglycans, elastin, 
fibrillin and extracellular matrix (ECM) [4,10]. Artificial tissue cages have been constructed 
from proteins to support cell growth and differentiation [11,12].  Medical implants 
encompass a vast variety of applications; hard or soft tissue repair or replacement, tissue 
regeneration and biomedical coatings [13,14]. Advances in the field of material science 
have led to the development of complete artificial organs such as heart, kidney and lung 
[15,16]. A total artificial heart can replace the functions of a normal human heart without 
inducing harmful effects [17]. Similarly, artificial lungs can support over 200 million people 
suffering with lung diseases [18]. The establishment and optimization of artificial organs is 
a new era in the field of health care. In most of clinical situations, hard tissue repair 
necessitates medical implants of high strength and stiffness. Metallic implants are 
preferably used due to their superior mechanical properties (strength and hardness) 
[19,20]. A complication with permanent implants is the requirement of revision surgery for 
their removal when the organs are restored [21]. This implant removal is considered 
invasive, particularly for old people [22]. However, biodegradable materials could 
overcome this unwanted surgery [23-25]. Biodegradable polymeric implants lack basic 
strength and stiffness therefore they cannot support hard tissue. This disadvantage shifted 
the main attention towards the degradable metals. Recently, degradable metallic implants 
have been introduced which have high stability and strength. Screws and pins made from 
degradable metals were already clinically used for internal bone fixation or tubular cages 
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used as coronary stents [26]. Iron as well as iron alloys have been proposed as degradable 
metallic implant material [27-29]. Still, corrosion particles released as a result of iron 
degradation may induce tissue irritations [27]. As an alternative, magnesium-based alloys 
have recently gained increasing attention as degradable metallic implants. They possess 
sufficient strength to support hard tissue. Magnesium-based medical devices have already 
demonstrated promising potential to support tissue functionalities in animal models and in 
human beings as well.  
1.1.1 Magnesium as a potential biodegradable material 
Magnesium degrades gradually inside the body and therefore can support the tissue for a 
time sufficient for the completion of healing process. After its exposure to physiological 
fluids, following chemical reaction takes place [30,31]. 
   Anodic reaction:       Mg →Mg2++2e-  
Cathodic reaction:  2H2O+2e-→H2+2OH- 
                                                             Mg2++2OH-→  Mg(OH)2 
As a degradable implant, corrosion products of magnesium are usually acceptable for host 
and non-allergic to surrounding tissue. Magnesium ions (Mg2+) released as degradation 
product are excreted out of the body without inducing any harmful effects. Hydrogen 
produced during the reaction leads to the formation of small cavities in the surrounding 
tissue and no toxic effects from it have been reported so far. Magnesium corrosion is 
complicated phenomenon and it varies with the composition of the surrounding medium. 
Generally, it is fast in the presence of physiological solutions with low pH or high chloride 
concentration [32]. On the other hand, magnesium corrosion is slow in the presence of 
biological solutions in the presence of proteins and in vivo [33,34].  Interestingly, 
magnesium degradation triggers the precipitation of a corrosion layer on its surface which 
attracts the deposition of different elements from the surrounding environment [35,36]. 
With the establishment of this layer, the degradation process of magnesium also 
decelerates [37]. Many studies have shown that the corrosion layer is composed of the 
elements magnesium (Mg), oxygen (O), carbon (C), phosphorus (P), calcium (Ca) and traces 
of nitrogen (N) and sodium (Na) [38,39]. Calcium and phosphorus accumulating on the 
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surface of magnesium might be contributing to potentiate the process of new bone 
formation.  
1.1.2 Magnesium (Mg2+) as essential element for life  
Mg2+ is essential for all living organisms. A human body of approximately 70 kg contains 
normally 24 g of magnesium which is equal to 1 mole. It is 4th most abundant cation of 
human body and the 2nd  most abundant intracellular cation [40]. Normal plasma contains 
0.7-1.1 mmol/l of magnesium, approximately 45% of which is protein-bound [41]. Mg2+ is 
involved in numerous biological activities. It serves as co-factor for ATP and many 
metabolic enzymes, co-regulator of protein synthesis and plays an important role in the 
stabilization of RNA and DNA structures [42]. Magnesium plays critical role in human 
metabolism and a slight variation in its normal blood concentration may lead to 
hypotension, muscular paralysis and respiratory distress [43]. Shortage of magnesium can 
lead to the incomplete formation of pigmented layer of eye [44]. Generally, during 
hypomagnesaemia (lack of magnesium in body), reserves of magnesium already stored 
inside bones are released in general circulation to compensate this deficiency. In case if 
magnesium level exceeds than its normal limits, excess amount is efficiently secreted out of 
the body without inducing any harmful effects on kidneys [45]. In addition, Mg2+ plays a 
critical role in the regulation of different intracellular pathways and in the activation of cell 
surface receptors mainly involved in human immune system. Mg2+ is also essentially 
required for activation and proliferation of blood lymphocytes in combination with Ca2+ 
[46,47]. Recently, Mg2+ has been reported to serve as second messenger during the 
pathways required for the activation of human T-lymphocytes [48]. Mg2+ was found to 
interact with magnesium transporter gene MAGT1 during T-cell activation and stimulation 
of epithelial cells. Therefore, disruption in the normal supply of Mg2+ within cells resulted 
into the CD4 lymhopenia, induction of severe viral infection and defective T-lymphocytes 
activation (Figure 1) [48]. Mg+2 have been reported to play an active role in the functioning 
of Reactive oxygen species (ROS). ROS are important signaling molecules produced inside 
live tissues and play important role in pathogen defense and programmed cell death 
[49,50]. Hence, imbalance between extracellular and intracellular Mg2+ levels can 
significantly influence ROS and indirectly to human or animals defense system against 
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pathogens [51]. In addition, magnesium is critically required for embryonic development in 
pregnant females [52,53]. A study in mice was conducted and it was found that the 
deficiency of magnesium during pregnancy resulted into growth retardation, abnormal fat 
metabolism, insulin resistance and diabetes in new born [54,55].  
 
Figure 1: Distribution of magnesium in adult human body [56]. 
Table 1. Importance of magnesium (Mg2+) in human body. Magnesium (Mg2+) is 
actively involved in numerous activities of human body. Modified from [57].  
Activities                                                      Examples 
Structural functions                                     Mitochondria  
                                                                        Proteins 
                                                                        Polyribosomes 
                            Nucleic acids 
                            Multiple enzyme complexes 
 
Membrane functions                   Cell adhesion 
                 Transmembrane electrolyte flux 
Enzyme function                                             Enzyme Substrate (ATP-Mg, GTP-Mg) 
      Kinases B 
           Hexokinases 
                      Creatine Kinase 
                      Protein Kinase 
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                                                                         ATPases or GTPases 
           Na+/K+-ATPase 
           Ca2+-ATPase 
                      Cyclases 
           Adenylate cyclase 
           Guanylate cyclase 
      Direct enzyme activation 
      Phosphofructokinase 
      Adenylate cyclase 
      Na+/K+-ATPase 
                                                                             
Calcium antagonist               Muscle contraction/relaxation 
                            Neurotransmitter release 
                 Action potential conduction in nodal tissue 
 
ATP, adenosine triphosphate; GTP, guanosine triphosphate; K, potassium; Mg, magnesium; 
Na, sodium; Ca, calcium. 
1.1.3 Magnesium as biomedical implant 
Magnesium has density 1.74 g/cm3 and is the lightest of all commonly used metals. It is, 
therefore, implantable without putting much stress on the surrounding tissue [58]. For 
orthopedic applications, it has sufficient fracture toughness and its compressive yield 
strength as well as elastic modulus and Young’s modulus values are close to natural bone 
[59,60]. After its application in the bone tissue in animal models, magnesium demonstrated 
excellent interaction with surrounding bone and stimulated the formation of new bone 
[37]. This means that magnesium would be the most appropriate candidate for repair of 
bone tissue as it could accelerate the process of new bone formation [37]. Hence, 
magnesium is a unique degradable metallic implant which can stimulate bone repair of 
fractured bones. Medical implants are always under the risk of being contaminated by 
resistant bacterial communities called biofilm [61]. Magnesium has demonstrated potential 
antibacterial properties in vitro against Pseudomonas aeruginosa, Staphylococcus aureus 
and Escherichia coli [62]. With inherent antibacterial properties, magnesium could 
overcome problems associated with device-related infections. Additional properties of 
magnesium are discussed further in detail below. 
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1.1.4 Cells and tissue response against magnesium 
Implant materials act as “foreign body” for host tissue thus activating the immune system 
and recruiting host inflammatory cells [63]. If host immune reactions against implanted 
material are excessive, the material is not appropriate and it can have severe adverse 
effects on patient health [64]. Therefore, compatibility of biomaterial with host tissue is a 
fundamental requirement. A biocompatible implant material should be tissue friendly 
without provoking adverse effects like allergy and inflammation. Primarily, implant 
material candidates are first tested in vitro with different human or animal cell lines 
[65,66]. To this end, direct as well as indirect in vitro cell compatibility tests were 
conducted with magnesium as well as magnesium based alloys by using murine fibroblasts 
(NIH3T3 and L-929), osteoblasts (MC3T3-E1 and MG63) and blood vessels related cells 
(ECV304 and VSMC) and no cytotoxicity or reduced cells viability could be observed 
[67,68,65,69]. Fibroblasts were mainly employed because they are fundamental cells to 
establish tissue capsule around implants and remain in direct contact with implanted 
materials [70]. After exhibiting good compatibility with the individual cells, magnesium 
based implants have been evaluated in vivo in different animal models and were found 
compatible with the adjacent soft or hard tissues [37,71-73]. A comprehensive gene 
expression analysis of the tissue adjacent to magnesium after four weeks of implantation 
was also performed. It was found that gene expression pattern of the tissue surrounding 
magnesium was similar to standard materials titanium and polyglactin [74]. After showing 
promising compatibility with individual cells and animals, small screws made from 
magnesium were implanted into human being where they exhibited good compatibility and 
stability with the surrounding bone tissue without showing harmful effects on different 
body organs [73]. From this, it becomes quite evident that magnesium based implants 
show a promising compatibility with cells, in animals and in human tissue during 
preliminary clinical trials. Therefore, magnesium based implants can be proposed for 
clinical applications.  
1.1.5 Major hindrances for clinical applications of magnesium  
Despite having such advantageous properties, medical devices manufactured from 
magnesium have not been applied clinically so far due to certain limitations. Sometimes, 
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magnesium exhibits rapid degradation behavior in certain environments [75,76].  This may 
lead to pitting corrosion, cracks and cavities [77].  Associated with fast magnesium 
degradation is the production of hydrogen gas [78]. This gas release leads to the creation of 
gas cavities at implantation site (Figure 2) [79]. Although such gas bubbles have not been 
reported to pose toxic effects they may disrupt the contact between tissue and implant 
[80]. A strong tissue-implant interaction is necessary for fibrous tissue formation during 
the healing process and tissue repair that may be affected with such gas pouches. These gas 
cavities can also disturb the blood supply at the site of implantation thereby delaying 
healing process [81].  In some situations, gas cavities may result into cyst formation and 
tissue necrosis [82,83]. As alloy, magnesium is mixed with other metals and magnesium-
based alloys are synthesized to overcome shortcomings [84,85]. However, some of the 
alloying elements have been found cytotoxic and must be avoided [86]. Biomedical surface 
coatings are another strategy to solve the problem of fast degradation [87,35]. Surface 
coatings are degradable and are replaced by a natural corrosion layer from the degradation 
of magnesium. 
 
Figure 2: Corroding magnesium implants lead to the formation of gas cavities. Schematic diagram 
showing different stages after implantation of magnesium implants. A: Magnesium implant inserted in 
fractured radius bone. B: After sometime, magnesium starts to degrade into its corrosion products: hydroxide 
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ion (OH-), hydrogen gas (H2), magnesium ions (Mg2+) and precipitation of magnesium hydroxide Mg(OH)2 
layer starts around magnesium. C: Hydrogen gas (H2) starts to accumulate at the site of implantation leading 
to formation of gas bubbles.    
1.2 Implant-associated infections 
Bacteria thrive on medical implants [88-90]. Generally, surgical procedures for 
implantation are not completely sterile thus provide initial routes of entry for pathogens  
known as perioperative contamination [91]. Even if this implant insertion process is 
strictly hygienic, patients bearing fresh implants are inevitably hospitalized for short or 
long periods of time to support wound healing which is another threat for bacterial entry 
known as postoperative contamination or nosocomial infections [92]. Medical implants 
provide sites for initial microbial adherence [93]. Generally implant materials with rough 
surfaces augment bacterial adherence and therefore are more prone to infections [94]. 
Local immune system responses in the tissue adjacent to implant materials are also weak, 
such immune compromised zones provide an opportunity for bacterial colonization [95-
97]. After in vivo implantation, medical device surfaces become a place of competition 
between host cells and bacteria. This competition has been phrased as “race for the 
surface” meaning that tissue cells and bacteria  are in competition to make and initial 
attachment with implant surfaces [92]. Bacteria then undergo different stages to finally 
establish biofilms on the surface of medical implants. Biofilm is a structured consortium of 
surface attached bacteria surrounded by self-produced extracellular polymeric matrix [98]. 
Structurally, biofilms are constituted from well regulated release and amalgamation of 
polysaccharides, proteins, nucleic acids, lipids and DNA [99,100]. Diversity exists in the 
mechanisms of biofilm formation between different pathogens which varies from surface to 
surface. Generally biofilm formation can be divided into three different phases (A) Initial 
surface attachment (B) Proliferation and development of mature biofilm (C) Biofilm 
dispersal or detachment (Figure 3)[101]. Even though, under in vivo situations, molecular 
mechanisms involved in process of biofilm formation have not been well characterized and 
therefore little is known about them [102,103]. It has been reported that a conditioning 
film starts to develop on the surface of medical device after its exposure to body. This film 
facilitates subsequent bacterial adherence and is composed from different components 
from surrounding body fluids such as saliva, urine, blood and proteins such as fibrinogen, 
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collagen and fibronectin [104]. In addition, certain bacterial surface structures such as pili, 
fimbria and flagella help bacteria in the initial adherence and subsequent formation of 
micro colonies. Successful bacterial attachment is itself a shift into the second stage of 
biofilm maturation. During this stage, bacteria secrete certain proteins, exopolysaccharides, 
eDNA (extracellular DNA) and some other polymers and these components enable the 
formation of a multilayered extracellular matrix which provides protection from host 
defense [105]. Bacteria have cell-cell communication systems through diffusible chemical 
signaling molecules known as quorum sensing (QS) which plays an important role in 
biofilm maturation [106,107]. With the passage of time, nutrients deplete and waste 
products accumulate within biofilms. Therefore, bacteria trigger the release of certain 
factors such as D-amino acids leading towards biofilm disassembly so that they switch to 
the planktonic phase and may establish fresh biofilms at new sites [108]. This means that 
biofilms can have a finite life span depending on the availability of nutrients.  
 
Figure 3: Schematic diagram demonstrating the process of biofilm formation on implant surfaces. 
Initially bacteria in their planktonic phase adhere on implant surfaces and start to make micro colonies. 
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Therewith, bacteria release certain quorum sensing molecules to attract other bacteria and side-by-side 
bacteria release mucous substances mainly composed from different proteins, sugar polymers and DNA 
which collectively lead to the formation of rigid Exopolysaccharide (EPS) matrix or mature biofilm. Within 
their respective biofilm matrix, bacteria show extremely low metabolic activities and therefore demonstrate 
resistance against antibiotics and host immune system. Due to nutrient depletion, bacteria release certain 
factors which lead to the biofilm disruption. Bacteria are then released from this self-produced matrix and 
switch back to their planktonic phase whereby they disperse to new appropriate surfaces to establish fresh 
biofilms.  
 
1.2.1 Characteristics of bacteria within a biofilm matrix 
Biofilm formation is a complex process. When bacteria transform to this distinct mode of 
living, they activate certain genes. Therefore, biofilm bacteria demonstrate different gene 
expression profiles as compared to their free-living (planktonic) counterparts. This is 
associated with phenotypic changes and therefore bacteria show different morphologies 
within both modes [109]. Bacteria in biofilms demonstrate strong resistance against 
conventional antibiotics and different antimicrobial agents (Figure 4) [90]. There are 
different factors responsible for the antibiotic resistance of biofilm bacteria. First, bacteria 
within biofilms are surrounded by a exopolymeric matrix structures which serve as 
diffusion barrier against antibiotics [110]. Second, growth rates, respiration rates and 
metabolic activities of biofilm bacteria are low and most antibiotics can only effectively 
target bacteria if they are actively growing. Third, higher cell densities and over-
expression of protective molecules by bacteria within biofilms have been identified as 
important reason for antibiotic resistance [111]. Another serious concern of biofilms is 
their strong resistance against the host defense system. For this, bacteria release certain 
extracellular factors such as proteases, toxins and lipases that hinder the normal functions 
of immune cells (such as phagocytes, NK cells, T cells), inactivate certain cytokines (IL-
1,IL-2), cause disruption of immunoglobulins and also inactivate the complement system 
[112]. Therefore, biofilms on biomedical implants are extremely difficult to eradicate. Such 
implant failures can result in severe implications for patient health and treatment costs 
[113].  
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Figure 4: Biofilm resistance against host immune system and antibiotics. A: Planktonic bacterial cells are 
susceptible to conventional antibiotics and host defense system. B: bacteria attach with the surface of implant 
material and make biofilm which leads to the recruitment of antibodies, antibiotics and phagocytes. C: 
antibiotics, antibodies cannot penetrate inside biofilm matrix and phagocytes cannot engulf them. D: Inability 
of phagocytes to engulf biofilms leads to the massive release of phagocytic enzymes which may harm cells 
and tissue near implant surface.    
1.2.2 Biofilm formation by major pathogens involved in implant-related infections 
Staphylococcus aureus and Pseudomonas aeruginosa are major pathogens responsible for 
biomaterial-associated infections [114]. Normally, Staphylococcus aureus manage to infect 
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medical implant surfaces during surgical procedures or from transitory bacteremia. After 
attachment S. aureus proliferate and finally develop resistant biofilms on implant surfaces. 
Biofilm formation by S. aureus on medical implants can be divided into different stages; (1) 
primary bacterial attachment on implant surface (2) further proliferation to establish 
multiple layers and convert into micro colonies (3) finally, secretion of extracellular matrix 
and subsequent development of mature biofilm around bacteria (4) biofilm disassembly 
and conversion of bacteria into planktonic cultures. During the first stage of biofilm 
formation, S. aureus come into contact with abiotic implant surfaces and it is assumed that 
electrostatic and hydrophobic forces between material surfaces and bacteria accomplish 
the initial attachment. In addition, to augment stable attachment bacteria release specific 
proteins like autolysin and adhesins [91,92]. In the second stage, bacteria multiply and 
form micro colonies [84,115]. In the third stage, bacteria extend cell-cell adhesion by 
secreting polysaccharide intercellular adhesion (PIA) molecules and progressively move to 
subsequent biofilm formation on colonized surfaces [102]. This is most critical stage during 
which biofilm maturation and its persistence by S. aureus is regulated by a coordinated 
release of specific proteins such as Bap (Biofilm associated proteins), Aap (accumulation 
associated protein), FnBPs (fibronectin-binding proteins). S. aureus become completely 
encased within extracellular polymeric matrix which is constituted by exopolysaccharide, 
protein and extracellular DNA (eDNA)[103]. S. aureus also activate cell-cell communication 
system called quorum sensing (QS) which is encoded by agr (accessory gene regulator) 
locus and plays an important role in biofilm formation [94,104,116,101]. Biofilms in the 
maturation phase cannot last longer due to nutrient depletion and therefore enter into 
detachment phase. Auto inducing peptide (AIP) is released which trigger biofilm 
disassembly phase. With this, expression of RNAIII and production of extracellular 
proteases and phenol- soluble modulins is considerably increased which cause the lysis of 
biofilm [105]. agr (accessary gene regulator) mediated quorum-sensing system is also 
reactivated during dispersal stage and triggers biofilm detachment [117]. After biofilm 
disruption bacteria switch again to their planktonic phase and search for new surfaces to 
establish fresh biofilms. 
 Pseudomonas aeruginosa is an opportunistic pathogen and is the leading cause of 
morbidity and mortality in cystic fibrosis patients. Most commonly this pathogen colonizes 
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the lungs and air ways of patients and establishes mucoid biofilms [108]. In addition these 
bacteria can colonize on non-living surfaces like medical implants and can establish 
resistant biofilms [109].  Biofilm formation by Pseudomonas aeruginosa on medical 
implants involves three stages and is similar to S. aureus. In addition to proteins and 
exopolysaccharides, extracellular DNA (eDNA) is major constituent of the P. aeruginosa 
biofilm matrix [118]. Flagella and type IV pili facilitate the process of initial attachment 
[106,107]. Then, bacteria start to form micro-colonies. Attachment is a stimulus for the 
activation of genes such as algC, algD and algU::lacZ [110,111]. These genes are involved in 
the synthesis of extracellular matrix which is required for the formation of mature biofilms. 
In the next step, these surface attached micro colonies differentiate into a more complex 
architecture to form mature biofilms. During differentiation P. aeruginosa also activate the 
quorum sensing (QS) system and release signal molecules known as auto inducers (AI). The 
role of these AI in biofilm maturation has been evidenced after their isolation from infected 
catheters [112]. Usually, production and activation of AI is known to directly correlate with 
cell density. P. aeruginosa uses two well-known QS systems, las and rhl [119]. Both of these 
systems coordinate virulence gene products and are mandatory for biofilm maturation 
[120]. las and rhl mutant P. aeruginosa strains made thin biofilms which were lacking major 
biofilm components [119]. After sometime, bacteria start to detach and disperse to convert 
themselves into planktonic cells. The detachment process in P. aeruginosa is triggered by a 
self-produced process of local hydrolysis which digests extracellular polysaccharide matrix 
and converts sessile communities of bacteria into motile free living cells. A phenomenon of 
physical detachment was observed by which small biofilm micro colonies are disconnected 
from surfaces and carried by fluid to new places [121]. P. aeruginosa also activate 
anaerobic metabolism leading the production of nitric oxide (NO) which is involved in 
biofilm dispersal [122].    
1.2.3 Strategies to combat biomaterial associated infections 
Biofilms on implants can become life threatening. It is difficult to eradicate biofilms using 
conventional antibiotics or anti-biofilm compounds. The only effective treatment is 
revision surgery and prolonged antibiotic administration. Surgical procedures along with 
post-operative medication expenditures inflict serious consequences on patient health and 
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economy. Estimated medical expenses on the treatment of such infections are more than 3 
billion dollars in USA alone [123]. Recently two important strategies have evolved (1) 
Establishment of antibacterial coatings on medical implants (2) antimicrobial and 
microbial adhesion resistant implant surfaces [124]. Controlled release of antibiotics 
directly from medical implants surfaces seems to be a suitable strategy to improve the 
efficacy of drugs against biofilms. Local drug delivery at the site of implantation has certain 
advantages. It allows the application of selected antibiotics against targeted pathogens. 
High drug concentration at the implantation site avoids the problem of systemic toxicity. 
Antibiotics such as amoxicillin, vancomycin, tobramycin, cefamendol, cephalothin, and 
gentamycin were coated on the surfaces of polymers which effectively prevented microbial 
adhesion [125,126]. Bacteria can develop resistance against antibiotics. To overcome this 
difficulty, local delivery of alternative antibacterial agents has been applied [127]. Silver 
nanoparticles (AgNPs) are reported as antibacterial and biocompatible agents [128]. 
Medical implants coated with silver nanoparticles do not induce resistance and synergistic 
antibacterial effects of silver and zinc coatings on implant surfaces have been reported 
[129]. Nitric oxide (NO) is reported as potent antibacterial agent and implant coatings with 
promising antibacterial and biofilm dispersal activities [130,131].  As another strategy, 
polymers with anti-adhesive surfaces demonstrate resistance against initial bacterial 
attachment. Due to their intrinsic properties, they facilitate mammalian cell attachment but 
pose significant resistance against bacterial attachment [132]. Similarly, broad-spectrum 
anti-biofilm peptides have been discovered which specifically target cellular stress 
responses and inhibit initial biofilm formation and disrupt existing ones [133]. Interference 
with biofilm formation using targeted molecules can be another strategy. Peptides have 
been discovered that inhibit quorum-sensing [134]. All these strategies established to 
overcome device related infections can significantly enhance the performance of medical 
implants. Still, there is great demand to investigate and establish new assays to protect 
medical implants surfaces from bacterial contamination.  
1.2.4 Different animal models for biofilm formation 
The majority of the molecular tactics used by bacteria to transform into biofilm mode have 
been discovered using in vitro assays. In vitro test systems are conducted in rather simple 
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conditions and therefore it is unpredictable if bacteria use similar strategies in vivo. 
Alternatively, animal models are established to verify in vitro results. Specifically, to 
understand biofilm formation on indwelling devices, different in vivo models representing 
device-related infections have been introduced. Urinary tract infection is the most frequent 
example of biomaterial-associated infections. Therefore, as a first attempt to establish an in 
vivo model, small catheter tubes infected with Staphylococcus epidermidis were 
subcutaneously implanted in mice [135]. In this foreign body mouse model, bacterial 
biofilms were evaluated by abscesses, adhesions, erythema and excessive slime 
productions. Further, intravascular venous catheter (IVC) and totally implantable venous 
access ports (TIVAP) rat models were introduced to study microbial colonization of 
medical implants [136]. For example, using such models the role of polysaccharide 
intercellular adhesion (PIA) and autolysin AtE in S. epidermidis biofilm formation was 
validated in vivo [137]. Later, this central venous catheter (CVC) model was successfully 
adopted and investigated in mice and rabbits [138,139]. After successful use of hollow 
structures to support artificial biofilm formation, stainless steel pins were inserted as 
foreign-body into rabbit tibia to support biofilm formation by S. aureus [140]. This model 
was successfully used to understand osteomyelitis and prosthetic joint infections (PJI) 
[141]. Endotracheal tubes were implanted into sheep, pigs or dogs as biofilm models for P. 
aeruginosa [142,143]. Tissue cages consisting of rigid tubes with holes were 
subcutaneously implanted into mice, rats, hamsters and guinea pigs to serve as foreign 
body biofilm animal models [144]. A vascular catheter animal model has been most 
frequently used for biofilm formation. In this model, vascular catheters were 
subcutaneously implanted into the animals [145]. With the advancement in imaging 
systems, bioluminescent bacterial strains have been used for the investigation of biofilms 
in vivo. It allowed a non-invasive in vivo imaging of biofilm formation [146]. Validation of 
staphylococcal accessory regulator (sarA) and ica in S. aureus in vivo biofilm formation was 
done using this mouse model [147]. Moreover, cardiac valves, vascular grafts, bone cement 
and surgical meshes have also been subcutaneously implanted in animal models as 
artificial devices to support biofilm formation [148-150]. Different animal models have 
significantly helped to understand in vivo biofilms. These models have been used to test 
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anti biofilm properties of different peptides [132]. There is still much to improve for animal 
models which mimic biofilm formation. 
1.3 Aim  
The present study was divided into different parts (Figure 5). Major aims of the this study 
were  
(i) To establish suitable in vitro test systems to identify relevant parameters and 
suitable degradation conditions for metallic magnesium as medical implant 
material. 
(ii) To establish biomechanical test systems to investigate interaction between 
magnesium for its application as orthopedic implant material with murine bones 
(iii) To find novel strategies to overcome major problems associated with clinical 
application of magnesium as an implant material.  
(iv) To identify underlying mechanisms responsible for in vitro antibacterial 
properties of magnesium. 
(v) To establish a mouse model to study biomaterial-associated infections  
(vi) To develop different strategies and animal models to combat biomaterial-
associated infections. 
 
Figure 5: Schematic diagram representing the classification of current study into different projects. 
Magnesium was center of investigation and research during present study. 
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2 Material and Methods 
2.1 Materials 
2.1.1 Implant materials 
Table 2: List of implant materials investigated during present study. 
Implant material and their properties Supplier 
Magnesium discs with 99.99% purity and 
5mm diameter and 2mm thickness 
Institute of Materials Science, Leibniz 
University Hannover, Germany 
Magnesium discs coated with fluoride 
(Shaped in discs with 5mm diameter and 
2mm thickness) 
Institute of Materials Science, Leibniz 
University Hannover, Germany 
Magnesium wires (99.99% pure, 0.4 mm in 
diameter) 
Good fellow Cambridge Ltd., Huntingdon 
Magnesium granulates Riedel-de Haen AG, Seelze, Germany 
Magnesium silver alloy discs with 5mm 
diameter and 2mm thickness) 
Helmholtz-Zentrum Geesthacht, Germany 
Magnesium silver alloy wires (0.4mm in 
diameter) 
Helmholtz-Zentrum Geesthacht, Germany 
Plain titanium discs (Grade5 with 7mm 
diameter and 2mm thickness) 
3di GmbH, Jena, Germany 
Porous titanium discs (7mm diameter and 
2mm thickness) 
Department of Powder Technology, 
Helmholtz Center Geesthacht 
Titanium wires (0.4 mm in diameter) Good fellow Cambridge Ltd., Huntingdon 
Mg,Fe-LDH pellets 
(Mg4Fe2(OH)12/(CO3)·3H2O with M(III) = Fe
3+) 
Fluka, Buchs, Switzerland 
 
Mg,Al-LDH pellets (Mg4Al2(OH)12/(CO3)·4H2O 
with M(III) = Al3+ 
Fluka, Buchs, Switzerland 
Porous glass (4mm beads with 60µm pore 
size)  
Robu, GmbH, Germany 
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Poly L lactic acid (PLLA) (5mm beads) Good fellow Cambridge Ltd., Huntingdon 
Magnesium granulates Non ferrum, GmbH, Austria 
  
2.1.2 Chemicals and antibiotics 
Table 3: List of chemicals and antibiotics used in present work. 
Chemical Supplier 
Potassium di-hydrogen phosphate Carl Roth GmbH, Karlsruhe, Germany 
Potassium mono-hydrogen phosphate Merck, Darmstadt, Germany 
Sodium di-hydrogen phosphate Merck, Darmstadt, Germany 
Magnesium chloride Carl Roth GmbH, Karlsruhe, Germany 
Magnesium hydroxide Fluka Chemie GmbH, Deisenhofen, 
Germany 
Magnesium powder Riedel-de Haen AG, Seelze, Germany 
Sodium hydroxide Sigma Aldrich 
Ciprofloxacin (Powder) (Fluka Chemie GmbH, Deisenhofen, 
Germany) 
Cipro HEXAL Hexal, Germany 
Hydrochloric acid Roth 
Layered double hydroxide micro particles 
(Mg4Al2(OH)12(SO4)2·6H2O) 
Fluka Chemie GmbH, Deisenhofen, 
Germany 
Isofluran Albrecht Gmbh, Germany 
Luciferin Caliper LS 
Bepanthen eyes cream Bayer 
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2.1.3 Buffers, media and reagents 
Table 4: Overview of buffers, media and different reagents used in current study. 
Buffers, media and reagents Supplier 
FCS (fetal calf serum) Gibco/Life Technologies, Darmstadt, Germany 
DMEM (Dulbecco’s modified Eagle’s 
medium)  
Gibco/Life Technologies, Darmstadt, Germany 
CFSE (Fluorescent cell proliferation dye), (5- 
and 6-Carboxyfluorescein diacetate 
succinimidyl ester) 
eBioscience, Inc., San Diego, CA, USA 
Xylidyl blue reagent Magon, Pointe Scientific, Inc. USA 
β-mercaptoethanol Sigma Aldrich 
DMSO Sigma Aldrich 
TRIzol reagent Life Technologies, Darmstadt, Germany 
DNA loading dye Bioline 
 
2.1.4 Cell lines 
Table 5: List of cell lines mainly used to test biocompatibility of implants in present 
study. 
 
Cell line Supplier 
Fibroblasts (NIH3T3) ATCC CRL-1685; LGC Standards GmbH, 
Wesel, Germany 
Osteosarcoma (MG63) ATCC CRL-1427; LGC Standards GmbH, 
Wesel, Germany 
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2.1.5 Bacteria 
Table 6: List of bacterial strains used in the present work. 
Strain Source 
Pseudomonas aeruginosa (1 CTX::lux) Laboratory strain which has been Genetically 
made bioluminescent by the insertion of the lux 
into the genomic DNA [151,152]. 
Pseudomonas aeruginosa (pqsA-)  Bioluminescent by the insertion of the lux into 
the genomic DNA. This mutant strain is 
deficient in quorum sensing system [152]. 
Pseudomonas aeruginosa (1 WT) Kindly donated by Dr. Susanne Häussler 
Pseudomonas aeruginosa (PA14 WT) Kindly donated by Dr. Susanne Häussler 
Staphylococcus aureus (XEN29)  Bioluminescent by the insertion of the lux into 
the genomic DNA. (PerkinElmer, 
Massachusetts, USA) 
Staphylococcus aureus (WT) Kindly donated by Dr. Susanne Häussler 
E. Coli (lux)  Bioluminescent by the insertion of the lux into 
the genomic DNA [153]. 
Salmonella (lux)  Laboratory strain genetically made 
bioluminescent by the insertion of the lux into 
the genomic DNA [154] 
 
2.1.6 Kits 
Table 7: List of kits employed during present study. 
Kit    Supplier Catalog No. 
RNeasy mini kit(50) QIAGEN 74104 
Power Biofilm RNA isolation kit MO BIO Lab, Germany 25000-50 
DNase treatment kit Life Technologies, 
Darmstadt, Germany 
AM1906 
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RNase-free DNase  QIAGEN 79254 
QIA shredder  QIAGEN 79656 
MICROBE Enrich Kit Life Technologies, 
Darmstadt, Germany 
AM1901 
MICROB Express™ Bacterial mRNA 
Enrichment Kit 
Life Technologies, 
Darmstadt, Germany 
AM1901 
Script Seq™ (RNA-Seq Library Preparation 
Kit) 
(HiSeq2500, Illumina, 
USA) 
SSV21106 
SSV21124 
 
2.1.7 Equipment 
Table 8: Overview of laboratory equipment used in current work. 
Equipment Manufacturer 
Electron microscope Zeiss, Oberkochen, Germany 
EDX (Energy dispersive x-ray spectroscope) Hitachi REM-S3400N 
Diffractometer STOE & Cie GmbH, Darmstadt 
Microscopes Zeiss, Jena, Germany 
Fluorescent microscope Zeiss, Jena, Germany 
Autoclave Belimed steam sterilizer 6-6-6 HS1 FD 
Centrifuges OMNILAB, GmbH, Germany, Thermo Fisher 
SCIENTIFIC 
Binocular Microscope Zeiss, Jena, Germany 
Camera CASIO, SAMSUNG 
Nano drop Peglab, Erlagen, Germany 
-20C freezer Liebherr 
-80C freezer Thermoforma 
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4C refrigerator Liebherr 
CO2 incubator for cell culture Labotect 
Hot plate IKA®-Werke GmbH & Co. KG, Staufen, 
Germany 
Deionized water setup Millipore MilliQ 
Micropipettes Gilson 
pH meter (microelectrode) Mettler-Toledo GmbH, Giessen, Germany 
Nanodrop ND-1000 UV-Vis 
Spectrophotometer 
Nanodrop Technologies, Wilmington, USA 
Weight measurement Sartorius 
Sterile work benches (Maxisafe 2020) Thermoscientific 
Vortex Scientific industries Vortex Genie 2 
Water bath GFL 
Microwave oven Whirlpool 
Pipette boy Pipettboy IBS integra Biosciences 
Pipettes Gilson 
Xenogen IVIS 200 Caliper Life Sciences 
Surgical tools (forceps, scissors, scalpel) Fine Science Tools GmbH, Germany 
Tissue homogenizer Milteryi biotec, Germany 
Metal fixture Rencast FC52/53 Isocyanate, FC53 Polyol, 
Füller DT 082; Gössl & Pfaff GmbH, 
Karlskron/Braulach, Germany 
Vernier caliper  (Wisent tools, Germany) 
Materials testing machine Zwick/Roell 1445, Zwick GmbH & Co KG, Ulm, 
Germany 
Hair trimmer Aesculap suhl GmbH, Germany 
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2.1.8 Consumables 
Table 9: List of consumables used in present study. 
Material Supplier 
Multi well Cell culture plates (96wells, 96wells with black 
background, 48 wells, 24 wells, 12 wells and 6wells) 
Nunc, Denmark 
Petri dishes Nunc, Denmark 
Pipette tips (10µl,100µl,1000µl) Star Lab 
Falcon tubes (15ml and 50ml) Griener bio-one 
Eppendorf tubes (1.5ml and 2ml) Sarstedt Labor 
PCR tubes Biozym 
Syringe filters(0.2µM and 0.45µM) Sartorius 
Syringes (1ml, 3ml, 5ml,10ml and 20ml) Omnifix 
Needles(16gauge, 18gauge, 20gauge and 23 gauge) B-Bern, Germany 
Cell culture flasks (25cm2, 175cm2 and 300cm2) Nunc,TTP 
Cryovials Corning, Sigma Aldrich 
Gloves Microflex 
Spectrophotometric cuvettes Sarstedt Labor 
Suture material Vicryl Ethicon, Johnson and 
Johnson 
Metal fixture (cold-curing resin)  Rencast FC52/53 Isocyanate, 
FC53 Polyol, Füller DT 082; 
Gössl & Pfaff GmbH, 
Karlskron/Braulach, Germany 
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2.1.9 Software 
Table 10: Overview of software used in present study 
Software Manufacturer 
Axiovision Rel. 4.5 software Carl Zeiss MicroImaging Inc., Jena, Germany 
Living Image software®, version 2.6 Xenogen, USA 
Image J National Institutes of Health, USA 
GraphPad Prism (v5) Statcon 
MS office (2010) Microsoft 
 
2.1.10 Animals 
Table 11: Mice employed for animal studies 
Animal Supplier 
BALB/c mice Harlan-Winkelmann, Borchen, Germany 
C57Black/ 6 mice Harlan-Winkelmann, Borchen, Germany 
β-IFN-Luc mice Luciferase reporter mice which allowed 
interferon-beta gene induction in response to 
bacterial infection [155]. 
 
 
 
2.2  Methods 
2.2.1 In vitro and in vivo characterization of implant materials (Part A) 
2.2.1.1 Sterilization 
Plastic materials, bacterial culture, solutions for cell culture and corrosion study were 
autoclaved at 121°C before use. Implant materials were sterilized either by autoclave or 
immersion in 70% ethanol. 
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2.2.1.2 Properties and dimensions of tested implant materials 
Magnesium discs were manufactured and processed in Institute of Materials Science, 
Leibniz University Hannover, Germany. Manufacturing was mainly done by gravity 
dicasting process. Pure magnesium (99.94% pure; Magnesium Elektron UK, Manchester) 
was melted at 750oC in a tilting crucible furnace. The melting was performed in a SF6 
shielding gas atmosphere (volumetric flow rate of 21/min; Air Liquid, Dusseldorf) because 
of the high reactivity of liquid magnesium. Then, the melt was cast into a preheated steel 
die (450oC). Before extrusion billets were turned down to a diameter of 120mm to remove 
resulting cavities, pores and impurities from casting. Hot extrusion was carried out by a 10 
MN extruder (SMS Meer, Moenchengladbach). For this, cast billets, the die (4x6.5mm) and 
the container of the extruder were heated to 350oC. The extrusion process was conducted 
with a pressure of 4.9MN and a profile velocity of 1.9 m/min. A 5 mm diameter cylindrical 
form with a height of 2 mm was selected as specimen morphology. All specimens were 
manufactured by using constant machining parameters, special fixation and a low feed. 
Specimens had an average mass of 68.6 mg ±0.25 and a calculated surface area of 19.63 
mm2. Porous titanium discs  were prepared from Ti-6Al-4V micro beads grade 23 by metal 
injection molding (MIM) of 90%(w/w) beads with diameter from 125µm to 180 µm and 
10% Ti-6Al-4V powder with a grain diameter of less than 45 µm. Whole mixture was 
sintered at 1100C for 2h under high vacuum without further processing. 
2.2.1.3 Corrosion media and in vitro incubation conditions  
In vitro degradation properties of magnesium were investigated in cell culture media or in 
different salt chemical solutions. Corrosion media were as follows: (1) cell culture medium 
Dulbecco’s modified Eagle’s medium (DMEM) containing 10% FCS (Table 3). (2)  A spent 
cell culture media was introduced in present study which was synthesized as a supernatant 
after the incubation of mice fibroblasts (NIH3T3) (ATCC CRL-1685) with DMEM. (3) 
Phosphate buffer saline (1x PBS) (Table 3) (4) Potassium phosphate (KH2PO4). Incubations 
of samples were done at room temperature, at 37°C and at 37°C with 5% CO2 in a 
humidified cell culture incubator.  
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2.2.1.4 Determination of in vitro corrosion  
The corrosion rate of magnesium in the shape of wires or discs was evaluated 
independently by monitoring (1) Changes in the weight after immersion (2) Changes in the 
pH of corrosion media (3) Determination of Mg2+ concentration in the incubation media (4) 
measurement of hydrogen gas released from magnesium. 
2.2.1.4.1 Measurement of weight loss 
Weight of magnesium samples (wires and discs) was measured by microbalance 
(Sartorius) then these specimens were left in their respective media for indicated time 
period at standard cell culture conditions. At the end of incubation, the samples were 
removed from the corrosion media. Before measuring final weight, corrosion layers from 
all samples were removed by cleaning with diluted chromic acid. Final weight loss was 
calculated in (mg/cm2) which was then converted into corrosion rate (mm/year) according 
to ASTM-G31-72 as given below [156].  
CR=KW/Atρ 
CR is corrosion rate, coefficient K=8.76x104 W is weight loss (g), A is surface area of discs 
exposed to corrosion media, t is exposure time and ρ is magnesium density. 
2.2.1.4.2 Measurement of magnesium ions (Mg2+) concentration 
Magnesium samples were immersed in their respective media at standard cell culture 
conditions for mentioned time period. Soluble magnesium ion concentrations were 
determined daily by mixing 10 µl of appropriately diluted magnesium corrosion 
supernatants with 1000 µl of Xylidyl blue reagent according to the manufacturer's 
instruction (Magon, Pointe Scientific, Inc. USA). In parallel, 2.05 mM  Mg2+ standard solution 
provided with the kit was also mixed with 1000µl of Xylidyl blue. After 5-10 minutes 
incubation at room temperature, the OD546 of the reaction mixture was determined using a 
Nanodrop ND-1000 UV-Vis Spectrophotometer (Nanodrop Technologies, Wilmington, 
USA). Measured OD546 values were inserted into standard formula and Mg2+ concentration 
was determined in mg/dl. 
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2.2.1.4.3 Measurement of hydrogen gas evolution 
Hydrogen gas evolution was measured using 1 or 10 ml syringes attached to needles (B. 
Braun, Germany) at 37C in cell culture incubator. At the start of experiment, plunger was 
taken out of the syringe and test specimen was placed in it. The plunger was refixed and 
indicated amount of corrosion media was filled into the syringe. The syringe was then 
placed in glass jar already filled with corrosion media in a way that needle was completely 
dipped into media. This was done to inhibit environmental air penetration into the syringes 
from surrounding environment. Gas accumulation in syringes was recorded from scales of 
syringes and converted into units of ml/cm2. 
2.2.1.4.4 Monitoring changes in pH of corrosion media 
Magnesium specimens were immersed in respective media and incubated at 37C in cell 
culture incubator. The pH of media was measured using a micro electrode pH meter 
(Mettler-Toledo GmbH, Giessen, Germany). 
2.2.1.5 Biomechanical pull out tests  
Tibia bones were isolated from 6-8 weeks old BALB/c mice after euthanizing them with 
CO2. Bones were incubated in formalin minimum for up to 1 week for fixation. Magnesium, 
magnesium silver alloy or titanium wires (15 mm length and 0.4mm diameter) were 
inserted into the medullary cavity of bones separately. These bones bearing wires were 
incubated in 1.5ml DMEM at 37C in the presence of 5% CO2 in a humidified cell culture 
incubator for 7, 15 or 30 days. In parallel, magnesium wires alone were inserted into bones 
and incubated in 1.5 ml either of 100 mM solution of KH2PO4, DMEM or in spent cell culture 
medium at 37C in the presence of 5% CO2 in a humidified cell culture incubator for 3, 7, 15 
or 30 days. To exclude the effect of bones, magnesium wires (10 mm) were also directly 
incubated in 100 mM solution of KH2PO4, DMEM or spent cell culture medium at 37C in the 
presence of 5% CO2 in a humidified cell culture incubator for 7 days. After incubation, tibia 
bones containing wires were removed from their solutions.  The wire pull out force from 
tibia bones was determined in Newton (N).  For this, bones were embedded into a metal 
fixture using a cold-curing resin containing the three components (Rencast FC52/53 
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Isocyanate, FC53 Polyol and Füller DT 082 (Gössl & Pfaff GmbH, Karlskron/Braulach, 
Germany). The maximum pull-out force was determined with a materials testing machine. 
The mechanical testing was conducted with a pre-load force of 0 N and a velocity of 0.5 
mm/min.  The fixation strength between the wires and bones without any incubation was 
measured as control.   
2.2.1.6 Phosphate coating procedure 
Functional salt solutions for potassium di-hydrogen phosphate (Carl Roth GmbH, 
Karlsruhe, Germany), potassium mono-hydrogen phosphate (Merck, Darmstadt, Germany) 
sodium di-hydrogen phosphate (Merck, Darmstadt, Germany) and magnesium hydroxide 
(Fluka Chemie GmbH, Deisenhofen, Germany) described in table 12 were prepared with 
deionized water. Magnesium implants were incubated for three days in individual wells 24-
well cell culture plate (Nunc, Denmark) containing 2ml coating solutions. Two separate sets 
of these plates were incubated at two different environmental conditions (i) 37C in the 
presence of 5% CO2 in a humidified cell culture incubator (ii) and at 37C.  During 
incubation, the discs were flipped every 24 h to ensure vigorous corrosion layer formation.  
Following incubations, magnesium discs were removed and then placed on tissue papers so 
that small drops sticking with them were absorbed. Further, these discs were dried at room 
temperature for 48 h. Surfaces of magnesium were observed using a binocular microscope 
(Stemi SV11, Carl Zeiss Microscopy Gmbh, Germany). The weight of all discs was recorded 
before and after incubation and drying. For each immersion solution, magnesium discs 
were used in triplicates and data points correspond to mean value with standard deviation 
represented by error bars. 
2.2.1.7 Fluoride coating on magnesium  
For magnesium fluoride coating, specimens were boiled in NaOH (200 g/L) for 
120 minutes and subsequently placed in hydrofluoric acid (40 %). After a 96 hours 
immersion, the specimens were rinsed with distilled water and ethanol to remove the acid 
remains from the MgF2 layer. The chemicals used to achieve MgF2- coating were acquired 
from Carl Roth GmbH & Co. KG, Karlsruhe, Germany.  
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2.2.1.8  In vitro cell culture assays and conditions  
To test cell compatibility of implant materials, immortalized murine fibroblasts (NIH3T3) 
and bone cells (MG63) were used (Table.4). Cells were grown in Dulbecco’s Modified 
Eagle’s Medium at 37C in a humidified cell culture incubator with 5% CO2. Medical 
implants in the form of discs were sterilized using 70% ethanol and then placed 
individually into the wells of 24 well plates. Cells were directly seeded on the surfaces of 
these implants. Blank polystyrene wells of plates and titanium discs were used as control. 
After cell seeding, plates were incubated at 37C in a humidified incubator with 5% CO2 
until the cells got confluence in control wells. Then, cells were stained using a cell 
proliferation fluorescent dye. For this purpose, spent cell culture media and non-adherent 
cells were removed and adherent cells on implant surfaces were washed off with 1x 
phosphate-buffered saline (PBS). Cells were then treated with 4µM of cell proliferation dye 
CFSE prepared from 10 mM stock solution for 15 minutes. Afterwards, cell adhesion, 
spreading, and proliferation were observed by capturing green fluorescence from cells 
using Axio Observer A-1 microscope. While, fluorescent images of cells were taken using 
the Axiovision software, release 4.5 and cells from images were counted using Image J 
software.  
2.2.2 Implantation procedure in small animal model 
2.2.2.1 Animal permission 
All animal experiments were conducted in accordance with the regulations and approval 
from the local authorities Lower Saxony State Office for Consumer Protection and Food 
Safety (LAVES) under permission number 33.42502/07-10.5. 
2.2.2.2 Animal housing 
Wild type female BALB/c mice and transgenic β-IFN luciferase positive mice [157] (HZI 
breeding) of 8-10 weeks age with average weight 22-25 mg were considered for animal 
experiments (Table 10). Healthy β-IFN mice were bred in T2 facility while BALB/c mice 
were ordered from Harlan laboratory and then kept in cages under controlled 
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environmental conditions with standard diet and water ad libitum in the animal facility of 
Helmholtz center for infection research (HZI), Braunschweig. 
2.2.2.3 Surgical process for implantation  
In vivo implantations were carried either subcutaneously on the dorsum or into the tail 
artery of mice. Sterilized magnesium and titanium implants, in the shape of discs were 
preferably implanted subcutaneously while these implants in the shape of wires were 
inserted into tail artery. Before surgery, mice were anesthetized using intraperitoneal 
injection of ketamine (10 mg/kg) and Xylazine (4 mg/kg). Mice fur on the dorsum was 
removed using a hair trimmer. Mice were then shifted under the clean bench. First of all, 
Three incisions were made using surgical scissors to create small subcutaneous pockets on 
both right and left sides of hindquarter and one close to neck. With the help of tissue 
forceps, implants were inserted into these subcutaneous pouches. Then, openings of these 
subcutaneous pockets were closed by simple interrupted wound sutures with the help of 
surgical needle. For implantations into tail artery, small openings were made at three 
positions into the tail artery using 18 gauge needles. 1 cm long pieces of wires were 
directly inserted into the tail artery through these openings. After surgical intervention, 
mice were shifted back into their respective cages and their general health conditions and 
physical parameters were carefully observed after implantations.  
2.2.2.4 Measurement of hydrogen gas around subcutaneously implanted discs 
After implantation, mice were shifted back into their respective cages. Gas accumulation as 
primary degradation product around subcutaneously implanted magnesium was measured 
by establishing a novel method. For this, height and diameter of subcutaneously implanted 
discs were measured immediately after implantation using Vernier caliper (Wisent tools, 
Germany). Later, additional increases in diameter and height around implanted discs due 
to gas accumulation were measured on daily basis during the first week and on weekly 
basis for 8 weeks. Subcutaneously implanted discs after gas accumulation were considered 
showing a close similarity to half sphere therefore formula used to calculate volume (v in 
mm3) of a partial sphere was applied to get quantitative values for gas formation. 
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𝑉 = ℎ2𝑟 −  
 ℎ3
3
 
While “r” is radius of the partial sphere and “h” is height.                                                      
2.2.2.5 Histology of tissue surrounding implants 
For histological analysis, mice were sacrificed by CO2 asphyxiation followed by cervical 
dislocation. Disc implants sandwiched between 2 mm thick layer of skin on the upper side 
and skeletal tissue layer on the lower side were removed from mice. In the case of tail 
implants the whole tail piece containing the implant was placed in histology cassettes and 
fixed in 4% formalin for 48 hrs. Following fixation, tissues were dehydrated in 70% ethanol 
and then embedded in paraffin. Tissues embedded in paraffin were cut into 5 µm sections 
and then stained with hematoxylin and eosin (H&E). 
2.2.2.6 Energy Dispersive X-ray (EDX) spectroscopy  
Elemental compositions and surface properties of implant materials were analyzed in 
institute for Multiphase Processes, Leibniz University of Hannover, Germany using energy 
dispersive x-ray spectroscopy (EDX), a fully automated variable pressure Hitachi REM-
S3400N. For this purpose, samples were fully dried and then fixed with the help of 
conducting glue foil. 10 KeV was selected as acceleration voltage and the distance was 
adjusted to 10mm. Images were captured at a magnification of 200-fold at a working 
distance of 21-22 mm with emission current of 80-110 IA. Quantifications were performed 
in accordance with the standard less ZAF method (Z, atomic number effect; A, absorption 
correction; F, fluorescence correction). Different energy peaks represent respective 
electron transmissions to the K-shell, except for titanium where energies for both L- and K- 
shell were detected.  
2.2.2.7 X-ray diffraction analysis of implant materials 
To determine crystalline properties of coated and uncoated implants, XRD analysis was 
also performed in Institute for Inorganic Chemistry, Leibniz University of Hannover, 
Germany. LDH coatings on titanium and phosphate coatings on magnesium were 
characterized using the STOE Theta/theta Diffractometer (STOE & Cie GmbH, Darmstadt) 
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which was operated at 40 kV and 30 mA. Disc samples were scanned in reflection geometry 
at a step width of 0.02° with 2.0 s counting time per step, employing monochromatized 
CuKα 1 radiation at a wavelength of 1.54060 Å. 
2.2.2.8 Scanning electron microscopy (SEM) 
Detailed analysis of the surface morphologies of all implants before as well as after their 
incubation or implantation was done using a Merlin field emission scanning electron 
microscope using an acceleration voltage of 5 kV with the Everhart-Thornley SE-detector 
and Inlens SE-detector ratio set to 25:75. 
 
2.2.3 Implant associated-infections (Part B) 
2.2.3.1 Bacterial strains and their cultivation 
For biomaterial associated-infections and to test antibacterial properties of implants, 
bioluminescent strains of P. aeruginosa (1 CTX::lux), P. aeruginosa   pqsA (quorum sensing 
mutant), Staphylococcus aureus, wild type P. aeruginosa, Bioluminescent E. Coli, 
Bioluminescent Salmonella were employed (Table. 5). Bacteria were grown in LB medium 
(composition given below) in sterile glass flasks with loose caps to allow air penetration. 
For solid media growth, frozen cultures were first aerobically overnight grown at 37°C on 
LB agar plates (composition given below in table). Bacterial cultures were grown at 37°C 
on shaking speed of 150 rpm to desired optical cell density (OD600=0.1; approximately 
1x108 CFU/ml). For long term storage, planktonic cultures of all strains were stored in LB 
medium containing 25% glycerol at -80oC.  
2.2.3.2  Initial inoculum to infect implant surfaces  
For in vivo establishment of biofilm on implant surfaces, immediately or 24h after 
implantation 5 µl of bacteria in LB suspension at (OD600=0.1; approximately 5.45x106 
CFUs/5µl) were directly injected on the surfaces of implants.  
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2.2.3.3 Determination of minimum bacterial inoculum capable of biofilm formation  
To estimate minimum number of bacteria that could lead to biofilm formation, P. 
aeruginosa (PAO1 CTX::lux) were grown to an OD600=0.1 in LB suspension by conditions as 
mentioned previously. Initial inoculum (OD600=0.1; approximately 5.45x106 CFUs/5 µl) was 
further 1:3 diluted in LB suspension. Magnesium discs were subcutaneously implanted into 
eight BALB/c mice. Minimum three discs were implanted per mice. Soon after 
implantation, infection was done directly on the surface of each implanted discs. Implant 
infection was done separately in each mouse from different bacterial dilution. After 
infection, all animals were regularly observed under in vivo imaging system. 
2.2.3.4 Non-invasive in vivo imaging of biofilm on implant surfaces  
Bioluminescent activity of bacteria was detected using IVIS®-200 in vivo imaging systems 
(Xenogen, USA). This allowed non-invasive direct monitoring of implant infection without 
killing animals. Photons produced by luminescent bacteria diffuse through animal skin and 
were captured by a sensitive photon charged-coupled device (CCD) camera. For 
bioluminescent imaging, mice were initially anesthetized using 2% Isofluran (gaseous 
anesthesia) with the help of XGI-8 anesthesia unit (Calipers). Mice were then shifted inside 
IVIS with constant supply of Isofluran and in vivo imaging was done. Transgenic mice 
expressing β-IFN under luciferase promoter were also observed under the same system. 
For imaging, β-IFN luciferase mice were first injected intraperitoneally (i.p) with 150 
mg/Kg of luciferin in 1x PBS. After 10-15 minutes of injection, bioluminescent images were 
captured from mice. The luminescence intensity was determined using the Living Image 
software® Version 2.6 (Xenogen) and given as average radiance (p·sr−1·m−2). 
2.2.3.5 Bioluminescent imaging of E. coli on implant surfaces 
To investigate if E. coli could establish prolonged infections on implant surface, magnesium, 
plain titanium and porous glass discs were separately implanted subcutaneously into 
BALB/c mice. After implantation, bioluminescent E. coli were injected directly on the 
surface of discs. Soon after infection, bacterial luminescence from the surfaces infected 
discs was captured using the IVIS®-200 in vivo imaging system (Xenogen, USA).  
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2.2.3.6 Bioluminescent imaging of Salmonella on implant surfaces 
For infection, magnesium, plain titanium and porous glass discs were implanted 
subcutaneously in BALB/c mice. Bioluminescent Salmonella typhimurium were injected 
directly on the surface of each of the discs. Luminescence from infected implants was 
measured daily with an IVIS®-200 in vivo imaging system (Xenogen, USA).  
2.2.3.7  In vivo infection pattern by planktonic and biofilm cultures of P. aeruginosa 
Plain titanium discs were subcutaneously implanted each on right side in the region of fore 
and hind limbs of female BALB/c mice. Magnesium discs each on left side of the region of 
fore and hind limbs were implanted in same animal. Both titanium and magnesium 
implanted on upper limbs were infected with bioluminescent 5 µl P. aeruginosa 
(approximately 5.45x106 CFUs). While, same discs implanted on lower limbs were infected 
with 5 µl of bioluminescent P. aeruginosa in LB medium, isolated from a 12 days old biofilm 
established on magnesium discs in a separate mouse. These bacteria were prepared by 
taking small amount of pus from biofilm and then mixing it in LB shortly before infection. 
After infection, mice were observed under IVIS®-200 (Xenogen, USA). 
2.2.3.8 Time-dependent antibiotic administration against P. aeruginosa biofilms  
To test biofilm responses against antibiotics administered at different time points after 
initial infection, mice bearing magnesium implants were infected with bioluminescent P. 
aeruginosa directly on the surfaces discs. Then, 100 µl of ciprofloxacin (2mg/ml) was 
injected intravenously in first mouse. Second mouse was injected with ciprofloxacin (same 
dose and route) after 6h, 3rd mouse after 24h and 4th mouse after 48h post-infection. One 
mouse was kept as control where 100 µl of 1x PBS was injected intravenously post 
implantation and infection. Later antibiotic administrations at constant dose and route 
were continued on daily basis for two weeks. Antibiotic sensitivity of biofilms was imaged 
using IVIS®-200 (Xenogen, USA). 
2.2.3.9 Dose-dependent antibiotic administration against P. aeruginosa biofilms  
To test biofilm response to different concentrations of antibiotics, four independent groups 
(4 mice /group) of mice were organized. In individual mice of all groups, subcutaneous 
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implantation of magnesium and subsequent infection with bioluminescent P. aeruginosa 
was done. Ciprofloxacin (2mg/ml) and PBS in control mice was injected immediately after 
infection and then daily. Luminescence from all groups was captured daily. 
2.2.3.10   RNA isolation from in vitro cultures of P. aeruginosa  
Planktonic cultures of P. aeruginosa (PAO1 CTX:lux) grown at ambient conditions 
(mentioned previously) at OD600=0.4 were used for RNA isolation. In parallel, stationary 
bacterial cultures grown under same conditions at OD600=1.00 were also used for RNA. 
RNA isolation was done separately either using TRIzol reagent or using RNeasy mini kit 
(QIAGEN). Under both options, RNA isolation was done by following manufacturer’s 
protocol. The amount of RNA was determined using NanoDrop. RNA quality (RIN number) 
was checked by Bio analyzer. Isolated RNA was stored at -80C. 
2.2.3.11 Electron microscopy of biofilm 
2.2.3.11.1 Field emission scanning electron microscopy 
Mice bearing biofilm were euthanized and infected magnesium along with tissue were 
removed and fixed with 5% formaldehyde and 2% glutaraldehyde in HEPES buffer (100 
mM HEPES, 90 mM sucrose, 10 mM MgCl2, 10 mM CaCl2, pH 6.9) washed twice in TE buffer 
(10 mM TRIS, 2mMEDTA, pH 6.9), dehydrated with a graded series of acetone (10, 30, 50, 
70, 90, 100%) for 15 min on ice and further dehydrated in 100% acetone at room 
temperature. After critical-point drying with liquid CO2 (CPD300, Leica or CPD030 Bal-Tec) 
samples were sputter coated with palladium-gold (SCD500, Bal-Tec) and imaged in a Zeiss 
Merlin field emission scanning electron microscope with an acceleration voltage of 5 kV. 
Images were taken with the Zeiss Smart SEM software version 5.05. For imaging discs 
alone and porous glass beads samples were sputter coated with palladium-gold before 
examination in the Zeiss Merlin as above. 
2.2.3.11.2 Transmission electron microscopy 
Samples were fixed with 2.5% glutaraldehyde and 5% formaldehyde in HEPES-buffer on 
ice for 1 hour and then kept at 5°C. After washing with HEPES buffer samples were further 
fixed with 1% aqueous osmium for 1 hour at room temperature. Dehydration was achieved 
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with a graded series of acetone (10%, 30% and 50%) while on ice. After dehydration with 
70% acetone samples were incubated overnight in 70% acetone containing 2% uranyl 
acetate at 4°C. The following day samples were dehydrated further with 90% and 100% 
acetone on ice and finally with 100% acetone at room temperature. Samples were then 
embedded in the epoxy resin according to previously described procedures[158]. Ultrathin 
sections were cut with a diamond knife, picked up with butvar-coated grids, counterstained 
with uranyl acetate and lead citrate and examined in a TEM910 transmission electron 
microscope (Carl Zeiss, Oberkochen) set to an acceleration voltage of 80 kV. Images were 
digitally recorded at calibrated magnifications with a Slow-Scan CCD-Camera (ProScan, 
1024x1024, Scheuring, Germany) using the ITEM-Software (Olympus Soft Imaging 
Solutions, Münster, Germany). Contrast and brightness were adjusted with Adobe 
Photoshop version CS3 (Adobe). 
2.2.3.12 Histology of biofilm 
Peri-implant tissue was fixed with 3.6% neutrally buffered formaldehyde, dehydrated in 
70% ethanol, embedded in paraffin and then histological sections of 3µm thickness were 
prepared with a cryostat microtome (HM550,Thermoscientific, Germany). The sections 
were stained with Hematoxylin/Eosin (H&E) and Periodic Acid Schiff (PAS) staining 
according to standard procedures[159,160]. Anti-Pseudomonas antibody (Biotrend, AP086 
at dilution 1:400) staining was performed after heat-mediated-antigen retrieval of the 
samples. The slides were evaluated histo-pathologically using a light-microscope 
(Axioscope.A1, Zeiss, Germany) accompanied by camera (AxioCam ICc1, Zeiss, Germany), 
.Images from the slides were taken using Axiovision software, release 4.5 (Carl Zeiss Micro 
Imaging Inc., Germany) randomized and blinded to the experimental groups. Contrast and 
brightness were adjusted using Adobe Photoshop version Cs5. 
2.2.3.13 In vivo imaging of IFN-beta response against biofilm 
Interferon-β expression against P. aeruginosa biofilm on the surface of magnesium discs 
was monitored using transgenic Interferon-β luciferase positive mice. In each transgenic 
mouse two magnesium discs were subcutaneously implanted and side by side one sham 
surgical pouch was created. Wild type P. aeruginosa (PAO1) were injected separately on the 
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surface of magnesium disc and into sham pouch. One magnesium disc was left without 
infection in each mouse. Soon after infection, 150 µl (30 mg/ml) of luciferin was injected 
intravenously into each mouse. 15 minutes after injection, mice were placed under IVIS 
system supplied by gaseous anesthesia and luminescence images were daily for two weeks.   
2.2.3.14 Colony forming unit (CFU) of P. aeruginosa in biofilm and different organs 
P. aeruginosa made slimy biofilms in the present animal model with pus formation. 50 µl of 
this liquid biofilm was taken and mixed into 450 µl of 1x PBS. This mixture was mixed and 
vortexed well and 10 fold dilution series in 1x PBS was made till 10-9. Later 10 µl drop from 
each of dilution was taken and dropped directly on LB agar plates three times at separate 
places. These plates were overnight incubated at 37C. Freshly grown single colonies were 
counted from countable dilution. Then CFU/ml was achieved by multiplying number of 
colonies with dilution factor and dividing it by the volume. To calculate CFU from the 
organs of mice bearing P. aeruginosa biofilm, animals were sacrificed and liver and gut 
were isolated from them. Weight of these organs was measured and then they were shifted 
separately into homogenizing tubes containing 2 ml of 0.1% triton in 1x PBS for liver and 
5-6 ml of 0.1% triton for gut. Tissues were homogenized for 86 seconds. After 
homogenization, 100 µl from each tube was taken and mixed with 900 µl of PBS. Then a 10 
fold serial dilution series was made till 10-6 dilution. 100 µl from each dilution was taken 
either from liver or gut samples and streaked on LB agar plates. Plates were overnight 
incubated at 37C. Fresh colonies were counted from plates in case of liver or gut and 
finally CFU/grams of bacteria were calculated. 
2.2.3.15 RNA extraction from in vivo grown P. aeruginosa biofilm 
RNA was isolated from in vivo established P. aeruginosa biofilms using a Power Biofilm 
RNA isolation kit or TRIzol reagent following manufacturer’s protocol. RNA isolation was 
done using RNAse free tubes and water. Briefly, mice bearing P. aeruginosa were killed 
with CO2 and shifted in cold room to maintain RNA integrity during isolation process. 
Whole biofilm matrix from the back of mice was removed and shifted into RNAse free 
Power Biofilm bead tubes containing beads. These tubes are equipped with beads which 
can efficiently break biofilm structures during homogenization process. Power tubes were 
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fixed on a tissue homogenizer and shaking was set at full speed for 15 minutes. Then 
homogenized supernatant was collected and mixed with chloroform and centrifuged. After 
centrifugation, RNA is mainly concentrated in aqueous phase. RNA precipitation was done 
by mixing this aqueous phase with 100% isopropanol. After centrifugation, RNA pelleted at 
the side and bottom of tubes. The supernatant was removed and the pellet was washed 
with ethanol. Finally, RNA was resuspended using RNAse free water. RNA concentrations 
were determined on NanoDrop and RNA was stored at -80C for further use.   
2.2.3.16 RNA clean up using DNase digestion kit 
100 µg of RNA in 100 µl of RNA free water was taken for cleaning process. DNase treatment 
was given using (DNA-free DNA removal Kit, Life technologies, Germany) following 
manufacturer’s instructions. 
2.2.3.17 Agarose gel electrophoresis 
Agarose gels were prepared by adding 0.3 grams of agarose into 30 ml of 1x TAE buffer 
into cassette. 5µl of Midori green was added into this mixture and slowly mixed to avoid 
bubble formation. The cassette was placed at room temperature for up to 20 minutes so 
that the agarose did get solidified. The cassette was fixed in electrophoresis chamber and 
was filled with 1x TAE buffer. 1.5 µl of DNA loading dye was mixed with 8.5 µl of isolated 
RNA and this total of 10 µl was loaded into gel. After RNA loading, the chamber was 
connected with positive and negative electrodes and electrophoreses of the samples was 
done at 70 V for 30 minutes. The gel was removed from the chamber and placed under a UV 
trans-illuminator. 
2.2.3.18 RNA sequencing 
RNA isolated from a P. aeruginosa in vivo biofilm was subjected to sequencing. To remove 
host RNA contamination, bacterial RNA enrichment was done using MICROBE Enrich kit as 
per manufacturer’s protocol. Then bacterial mRNA enrichment was done with MICROB 
Express kit as per manufacturer’s protocol. Library preparation was done using ScriptSeq 
(Illumina, USA). Small amount of the library was sequenced to evaluate the libraries (Table 
6).  
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2.2.3.19 General composition of media used  
DMEM (Dulbecco’s Modified Eagle’s Medium) 
Na+ 127.3 mM/L     K+ 5.3 mM/L     Mg2+ 0.8 mM/L     Ca2+  1.8 mM/L     Cl-   90.8 mM/L     1% 
(v/v) glutamine, 1% (v/v) penicillin and streptomycin (100U/ml penicillin G and 100µg/ml 
streptomycin) and 10% (v/v) fetal calf serum. 
PBS (Phosphate buffer saline) 
NaCl 140, 27 mM KCl, 7.2 mM NaH2PO4 pH 7.0-7.4. 
r-SBF (Simulated body fluid) 
Na+ 142 mM/L, K+ 5.0 mM/L, Ca2+ 2.5 mM/L, Mg2+ 1.5 mM/L, Cl- 103 mM/L, HCO3- 27.0 
mM/L, HPO4-2 1.0 mM/L, SO4-2 0.5 mM/L at pH 7.4. 
Plasma 
The plasma was obtained after the centrifugation of blood of several pigs and stored at a 
temperature of -80° C. After thawing, in a water bath, 1 vol. % of penicillin was added to 
plasma to prevent bacterial growth during the incubation period. Na+ 142 mM/L, K+ 5.0 
mM/L, Ca2+ 2.5 mM/L, Mg2+ 1.5 mM/L, Cl- 103 mM/L, HCO3- 27.0 mM/L, HPO4-2 1.0 mM/L, 
SO4-2 0.5 mM/L at pH 7.4 
LB (Lysogeny broth) 
10g/l bactotrypton, 5g/l yeast extract, 10g/l NaCl 
LB agar 
10g/l bactotypton, 5g/l yeast extract, 10g/l NaCl and 15g/l agar 
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3 Results 
3.1 Characterization of implant materials (Part A) 
3.1.1 Effect of corrosion media on the weight of magnesium samples  
To identify relevant parameters and suitable degradation conditions, magnesium implants 
were incubated in immersion media with variable compositions and various biological 
conditions were evaluated. Weight loss is assumed as simple and fast method to determine 
degradation of metals thereby changes in weight of magnesium pins were measured over 
the time. A significant weight loss was observed for pins incubated in spent cell culture 
medium at 37C in the presence of 5% CO2 in a humidified cell culture incubator (Figure 6B 
filled rhombi). At room temperature as well as at 37C the weight of pins in same medium 
remained constant (Figure 6A, B filled rhombi). Magnesium pins incubated in potassium 
phosphate solution showed significant increases in weight after all incubations (Figure 6 A, 
B, C, black squares). However, no change in weight of these pins could be observed when 
incubated in DMEM (Figure 6A, B, C, black circles). The weight of pins incubated with 
DMEM in the presence of live fibroblasts (NIH3T3) also remained unchanged during first 6 
days, however at later time points; it started to decrease slowly (Figure 6B empty rhombi). 
Magnesium pins incubated with PBS also showed a slight weight gain at tested 
environmental settings (Figure 6A, B and C blank squares). It seemed spent cell culture 
medium containing cellular excretion products was highly corrosive medium particularly 
at 37C with 5% CO2 at standard cell culture conditions. Independent of environmental 
conditions, potassium phosphate solution was a highly corrosive medium for magnesium 
enhancing corrosion layer formation and the subsequent sample weight gain was highest 
for magnesium pins incubated.  Overall, these results show that weight of magnesium is 
greatly influenced by the variation in composition of incubation media and surrounding 
conditions.  
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Figure 6: Weight of magnesium pins is influenced by variation in incubation settings. Magnesium pins 
with 10 mm length and 0.4 mm diameter were incubated in DMEM (filled circles), used DMEM (filled 
rhombi), fibroblasts (empty rhombi), KH2PO4 (filled squares) and PBS (empty squares) at room temperature, 
at 37C with 5% CO2 under standard cell culture conditions and at 37C and then changes in weight of 
individual pins were measured daily over the time. Percent change in the weight of magnesium pins 
incubated in DMEM (filled circles), used DMEM (filled rhombi), fibroblasts (empty rhombi), KH2PO4 (filled 
squares) and PBS (empty squares) at room temperature (A), at 37C plus 5% CO2 in a humidified cell culture 
incubator (B) and at 37C (C).  Magnesium pins without immersion in physiological solutions served as 
control (dotted line). Statistical analysis was done using Student’s T-Test. 
3.1.2 Effect of magnesium degradation on local pH of corrosion media  
During the degradation of magnesium, hydroxide ions (OH-) are released as corrosion 
product which leads to the rise in pH of the surrounding medium. Therefore, a change in 
pH of the immersion media containing magnesium implants is another criterion to estimate 
the degradation rate. For monitoring pH values, magnesium wires were cut into pins with 
5mm in length and incubated in 250 µl of test solutions.  pH values of all media containing 
magnesium pins increased after 24h incubation (Figure 7A-C). Rises in pH of test solutions 
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due to degradation of magnesium were higher in media incubated at 37C or room 
temperature as compared to the solutions that were incubated at 37C with 5% CO2 under 
standard cell culture conditions. However, at later time points, pH values of all media 
became stable. This could be explained by the influence of the pH, whereby CO2 decreases 
the pH and increases the initial degradation rate. The corrosion product Mg(OH)2 increases 
the pH and decreases the degradation rate. 
 
 
Figure 7: Magnesium degradation increases pH of corrosion media. Magnesium pins with 5 mm length 
and 0.4 mm diameter were immersed in 250 µl of DMEM (filled circles), used DMEM (empty circles), used 
DMEM with pH adjusted to 7.5 (filled triangles), fibroblasts (empty triangles), KH2PO4 (filled squares) and 
PBS (empty squares) and then incubated at three variable environmental setting (A-C). Changes in pH of 
DMEM (filled circles), used DMEM (empty circles), used DMEM with pH adjusted to 7.5 (filled triangles), 
fibroblasts (empty triangles), KH2PO4 (filled squares) and PBS (empty squares) containing magnesium pins 
incubated at room temperature (A), at 37C plus 5% CO2 in cell culture incubator(B) and at 37C (C) were 
recorded over the time.  
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3.1.3 Measurement of hydrogen generation  
Hydrogen gas is generated as a result of magnesium degradation. The measurement of 
hydrogen gas is considered another criterion to determine the degradation rate of 
magnesium implants. It is also known that degradation of one gram magnesium leads to 
the generation of one ml of hydrogen gas. Hence, this method is too simple and direct way 
to determine corrosion of magnesium. Due to the small dimensions of magnesium pins and 
fast escape of hydrogen gas, it was difficult to measure the exact amount of hydrogen. 
However, due to rapid corrosion properties, it was possible to measure hydrogen 
production from magnesium incubated in used DMEM and to compare it with fresh DMEM. 
To measure hydrogen gas, samples were incubated under standard cell culture conditions 
(Figure 8). Amount of hydrogen produced was significantly higher for wires dipped in 
spent cell culture medium (Figure 8 empty circles) as compared to DMEM (filled circles).  
 
Figure 8: High release of hydrogen is produced form magnesium implants. Magnesium pins with 15 mm 
length and 0.4 mm diameter were individually placed into 1ml syringes each filled with fresh cell culture 
medium DMEM or used cell culture medium. Syringes were incubated at 37C with 5% CO2 under optimum 
cell growth conditions and hydrogen gas as degradation product was measured from the scale of each syringe 
at indicated time points. Hydrogen volume produced by magnesium incubated in used DMEM (empty circles) 
as compared to magnesium incubated in DMEM (black circles). (Statistical analysis was done using Students's 
T-Test (paired) and p-value was calculated) 
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3.1.4 Surface properties of magnesium implants  
To reveal surface properties of magnesium implants incubated in fresh DMEM and spent 
DMEM, magnesium pins were incubated for the indicated time points at optimum cell 
culture conditions.  After incubations, corrosion layers on magnesium implants were 
observed by scanning electron microscopy.  Magnesium implants incubated in fresh DMEM 
corroded slowly therewith remained intact for 8 weeks and evidenced the formation of 
corrosion layer (Figure 9A-C). In comparison, used cell culture medium led to rapid 
degradation of magnesium pins and completely dissociated into small corrosion fragments 
within 2 weeks of immersion (Figure 9D-E). This confirmed that used cell culture medium 
containing cellular excretion products had more aggressive corrosion potential. 
 
Figure 9: Magnesium corrodes more rapidly in spent cell culture medium. Magnesium pins with 15 mm 
length and 0.4 mm diameter were immersed in DMEM and used DMEM for 2, 4 and 8 weeks at 37C with 5% 
CO2 in a cell culture incubator. Then these pins were observed by SEM after 2 (A), 4 (B) and 8 weeks (C) of 
incubation in fresh DMEM and after 2 (D), 4 (E) and 8 weeks (F) of incubation in used cell culture medium. 
Small picture (A-F) indicates detailed morphology of corrosion layer in each case. Scale bar in each large 
image corresponds to 100 µm and 20 µm to each small image. (SEM images courtesy by Manfred Rohde, HZI) 
3.1.5 In vivo implantation of wires in mouse model 
To compare in vitro degradation with in vivo, magnesium pins were implanted 
subcutaneously and in tail artery of mice as described [27]. To see if difference in site of 
implantation and tail movement had any apparent effect on the degradation of magnesium, 
A B C
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Results 
 
47 
 
magnesium pins were implanted either under the skin (subcutaneously) or into tail artery 
for indicated time. After implantation, surfaces of magnesium were observed with SEM 
(Figure 10). The surfaces of magnesium implants after residing in subcutaneous tissue 
seemed more closely to specimens which were incubated in DMEM. However, surfaces of 
implants explanted either from subcutaneous region or from tail artery seemed similar and 
remained intact after 8 weeks of implantation (Figure 10A-F). Over all, changes in site of 
implantation as well as tail movement did not seem to lead to differences in the 
degradation and formation of corrosion layer on the surface of magnesium. In vitro 
degradation and the degradation rate in vitro seemed  
 
Figure 10: Changes in site of implantation shows no apparent effects on degradation of magnesium. 
Magnesium implants with 10 mm length and 0.4 mm diameter were surgically inserted into the tail artery 
and under the skin of BALB/c mice. Implants were then removed from the body of animals after 2, 4 and 8 
weeks of implantation and their surfaces were observed by scanning electron microscopy (A-F). Surface 
morphology of magnesium pins after residing for 2 (A), 4 (B) and 8 weeks (C) under the skin of mice. Surfaces 
of magnesium implants after staying for 2 (D), 4 (E) and 8 weeks (F) in tail artery. Small picture (A-F) 
indicates detailed morphology of corrosion layer in each case. Scale bar in each large image corresponds to 
100 µm and 20 µm to each small image. (SEM images courtesy by Manfred Rohde, HZI) 
3.1.6 In vivo compatibility of magnesium pins with the adjacent tissue 
To determine the host reaction against magnesium pins, histology of the respective tissue 
sections was performed. It was found for magnesium pins implanted in subcutaneous 
A B C
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region that they were enclosed in connective tissue and isolated from skin and skeletal 
tissue fibers due to their small dimensions. Thereby, histological evaluations of tail tissue 
containing magnesium pins were performed only. For comparison, tail tissues implanted 
with standard titanium and magnesium silver alloy pins as well as mice without 
implantations were used as controls. No gross pathological changes as well as recruitment 
of high number of inflammatory cells could be seen in tissues around magnesium, 
magnesium silver alloy or titanium implants (Figure 11A-D). However, a fibrous tissue 
layer was visible around each of the tested implant (Figure 11B-D; i). The connective tissue 
seemed thicker around magnesium silver pins (Figure 11C; i). This analysis showed that 
degrading magnesium implants were as tissue compatible as titanium. 
 
Figure 11: Magnesium implants are compatible with tail tissue similar like titanium. Magnesium, 
magnesium silver alloy and titanium pins with 10 mm length and 0.4 mm diameter were taken after 8 weeks 
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of implantation in tail artery of mice, formalin fixed, paraffin embedded and hematoxylin and eosin-stained. 
Tail implants (i) were removed before tissue sectioning. Mouse tail tissue without any implantation was 
stained for comparison (A), tail tissue adjacent to magnesium implant (B), magnesium silver alloy (C) and 
titanium (D). The labelled structures shown are as follows: site of implantation (i); adipose cells (a); granular 
tissue (g); muscle fiber (m); tail bone with marrow (b) and epidermis (e). (Histology courtesy by Andreas 
Weizbauer and Elmar Willbold from MHH, Hannover)  
 
3.2  Interlocking strength between magnesium and tibia bones 
3.2.1 Determination of interlocking force between magnesium and tibia bones 
To investigate if magnesium can establish strong bonding with surrounding hard tissue, 
magnesium pins were inserted into tibia bones and incubated in DMEM under standard cell 
culture conditions. For comparison magnesium silver alloy and non-degradable titanium 
pins were inserted in tibia bones and subsequently incubated under same conditions. To 
completely eliminate the contribution of live tissue, tibia bones isolated from mice were 
immersed in formalin solution for one week so that osteocytes are dead. To determine 
strength of bone-implant interaction a biomechanical pull-out test was performed by 
employing material testing machine. Pure magnesium as well as magnesium silver pins 
evidenced significantly higher pull out force as compared to titanium at all tested time 
points (Figure 12A). To confirm if increase in binding force between magnesium and tibia 
bones were purely due to corrosion process, magnesium pins were inserted in tibia bones 
and incubated in three different immersion solutions as described. Pull out force between 
magnesium wires and tibia bones in effect to different incubation media (Figure 12B) also 
increased. However, this pull out force was significantly higher when specimens were 
incubated in fast corroding medium which led to the formation of robust corrosion layer. 
Hence, it was confirmed that development of strong interlocking at magnesium-bone 
interface was mainly due to formation of corrosion layer around degrading magnesium and 
not dependent on new bone formation. This indicates that pull-out experiments cannot be 
used as parameters for bone healing or bone conductive effects of magnesium implants.  
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Figure 12: Interlocking at magnesium-bones interface is increased even in the absence of cells. 
Magnesium (Mg), magnesium silver alloy (Mg2Ag) and titanium pins (Ti) with 15 mm length and 0.4 mm 
diameter were inserted into tibia bones isolated from BALB/C mice which were then treated with formalin to 
eliminate live cells. Tibia bones inserted with implants were immersed in corrosion media and incubated at 
37oC with 5% CO2 under standard cell culture conditions for indicated time points. At each of the indicated 
time points, interlocking strength between implants and bones was determined by applying mechanical pull 
out test setup. A: The bars indicate average values of pull out force measured between magnesium and tibia 
bones (grey bars), magnesium silver alloy and tibia bones (empty bars) and titanium and tibia bones (black 
bars). In parallel, magnesium implants inserted in tibia bones were incubated in fresh DMEM containing 10% 
serum, used DMEM and 100 mM KH2PO4 under the same conditions. Pull out force in effect to different 
corrosion media was measured at indicated time points. The bars represent average of pull out force 
determined between magnesium and tibia bones after incubations in DMEM (empty bars), KH2PO4 (grey 
bars) and used DMEM (black bars). (Statistical analysis was done using Students's T-Test (paired) and p-
value was calculated. (Pull out measurements courtesy by Andreas Weizbauer from MHH, Hannover) 
3.2.2 Surface morphology of corrosion layers on magnesium 
Formation of corrosion layer around magnesium seemed a major player to stimulate 
strengthening of bone-implant interlocking. Therefore, to reveal its morphology, 
magnesium pins were directly incubated in DMEM, used DMEM and KH2PO4 under 
standard cell culture conditions for seven days and then observed under scanning electron 
microscope (Figure 13A-D). Scanning electron microscopy of magnesium wires was done 
to see morphologies of corrosion layers after incubations in DMEM, spent cell culture 
medium and KH2PO4. As compared to magnesium pins without incubation (Figure 13A), a 
thick corrosion layer developed over the time around the corroding magnesium in effect to 
immersion solutions (Figure 13B-D). However, this layer was variable in shape with the 
composition of corrosion media and probably this might be the reason for variation in pull 
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out force. Thus, corroding magnesium implants develop a corrosion layer and the elements 
of this layer interact with bone tissue and develop strong bonding showing that the 
increase in the implant pull out force occur independent of bone growth. This technique 
therefore appears not appropriate to demonstrate bone- growth stimulating effects of 
magnesium implants [161].  
 
Figure 13: Corroding magnesium implants develop a corrosion layer over the time. Magnesium pins 
with 15mm length and 0.4 mm diameter were incubated for 7 days under standard cell culture conditions. 
Samples were then removed and the corrosion layer on each was visualized by employing SEM. Surface of 
magnesium pins before incubation as control (A) and after incubation in fresh DMEM (B), in spent DMEM (C) 
and in 100 mM KH2PO4 (D) attracted the formation of corrosion layer. (SEM courtesy by Florian Evertz from 
Leibniz University, Hannover) 
3.2.3 Surface analysis of pulled out wires from tibia bones 
To know the elemental composition of corrosion layer and factors responsible for the 
increase in pull out force, magnesium pins incubated directly or those removed from bones 
by pull out setup were subjected to Energy dispersive X-ray spectroscopy (EDX). EDX 
analysis of magnesium wires before incubation showed elements of magnesium (Mg), some 
amount of oxygen and also carbon (Figure 14A). After corroding for seven days, a corrosion 
layer mainly composed from additional elements of carbon, oxygen, sodium, magnesium, 
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calcium and phosphorus was detected (Figure 14B-D). However, calcium was detected only 
on the surfaces of implants which were incubated in DMEM and in spent cell culture 
medium (Figure 14B, C). The cavity of tibia bones analyzed for comparison and the 
elements of carbon as a major element and additionally oxygen, phosphorus and calcium 
were detected (Figure 14E). Then EDX analysis of pulled-out magnesium implants 
indicated the presence of carbon, oxygen, sodium and magnesium (Figure 14F-H). In 
addition, potassium was detected only from the surfaces of wires incubated in KH2PO4 
(Figure 14H). This indicated that elemental compositions of magnesium pins remained 
same if implants were incubated directly or after insertion in bones into their respective 
media. Increase in the amount of carbon on each of the pulled-out wire also did not seem to 
be from bone as the samples were incubated in the presence of carbon dioxide and 
therefore carbon was also detected from the samples incubated directly into the media 
(Figure 14B-D compare with F-H). This confirmed that the strong interlocking between 
magnesium and adjacent bone tissue is solely due to the formation of a corrosion layer. 
 
Figure 14: EDX analysis of magnesium implants. Magnesium pins with 15mm length and 0.4 mm diameter 
were directly incubated for seven days in physiological solutions and incorporation of corrosion layer 
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elements was determined by employing EDX.  EDX analysis and percent elemental composition of magnesium 
pins without incubation as control (A), after 7 days of incubation in  DMEM (B), in spent cell culture medium 
(C) and in 100 Mm KH2PO4 solution(D).  Magnesium pins which were pulled out from tibia bones after 
incubations in indicated media were also subjected to EDX. For comparison, EDX of the internal cavity of tibia 
bones isolated from mice (E). EDX of pulled-out magnesium pins after 15 days of incubation in DMEM (F), 
spent cell culture medium (G) and100 mM KH2PO4 solution (H). (EDX analysis courtesy by Florian Evertz 
from Leibniz University, Hannover) 
3.3 A protective coating for magnesium to limit fast degradation and 
hydrogen generation 
3.3.1 The selection of suitable phosphate solution as coating medium 
Phosphorus is essential component of natural corrosion layer deposited on the surface of 
corroding magnesium implants. To see the feasibility of phosphate coatings, magnesium 
discs were incubated in three phosphate compounds (Table 12) at 37C and 37C with 5% 
CO2 under cell culture conditions. A bulky crystalline phosphate coating adhering around 
magnesium formed when samples were incubated under cell culture conditions with CO2. 
In comparison, at 37C coatings with similar morphologies formed but to a minor extent 
(Table12, Figure 15). Out of tested phosphate solutions, KH2PO4 led to the accumulation of 
maximum coating mass around magnesium implants (Table 12). 
Table 12: Properties of coating solutions 
Coating solutions KH2PO4 K2HPO4 NaH2PO4 Mg(OH)2         MgF2 
Concentrations 100mM 100mM 100mM 1M  
NaOH 200 
g/l 
HF 40 % 
pH 4.62±0.02 9.23±0.005 4.65±0.03 
 
9.92±0.005 
- 
Coating mass (mg/cm2) 
at 37C+CO2 
14.23±0.29 3.72±0.78 11.62±0.59 16.06±0.51 -1.6±0.5 
Coating mass (mg/cm2) 
at 37C 
9.14±0.40 1.63±0.56 8.88±0.68 14.10±0.83 - 
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Figure 15: Di-hydrogen phosphate (H2PO4) forms a coating on metallic magnesium in the presence of 
CO2. Magnesium discs with 5 mm diameter and 2 mm height were incubated individually in 100 mM of 
KH2PO4, K2HPO4 and NaH2PO4 solutions for three days either at 37C with 5%CO2 under standard cell culture 
conditions (a-c)  or at 37C alone (d-f). After 3 days, discs were removed and images were taken using a 
bimolecular microscope. Magnesium coated with KH2PO4 (a, d), K2HPO4 (b, e) and NaH2PO4(c, f). 
3.3.2 Performance of phosphate coated implants in cell culture medium  
In vitro immersion assay by using DMEM was performed to select best phosphate 
compound as coating solution. Corrosion resistant properties of magnesium discs coated 
with or without indicated phosphate solutions were tested by measuring weight loss, 
hydrogen evolution and pH elevation at standard cell culture settings. All phosphate based 
coatings degraded slowly as compared to magnesium discs without coating during the 
tested time period (Figure 16A). No measureable hydrogen gas production from both 
KH2PO4 and NaH2PO4 coated discs was found. However, plain magnesium as well as K2HPO4 
coated magnesium led to H2 production (Figure 16B). Also, pH values of the corrosion 
medium for KH2PO4 and NaH2PO4 coated discs remained stable like control medium 
without discs. However, in case of plain magnesium as well as magnesium coated with 
K2HPO4 pH of the medium increased gradually (Figure 16C). On the basis of these data, 
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from three coating solutions, potassium dihydrogen phosphate was selected as best coating 
media because it led to the formation of degradable corrosion resistant stable coating 
around magnesium. For further studies, OH- ion formation as by-product of magnesium 
degradation that can promote precipitation of magnesium hydroxide Mg (OH)2 on the 
surface of magnesium was selected as coating solution. Fluoride coatings have been 
reported as corrosion resistant; therefore, fluoride coated magnesium discs (MgF2) were 
used as reference coating. 
 
Figure 16: KH2PO4 is preferred coating solution. Magnesium discs coated with phosphate salts were 
immersed in 10 ml of DMEM and incubated for 2 days at 37C with 5% CO2 under standard cell culture 
conditions. After 48h of incubations, the decrease in mass was determined.  A: Decreases in the weight of 
KH2PO4 coated (a), K2HPO4 coated (b) and NaH2PO4 coated (c) magnesium discs after 48h of incubations. 
Magnesium without coating served as control (d). B: Discs were incubated in syringes containing 10 ml of 
DMEM at conditions as described previously. Hydrogen gas measured from KH2PO4 coated (a), K2HPO4 coated 
(b) and NaH2PO4 coated (c) magnesium discs after 48h of incubation. C: Test specimens were immersed in 10 
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ml of DMEM and changes in pH of test solution containing KH2PO4 coated magnesium (a), K2HPO4 coated 
magnesium (b) and NaH2PO4 coated magnesium (c) plain magnesium discs after 48h of incubations.  
3.3.3 Determination of appropriate time required for KH2PO4 coatings 
To select a suitable time required for the formation of phosphate coatings, magnesium 
discs were incubated in KH2PO4 solutions at standard cell culture conditions and the 
resulting coatings mass was measured at indicated time points. In parallel, the pH of 
KH2PO4 in the presence of magnesium samples was measured. The degradation process of 
magnesium provokes a slow phosphate coating, a process that took a minimum of 3 days. 
Immersion in KH2PO4 at standard cell culture conditions led to gradual increase in the 
weight of these discs (Figure 17A). After immersion for 24h up to two weeks, no further 
addition in weight of magnesium discs incubated in KH2PO4 could be observed, indicating 
that 3 days was an optimum time period required for coating. Similarly, changes in pH of 
KH2PO4 solution containing discs showed an initial burst increase however at later stages 
pH of the phosphate solution became stable (Figure 17B).  This experiment confirmed that 
in the presence of potassium phosphate, magnesium discs develop a coating within three 
days. 
 
Figure 17: Process of phosphate coating on magnesium takes 3 days of incubation. Magnesium discs 
were incubated in 100 mM KH2PO4 solution to estimate minimum time required for coating process. A: 
Gradual increases in weight of coating mass on the surface of magnesium discs incubated in KH2PO4 due to 
accumulation of potassium phosphate crystals (filled circles) as compared to control (empty circles). B: 
changes in the pH of 100 mM KH2PO4 solution containing magnesium discs (filled circles) as compared to 
solution without discs. 
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3.3.4 Detailed analysis of KH2PO4 coated magnesium discs 
To reveal detailed morphology and elemental composition of phosphate coatings, SEM, EDX 
and XRD analyses were performed. Electron microscopy of phosphate coated magnesium 
discs showed the presence of white crystalline coating on magnesium implants (Figure 
18A). The EDX pattern of these coatings specifies that they were constituted mainly from 
oxygen, magnesium and phosphorus (Figure 18B). Further, XRD diffraction pattern at 
angles 2θ from plain magnesium and phosphate coated magnesium discs was also 
recorded. The diffraction peaks recorded from magnesium without coating were typical for 
pure magnesium surfaces. However, after the development of phosphate coatings, some 
additional peaks emerged most of which were corresponding to Newberyite 
(MgHPO4.3H2O) (Figure 18C right). Thereby, indicating that Newberyite (MgHPO4.3H2O) is 
most likely the dominant crystalline compound of the coating. 
 
Figure 18: Newberyite coating develops around magnesium after incubation in KH2PO4. Magnesium 
implants were incubated in 100 mM KH2PO4 solution for three days at 37oC with 5% CO2 under standard cell 
culture conditions. After indicated incubation time, magnesium discs were removed and to identify final 
coating these samples were subjected to SEM, EDX and XRD analyses. (A) SEM images of magnesium before 
phosphate treatment (left) and after treatment with KH2PO4 (left). Scale bar 100µm. (B) EDX of plain 
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magnesium (left) and after the development of phosphate coating. Corrosion elements correspond to the 
emitted X-ray energy and are shown above the particular peaks. Within corresponding inset tables, the 
percentage of elements is also given. O, oxygen; Mg, magnesium; P, phosphorus. (C) X-ray diffraction (XRD) 
analysis of magnesium discs without coating (left), and after coating with phosphate (right B). I, relative X-ray 
reflection intensity, 2θ, diffraction angle (SEM and EDX analysis courtesy by Florian Evertz and XRD analysis 
courtesy by Marc Kieke from Leibniz University, Hannover) 
3.3.5 In vitro immersion tests for phosphate treated magnesium implants 
To determine if phosphate coatings were protective, immersion tests were performed by 
employing DMEM cell culture medium containing proteins. Specimens were incubated in 
media for short and long time under standard cell culture conditions. Degradation after 
short exposure time was determined by measuring hydrogen (H2evo) and the pH. The mass 
loss was minute and could only be determined after prolonged incubation. Magnesium 
without coating (Mg) and magnesium hydroxide coated [Mg(OH)2] samples exhibited rapid 
corrosion and led to the generation of hydrogen gas and a rise in the pH of surrounding 
solution (Figure 19A). Contrary to it, phosphate coated specimens did not show any signs 
of gas production similar to fluoride coated magnesium and titanium (Figure 19B). This 
was also consistent with the weight change which was measured after removing corrosion 
products with chromic acid. Minimal weight loss was observed for phosphate coated (MgP) 
discs as compared to other coatings (Figure 19C and Table 3) 
 
Figure 19: Corrosion rate in magnesium is reduced after phosphate treatment. Magnesium implants 
before or after phosphate (MgP), fluoride (MgF2) or magnesium hydroxide Mg(OH)2 coatings were incubated 
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in individual setups containing 10ml of DMEM at standard cell culture environment. Early corrosion was 
assessed either by measuring hydrogen generation or pH elevation after 48h of incubation. However, overall 
corrosion rate was estimated after 8 weeks of incubation in DMEM by measuring weight loss after treating 
samples with diluted chromic acid. A:  Amount of hydrogen gas produced in DMEM due to corrosion of plain 
magnesium (Mg), magnesium coated with potassium phosphate (MgP), magnesium coated with fluoride 
(MgF2), magnesium coated with magnesium hydroxide (Mg(OH)2 and titanium after 48 h incubation. B: 
Variations in pH as an indicator of corrosion process measured after 48h in DMEM containing plain 
magnesium (Mg), phosphate coated magnesium (MgP), fluoride coated magnesium (MgF2), magnesium 
hydroxide coated magnesium Mg(OH)2 and titanium (Ti). DMEM without implants served as a control. C: 
Cumulative mass loss after 8 weeks of immersion.  
Table 13:  In vitro and in vivo comparison of degradation rates of coated magnesium 
implants 
Implant In vitro degradation (mm/year)*   In vivo degradation(mm/year)** 
Mg 0.17±0.02 1.01±0.33 
MgP 0.08±0.025 0.55±0.029 
MgF2 0.14±0.042 0.52±0.007 
Mg.Mg(OH)2 0.37±0.073 0.67±0.066 
Ti 0.00 0.00 
3.3.6 Elemental composition of coated discs after short and long-term incubation 
Magnesium corrosion layer components particularly calcium and phosphorus are known to 
be involved in new bone formation. To characterize the composition of the corrosion layer, 
specimens were subjected to SEM and EDX analyses after short term and long term 
incubations in cell culture medium (Figure 20A- D). Within 48h, white corrosion 
precipitates composed of the elements of magnesium, calcium and phosphorus emerged on 
the surface of magnesium (Figure 20A and B left to right). After this period, all coated 
implants had largely maintained the original coating composition (Figure 20A and B left to 
right). However, even though magnesium hydroxide coating did not completely disappear 
they appeared fragile and did not eliminate hydrogen evolution nor rise in pH. Titanium 
(Ti) surfaces remained unchanged (Figure 20A and B right). On all discs small amounts of 
Mg, magnesium without coatings; MgP, phosphate coated magnesium; MgF2, fluoride coated magnesium; 
Mg.Mg(OH)2, magnesium hydroxide coated magnesium; Ti, titanium. 
*Test specimens as indicated were immersed in DMEM for 8 weeks 
**Indicated surfaces were implanted subcutaneously in mice for 8 weeks 
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carbon emerged. After prolonged incubation in cell culture medium, surfaces of magnesium 
with as well as without coating were covered by thick corrosion layer containing the 
elements of magnesium, oxygen, calcium, phosphorus and traces of carbon (Figure 20C and 
D). However, internal features typical for original phosphate coatings were still apparent 
(Figure 20C and D). After corroding, the elemental compositions detected on phosphate 
coatings were highly similar to those on magnesium without coating or magnesium coated 
with fluoride and magnesium hydroxide coated magnesium. In comparison, phosphate 
coatings avoided the rapid initial corrosion of magnesium without disturbing the 
subsequent precipitation of corrosion products. In comparison, changes in the structure as 
well as composition of titanium discs could be detected (Figure 20C and D). 
 
Figure 20: Phosphate coatings preserve desirable properties of magnesium implants. Magnesium discs 
with and without coatings were immersed in DMEM for 48h and 8 weeks  at 37C with 5% CO2 in a humidified 
cell culture incubator A: SEM images of implants after 48 h of incubation from left to right magnesium 
without coatings, phosphate coated, fluoride coated, magnesium hydroxide coated and titanium. B: EDX 
pattern of indicated surfaces. C: SEM images of discs after 8 weeks of incubations. D: EDX pattern same of 
same discs. Corrosion elements correspond to the emitted X-ray energy and are shown above the particular 
peaks. Within corresponding inset tables, the percentage of elements is also given. C, carbon; O, oxygen; Mg, 
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magnesium; Na, sodium; F, fluoride; P, phosphorus; Ca, calcium; Al, aluminum; Ti, titanium. (SEM and EDX 
analysis courtesy by Florian Evertz from Leibniz University Hannover)   
3.3.7 Degradation kinetics of KH2PO4 treated magnesium in plasma and r-SBF 
To confirm the initial corrosion resistance provided of magnesium phosphate coatings, 
immersion tests were performed in blood plasma and simulated body fluid (SBF) by 
measuring magnesium ions concentration under standard cell culture conditions. Small 
concentrations of magnesium ions were detected in plasma supernatant of both 
magnesium implants with and without phosphate coatings (Figure 21A). However, lesser 
magnesium ion concentrations were measured in plasma containing phosphate coated 
magnesium as compared to magnesium without coating (Figure 21A). Simulated body fluid 
resulted in higher release of Mg2+ ions from magnesium implants. Even then, phosphate 
coated magnesium implants were more resistant against degradation particularly during 
the initial time period (Figure 21B). As listed in Table 14, the corrosion rate as calculated 
from the weight loss was slow in phosphate coated magnesium as compared to magnesium 
without coating. An examination of the corrosion layer composition by SEM and EDX after 
immersion in plasma and SBF showed presence of oxygen, carbon, calcium, magnesium, 
phosphorus and traces of sodium (Figure 21C-F). Hence, phosphate coatings proved 
efficient protective barrier against fast initial corrosion and also led to the formation a of 
corrosion layer closely resembling to a pure magnesium in composition.  
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Figure 21: Phosphate treated magnesium resistance to initial corrosion burst. Phosphate coated and 
plain magnesium discs were individually incubated in plasma and SFB under standard cell culture conditions 
for 6 weeks. Corrosion supernatants were collected on daily basis and magnesium ions concentrations were 
determined after mixing it with magnesium binding reagent. After 6 weeks, test specimens were subjected to 
SEM and EDX analysis and then treated with diluted chromic acid to determine mass loss. Measurement of 
magnesium concentration from plasma or rSFB corrosion supernatants containing plain or phosphate treated 
discs (A and B). Magnesium concentration determined at indicated time points from plasma containing discs 
without coatings (white circles) and after phosphate coating (black circles) (A). Magnesium concentration 
determined at indicated time points from plasma containing discs without coatings (white circles) and after 
phosphate coating (black circles) (B). Surface analysis of discs (C-F). SEM and corresponding EDX of 
magnesium without coating (C) and phosphate coated (D) after 6 weeks incubation in plasma. SEM and EDX 
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of magnesium without coating (E) and phosphate coated (F) after 6 weeks incubation in r-SBF. (SEM, EDX and 
corrosion measurement courtesy by Ana Silva from Leibniz University, Hannover) 
 
Table 14: Corrosion rates of plain magnesium and phosphate coated magnesium 
determined by immersion tests  
Implants Plasma 
(mm/year)            
r-SBF 
(mm/year) 
Mg*  0.41±0.04                              2.78±0.25 
 
MgP 0.35±0.04   1.80± 0.19 
   
 Mg*, magnesium without coatings; MgP, phosphate coated magnesium were incubated in the indicated media 
at 37oC with 5% CO2 under standard cell culture conditions for 6 weeks. Samples were removed treated with 
chromic acid and corrosion rate was determined by weight loss method. 
 
3.3.8 Compatibility of phosphate coatings with mammalian cells  
A cell culture assay was established by employing mouse fibroblasts (NIH3T3) to evaluate 
biocompatible properties of phosphate coated surfaces and compared with plain 
magnesium and standard titanium as controls. Cells were directly seeded on the surfaces of 
plain as well as coated magnesium implants.  Selection of fibroblasts was done on the basis 
of the fact that these are abundant tissue cells that in vivo contact the implant surfaces. 
Fluorescent staining and microscopy was applied to observe cell adherence and 
proliferation. After 3 days of cultivation at standard cell culture conditions, few cells were 
visible on the surface of magnesium without coating (Figure 22A). However, phosphate 
coatings promoted efficient adhering of cells exhibiting similar morphologies as on fluoride 
coated magnesium, standard titanium or on tissue culture plastic (Figure 22A; compared 
MgP with others). As presumed, magnesium hydroxide coatings did not support cells 
attachment and cell proliferation (Figure 22A; Mg(OH)2). Cells density on phosphate coated 
magnesium was similar to the controls (Figure 22B; MgP compare MgF2, Ti and CTR). Over 
all, phosphate coatings supported adhesion and proliferation of murine fibroblast thereby 
indicting excellent cell compatibility 
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Figure 22: Phosphate coated magnesium are compatible with murine fibroblast. Fibroblasts (NIH3T3) 
were seeded on indicated surfaces and incubated for three days under optimum cell culture conditions and 
then then stained with fluorescent cell proliferation dye (CFSE) A: Fluorescent microscopy of cells on the 
materials used as well as adhesion substrates were as follows: magnesium without coatings (Mg), KH2PO4 
coated (MgP), fluoride coated (MgF2), magnesium hydroxide coated discs (Mg(OH)2) and titanium (Ti) 
polystyrene surface (CTR) (Scale bar 100 µm). B: Quantitative determination of adherent cells counted from 
mentioned surfaces. 
3.3.9 Cell viability and interleukin 8 (IL-8) response  
To validate biocompatibility of phosphate coatings for various biomedical applications 
magnesium implants coated with or without phosphate were incubated with porcine nasal 
epithelial cells (PNEC). Metabolic activity of these cells after incubation with implants was 
determined as indicator of cells viability. Metabolic activity of these cells significantly 
decreased in the presence of magnesium samples without coatings (Figure 23A; Mg). 
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However, on phosphate coatings metabolic activity of cells remained normal similar like 
cells which were incubated without any implant (Figure 23A; MgP compare with CTR). In 
agreement with this finding, a gradual rise in magnesium concentration was determined 
from culture medium containing magnesium without coating as compared to phosphate 
coated magnesium at indicated time points (Figure 23B). Phosphate coated implants 
increased corrosion resistance and reduced the release of magnesium ions thereby 
promoting cells metabolic activity (Figure 23B; MgP). To determine potential inflammatory 
responses of cells to implants, magnesium implant with and without phosphate coatings 
were incubated with PNEC and IL-8 secretion as a pro-inflammatory marker was measured 
in the culture medium. IL-8 secretion increased significantly from cells containing 
magnesium implants without coatings (Figure 23C; Mg). In contrast to this, subtle increase 
in IL-8 production was measured from cells containing phosphate coated magnesium 
(Figure 23C; MgP). However, after 48h of incubation IL-8 release from PNEC increased 
even in the presence of phosphate coated magnesium samples (Figure 23D). Overall, it 
seemed phosphate coatings increased the corrosion resistance of magnesium and also 
improved the cell compatibility in cell culture assays. 
 
Figure 23: Phosphate treatment reduces corrosion and enhance viability of epithelial cells. Porcine 
nasal epithelial cells (PNEC) were cultivated for 48h with plain magnesium or phosphate coated magnesium 
discs under optimum cell culture conditions and then their metabolic activity was determined by employing 
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CellTiter 96 Aqueous One solution test. In parallel, concentration of magnesium released from the corroding 
implants into surrounding cell medium was also determined calorimetrically using commercial kit. A: 
Metabolic activity of cells without implants as control (CTR), after incubation with plain magnesium (Mg) and 
phosphate coated magnesium (MgP) B: Concentration of magnesium determined from the supernatant cell 
culture medium (AECGM) containing plain or phosphate coated magnesium discs. After 24(C) or 48h (D) of 
incubation, the culture medium containing each of the mentioned implants was collected and interleukin-8 
(IL-8) concentration was determined by commercially available ELISA Kits. (Cell viability as well as IL-8 
assays performed by Stephan Schumacher from TiHo, Hannover) 
3.3.10 Observation of gas cavities around subcutaneously implanted magnesium 
discs 
As an effort to investigate if phosphate coated magnesium were resisting fast corrosion in 
vivo, a novel strategy by employing a murine model (Figure 24). To facilitate the 
localization, implants were inserted subcutaneously at the back of mice (Figure 25A). 
Measurement of height and diameter of subcutaneous gas pouches around corroding 
implants was used to assess in vivo degradation kinetics. After a day of implantation, 
subcutaneous gas pockets started to develop around magnesium implants without coatings 
and magnesium hydroxide coated magnesium (Figure 25A; Mg and Mg(OH)2). In contrast 
to this, no signs of gas formation could be visualized around phosphate coated and fluoride 
coated magnesium discs (Figure 25A; MgP and MgF2). However, on day 7 post-
implantation, small gas bubbles emerged around fluoride coated magnesium discs (Figure 
25A; MgF2) which disappeared gradually. Gas pouches were always visible around 
magnesium hydroxide coated discs. This indicated that these coatings were not corrosion 
protective (Figure 25A; Mg(OH)2). Gas bubbles could be seen around magnesium discs 
without coatings during early weeks but they disappeared with time this confirmed that 
degradation rate of magnesium diminishes with the formation of a corrosion layer and 
suggests that modest gas volumes were diffusing through the tissue without leading to 
bubbles. The phosphate coated magnesium implants completely abrogate gas cavities while 
magnesium without coating and magnesium hydroxide coating led to gas burst shortly 
after implantation (Figure 25B).  
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Figure 24: Establishment of murine model for measurement of gas cavities around corroding 
magnesium discs. A: Magnesium discs were subcutaneously implanted into mouse. B: After implantation gas 
cavities are generated around the magnesium discs and this subcutaneous air bubble looks like partial 
sphere. C: Height and diameter of this partial sphere were measured with help of Vernier caliper as mention 
and then volume of gas was calculated D. 
 
Figure 25: Potassium phosphate treatment eliminates gas accumulation from magnesium implants. 
Magnesium without coatings (Mg), phosphate coated magnesium (MgP), fluoride coated magnesium (MgF2) 
and magnesium hydroxide coated magnesium were surgically implanted subcutaneously in Balb/C mice and 
A B
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then mice were observed for 8 weeks post-implantation. Gas accumulation around implanted discs was 
imaged using camera and their dimensions were measured with Vernier caliper at the indicated time points 
after transplantation. A: from left to right magnesium without coatings, phosphate coated, fluoride coated and 
magnesium hydroxide coated magnesium implants after subcutaneous implantation on the dorsum of mice. 
B: Volume of gas accumulation around implanted discs, plain magnesium (circles), KH2PO4 coated magnesium 
(squares), fluoride coated magnesium (triangles) and magnesium hydroxide coated magnesium (rhombi). 
3.3.11 Surface properties of discs after implantation 
The corrosion process of magnesium is greatly influenced by the environment. To 
investigate changes in the elemental distribution and corrosion morphology, all implants 
were explanted and subjected to EDX and SEM analyses. Two days after implantation, a 
corrosion layer consisting of carbon, oxygen, magnesium, phosphorus, calcium and traces 
of sodium could be detected on plain magnesium implants (Figure 26A). Interestingly, after 
two days incubation in DMEM, a compact corrosion layer was not established on plain 
magnesium. Accordingly, this corrosion of magnesium appeared rapid in the soft tissue as 
compared to cell culture medium. Phosphate coated magnesium implants maintained their 
original morphology and composition after short time of implantation (Figure 26A; MgP). 
No major changes in the structure of fluoride and magnesium hydroxide coated implants 
could be observed. However, phosphorus and calcium from tissue had accumulated on 
these implants (Figure 26A; MgF2 and Mg(OH)2). There were no detectable changes of 
titanium implants except accumulation of carbon which may consist of tissue remnants 
(Figure 26A;Ti). After residing for prolonged time in soft tissue, surfaces of magnesium 
implants with and without coatings were surrounded by clearly visible corrosion layer 
(Figure 26C). This layer was composed from carbon, oxygen, magnesium, phosphorus and 
calcium in case for plain or coated magnesium implants (Figure 26D). These experiments 
confirmed that phosphate based coatings while inhibiting initial hydrogen generation allow 
the formation of corrosion layer that is closely resembling in morphology and elemental 
composition to the layer formed with time on the surface of magnesium without coating. 
Carbon on titanium discs was remnant of fibrous tissue capsule (Figure 26D; Ti). 
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Figure 26: Structure and elemental composition of corrosion layers at early and later stages post-
implantation. Magnesium discs with or without coatings were surgically implanted subcutaneously in 
Balb/C mice and then after 48h and 8 weeks post-implantation, implants were removed and subjected to SEM 
and EDX analyses. The materials used were as follows: Magnesium without coatings (Mg), phosphate coated 
magnesium (MgP), fluoride coated magnesium (MgF2) and magnesium hydroxide coated magnesium. SEM 
and corresponding EDX of indicated surfaces after residing 48h in soft tissues (A, B). SEM and EDX of 
indicated surfaces after 8 weeks of residing in soft tissue. Corrosion elements correspond to the emitted X-ray 
energy and are shown above the particular peaks. Within corresponding inset tables, the percentage of 
elements is also given. C, carbon; O, oxygen; Mg, magnesium; Na, sodium; F, fluoride; P, phosphorus; Ca, 
calcium; Al, aluminum; Ti, titanium.(SEM and analysis courtesy by Florian Evertz from Leibniz University, 
Hannover) 
3.3.12 In vivo corrosion rate determined by weight loss  
In vivo corrosion of phosphate coated magnesium was estimated by the weight loss. As 
expected, magnesium discs without coatings showed the highest weight loss (Figure 27A 
and B). In addition, deep corrosion pits were observed (Figure 27A; Mg).  Interestingly, 
phosphate coated magnesium appeared corrosion resistant under the identical conditions 
and minor weight loss similar to fluoride coated magnesium was observed. Surfaces of 
phosphate coated and fluoride coated discs were intact (Figure 27A; MgP and MgF2).  In 
comparison, magnesium hydroxide coated magnesium samples showed a high weight loss 
and substantial gas generation (Figure 27B). Deep corrosion cracks was present on the 
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surface of Mg(OH)2 coated discs (Figure 27A). The corrosion rate of phosphate coated 
magnesium showed a modest corrosion compared to magnesium implants without coating 
Table 14. Hence, in addition to the elimination of gas cavities, phosphate coatings reduced 
weight loss and corrosion rate of magnesium.  
 
Figure 27: Phosphate treatment results in the reduction of mass loss after in vivo implantation. Tested 
implants were left in soft tissue for 8 weeks and then treated with diluted chromic acid to remove tissue 
debris and corrosion layer. A: Surfaces of magnesium without coating (Mg), phosphate coated (MgP), fluoride 
coated (MgF2), magnesium hydroxide coated Mg(OH)2 and titanium implants. B: Mass loss from indicated 
implants after 8 weeks of implantation. 
3.3.13 Modest inflammatory response against implanted discs 
Implants may trigger immune reactions and accumulation of inflammatory cells at tissue-
implant interfaces. To test the biocompatibility and to evaluate the reaction of living tissue 
to coated magnesium implants, tissue samples were stained with hematoxylin and eosin. A 
layer of fibrous tissue with infiltration of some giant cells and granulocytes was observed 
around magnesium discs without coating and titanium discs (Figure 28A and B). In 
addition, a focal infiltration of inflammatory cells including some foreign body giant cells, 
mostly granulocytes was visible (Figure 28D). Some foreign body giant cells could also be 
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detected in the vicinity of the site of implantation of the magnesium discs (Figure 28 D). All 
of the coated magnesium discs elicited an adequate host response (Figure 29). Fibrous 
tissue was observed to encapsulate the coated implants. The infiltration of inflammatory 
cells, mostly granulocytes, with some macrophages was slightly more pronounced in 
samples containing discs coated with fluoride (Figure 29 B, D). A small accumulation of gas 
could be observed around the implants surrounding degradable samples. Additionally, a 
substantial corrosion layer was visible on the surface of all of the implants. The tissue 
surrounding the magnesium implants coated with potassium phosphate indicated that this 
coating provides superior soft tissue compatibility. 
 
Figure 28: Non-inflammatory tissue-implant interface after implantation. Magnesium implants were 
inserted in mice and then after 8 weeks, implants with the adjacent tissue were removed and fixed in ethanol, 
paraffin embedded and stained with hematoxylin and eosin. (A) A magnesium disc without coating. (B) A 
titanium disc. (C) Few giant cells () at the magnesium disc interface. (D) Focal infiltration of inflammatory 
cells (mostly granulocytes) around the titanium implant (black arrows). Features are noted as follows: ‘i’ = 
implant, ‘c’ = corrosion layer, ‘ct’ = connective tissue, ‘gb’ = gas bubble, ‘*’ = giant cells, ‘black arrow’ = 
granulocytes. Scale bar = 100 µm in parts a and b; scale bar = 50 µm in parts c and d. (Histology courtesy by 
Andreas Weizbauer and Elmar Willbold from MHH, Hannover) 
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Figure 29: After phosphate treatment magnesium implants show compatibility with the soft tissue. (A) 
A magnesium disc with phosphate coating. B) A magnesium disc with fluoride coating. C) A magnesium disc 
with magnesium hydroxide coating. D) Inflammatory cells (mostly granulocytes) around the implant with 
fluoride coating. Features are noted as follows: ‘i’ = implant, ‘c’ = corrosion layer, ‘ct’ = connective tissue, ‘gb’ = 
gas bubble, ‘black arrow’ = granulocytes. Scale bar = 100 µm in parts a, b, and c; scale bar = 50 µm in part D. 
(Histology courtesy by Andreas Weizbauer and Elmar Willbold from MHH, Hannover) 
3.4  Mouse model to understand implant-associated infections (Part B) 
3.4.1 Prolonged survival of P. aeruginosa on magnesium implants  
Metallic magnesium shows antibacterial properties under in vitro conditions[62]. To see if 
such inherent properties could also be achieved under in vivo situations, magnesium discs 
were implanted subcutaneously on the back side in mice (Figure 30). For side by side 
comparison, titanium and porous glass beads were implanted. Planktonic cultures of 
bioluminescent pseudomonas aeruginosa were directly injected on the surfaces of implants 
either immediately or 24h after implantation. P. aeruginosa could be seen soon after 
infection on the surfaces of subcutaneously implanted magnesium (Mg), titanium (Ti) discs 
and porous glass (PG) beads (Figure 31A; d0) which started to disappear from the surfaces 
of all implants. Surprisingly, on day1, bacteria resurfaced on magnesium discs alone and 
continued to exist for more than two weeks (Figure 31; Mg mice). However, bacteria did 
Results 
 
73 
 
not reemerge on titanium discs and porous glass beads (Figure 31; Ti and PG). In case 
when P. aeruginosa were injected locally on the surfaces of indicated implants after one day 
post- implantation, bacteria established prolonged infections on magnesium discs alone 
(Figure 32; Mg). To investigate if magnesium implants are susceptible to systemic infection, 
P. aeruginosa were injected intravenously into mice either immediately after implantation 
of magnesium, titanium and porous glass beads or after 24h of implantation. In this case, 
bacteria did not reappear on any of the implants (Figure 33A and B). Overall, it seemed 
magnesium implants were prone to locally injected P. aeruginosa in vivo as compared to 
titanium or porous glass beads. Bacteria were persisting on magnesium implants for a 
prolonged period of time. Hence, antibacterial properties of magnesium were limited to in 
vitro situations. 
 
Figure 30: Establishment of biofilm on implant surfaces. A: Magnesium discs were implanted 
subcutaneously on the back of BALB/c mice. B: Soon after implantation, bioluminescent bacteria were 
directly injected on the surface of these discs. C: with the course of time, bacteria switch into biofilm mode of 
life. D: Bioluminescence of bacteria embedded within biofilm matrix was measured using a non-invasive in 
vivo imaging system 
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Figure 31: Magnesium implants are prone to P. aeruginosa infections. In each mouse implantations were 
done surgically subcutaneously on the back of mice as follows: Mg, magnesium; Ti, titanium; PG, porous glass. 
Immediately after implantation, 5µl of freshly grown bioluminescent P. aeruginosa at OD600=0.1 in LB 
suspension were directly injected on the indicated implants. Bacterial luminescence was measured by putting 
mice under in vivo imaging system at indicated time points. The bacterial luminosity was recorded shortly 
after infection (d0) later after 6h (d0.25) and then daily for two weeks (A). The relative average luminescence 
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associated with magnesium (circles), with titanium (squares) and porous glass beads (triangles) was 
determined at indicated time points. Average tissue luminescence values calculated from mice without 
infection are indicated with background line.  
 
 
 
Figure 32: Magnesium implants are susceptible to P. aeruginosa colonization 24h after implantation.  
In each mouse implantations were done surgically subcutaneously on the back as follows: Mg, magnesium; Ti, 
titanium; Pg, porous glass. 24h after implantation, 5µl of freshly grown bioluminescent P. aeruginosa at 
OD600=0.1 in LB suspension were directly injected on the indicated implants. Bacterial luminescence was 
measured by putting mice under in vivo imaging system at indicated time points. The bacterial luminosity was 
recorded shortly after infection (d0) later after 6h (d0.25) and then daily at indicated time points. 
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Figure 33: Magnesium implants are not systemically infected. In each mouse implantations were done 
surgically subcutaneously on the back of mice. Implant materials were as follows: Mg, magnesium; Ti, 
titanium; Pg, porous glass. 5µl of freshly grown bioluminescent P. aeruginosa at OD600=0.1 in LB suspension 
were injected into the tail vein of each mice either immediately or 24 h after implantation. Bacterial 
luminescence was measured from mice which were infected immediately after implantation (A) or 24h after 
implantation (B). 
3.4.2 Estimation of P. aeruginosa numbers required for infection  
To examine the possibility that prolonged infection might be due to high bacterial load 
present in the initial inoculum, infections were done with smaller bacterial numbers. 
Different colony forming units of bacteria were injected on the surfaces of magnesium discs 
implanted subcutaneously in individually mice. Minimum of 100 colony forming units 
(CFUs) of P. aeruginosa were capable to establish an infection on magnesium discs (Figure 
34; 74). This experiment proved that magnesium implants were highly susceptible even to 
low bacterial numbers.  
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Figure 34: Prolonged infection threshold inocula of P. aeruginosa. Magnesium discs were surgically 
implanted in mice and then 10 µl of indicated in d0 bacterial CFUs were injected locally on magnesium 
implants into individual mice. Bacterial luminescence was detected at indicated time points from all infected 
animals.   
3.4.3 Characterization of persistent bacterial infections 
3.4.3.1 P. aeruginosa exhibit strong antibiotic resistance  
To determine if bacteria were surviving on magnesium for extended time period by 
establishing biofilm a detailed characterization was performed. It is known that bacteria 
exhibit strong antibiotic resistance within biofilm matrix. Initially to see if bacteria are 
sensitive to antibiotic, P. aeruginosa were subcutaneously injected locally in the tissue of 
mice and then these mice were treated with intravenous injection of either antibiotics or 
PBS as control.  Bacteria disappeared from the mice which were treated with antibiotic as 
compared to PBS treated 4h after administration (Figure 35; CFX). However at later time 
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points, bacterial luminosity decreased from the control mice because of the immune cells 
invasion at the site of infection. It confirmed that P. aeruginosa injected in the absence of 
implants were sensitive to antibiotic. To see the sensitivity of bacteria in the presence of 
implants, magnesium discs were implanted in mice. Immediately after implantation, P. 
aeruginosa were injected on the surface of subcutaneously implanted magnesium discs. 
Intravenous antibiotic administration in these mice was started at variable times after 
infection as indicated (Figure 36). Despite antibiotic administration, bacterial luminosity 
remained higher on magnesium implants comparable to PBS treated mice (Figure 36). 
Antibiotic administration started at early or late post-infection had no influence on 
bacteria.  This indicated that bacteria adopt resistance against systemic antibiotic 
treatments if they are present on magnesium implants. For verification, mice were 
implanted with magnesium implants and then immediately after implantation, different 
numbers of P. aeruginosa were injected locally in individual mice. These mice were then 
intravenously treated with different concentrations of antibiotics daily for two weeks. PBS 
treated mice served as control. Groups of mice infected with varying inoculums of P. 
aeruginosa on magnesium implants showed a strong resistance against high concentrations 
of antibiotics (Figure 37 and 38). 
 
Figure 35: P. aeruginosa are susceptible to antibiotics in the absence of magnesium. 5 µl luminescent P. 
aeruginosa cultures were with an OD600 of 0.1 were injected subcutaneously without any implantation in 
mice. 100 µl ciprofloxacin 2 mg/ml was injected into tail vein of mouse (CFX) and PBS (CTR) in other. 
Bacterial luminosity was measured at indicated time points shortly after infection and subsequent antibiotic 
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administration (A). Average radiance (B) associated with ciprofloxacin treated mice (black bars) and control 
mice (white bars).  
 
Figure 36: P. aeruginosa grown on implant surfaces are antibiotic resistant. 3 magnesium discs were 
implanted subcutaneously in each mouse and then 5 µl luminescent P. aeruginosa cultures with an OD600 of 
0.1 were injected on the surface of implants. After infection, systemic administration of 100 µl ciprofloxacin 2 
mg/ml was started in each of the framed mouse which was then continued on daily basis at later time points 
(from left to right). One mouse served as control and received intravenous injection of PBS on daily basis.  
Bacterial luminescence measured from each animal at indicated time points (A). Average radiance calculated 
from the mice where systemic ciprofloxacin administration started at 0.5h (empty squares), 6h (filled 
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squares), day 1 (empty rhombi) and day 2 (filled rhombi) post infection. In control mice PBS was injected 
daily (empty circles).  
 
 
Figure 37: P. aeruginosa on magnesium implants pose strong resistance against high systemic doses of 
ciprofloxacin. 3 magnesium discs were implanted in each animal. Immediately after implantation, 1x106 
colony forming units of luminescent P. aeruginosa cultures were injected on magnesium implants (a), 1x104 
colony forming units were injected on implants (b), 1x102 colony forming units were injected on magnesium 
(c) while, implants in one animal (d) were kept un-infected. In first group (PBS) of animals 100 µl PBS was 
injected intravenously in each mouse daily. In second group (CFX 100), immediately after infection, 100µl of 
2mg/ml ciprofloxacin was injected daily. In third group (CFX 200), 200µl of 2mg/ml ciprofloxacin was 
injected daily. In the last group (CFX 300), 300µl of 2mg/ml ciprofloxacin was injected daily. After infection 
and antibiotic administration, bacterial luminescence was measured daily.  
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Figure 38: Antibiotic resistance of P. aeruginosa against systemic ciprofloxacin. 3 magnesium discs 
were implanted in each animal and then immediately after implantation infections were done with 
luminescent P. aeruginosa. Bacterial luminescence from each of the infected mice was captured at indicated 
time points using in vivo imaging system. Data was anylzed using a live imaging software and values 
correspond to the average radiance emitted from bacteria. Average radiance calculated from magnesium 
implants infected with 1x106 colony forming units of luminescent P. aeruginosa cultures (triangles), 1x104 
colony forming units (squares), 1x102 colony forming (rhombi) or without infection (circles). Animals 
receiving intravenous injections of PBS (A), 100 µl of 2mg/ml ciprofloxacin (B), 200 µl of 2mg/ml 
ciprofloxacin (C) and 300 µl of 2mg/ml ciprofloxacin injections (D).  
3.4.3.2 Effect of system antibiotics on established P. aeruginosa biofilms  
To investigate antibiotic sensitivity of bacteria growing on magnesium implants, an 
alternative method such as determination of viable bacteria as colony forming units was 
used after the removal of implants. Magnesium discs were implanted in mice and then 
immediately after implantation infections were done with luminescent P. aeruginosa in 
each animal.  After infection, intravenous injections of high doses of ciprofloxacin were 
administered in each animal daily for two weeks. One mouse was treated with PBS and 
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served as control. Bacterial luminescence and weight of mice were measured daily. After 
two weeks, mice were euthanized and implants were removed. Colony forming units per 
disc from each of the infected implant were then counted (Figure 39A-C). Ciprofloxacin 
treatment at high concentrations in mice containing magnesium inoculated with P. 
aeruginosa had no effect on bacterial luminosity which remained same as mice without 
antibiotic treatment (Figure 39A; b,c,d compare with a). High number of colony forming 
unit of bacteria were counted from infected implants isolated from mice even after high 
ciprofloxacin administration comparable to PBS treated (Figure 39B). Mice bearing 
infected implants showed initial decreases in weight similar to un-infected mice which 
seemed due to implantation stress (Figure 39C). Over all, these results support that 
bacteria show a strong resistance to high doses of antibiotics a feature which is typical for 
bacteria within biofilms.  
 
Figure 39: High bacterial numbers on implants after antibiotic treatment. 3 magnesium discs were 
subcutaneously implanted in each mouse and then these animals were infected with 5µl of approximately 
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1x106 CFUs luminescent P. aeruginosa. One animal was kept un-infected. After infection, antibiotic or PBS 
administration was done intravenously as follows: PBS was injected daily in mouse (a), 100µl of 2mg/ml 
ciprofloxacin in mouse (b), 200µl of 2mg/ml ciprofloxacin in mouse (c), 300µl of 2mg/ml ciprofloxacin in 
mouse (d), only implantation without infection and treatment (e). After two weeks, mice were euthanized by 
CO2 and infected or un-infected implants form each animal were removed and shifted to PBS. Followed by 
vigorous vortex, tenfold serial dilution in PBS was done individually for each implant and then 10 µl from 
each dilution were streaked on LB agar plates and overnight incubated at 37oC. Colonies forming units per 
each implant (CFU/disc) were calculated by the number of colonies counted form overnight incubated LB 
agar plates. Bacterial luminescence measured at indicated time points (A). Colony forming units counted from 
implants (B). Changes in weight of mice as indicated (C). 
3.4.3.3 Biofilm-like morphology of P. aeruginosa on implants 
To reveal morphology of bacterial overgrown magnesium implants and adjacent tissue, 
electron microscopy was used. Magnesium implants after two weeks of infection were 
removed from mice and observed under microscope.  Scanning electron microscopy (SEM) 
of tissue adjacent to infected magnesium was densely filled with large populations of P. 
aeruginosa (Figure 40A-L). Bacteria were also embedded in matrix like structures 
resembling closely to biofilms (Figure 40E,F). Similarly, bacteria were also seen adhering 
on magnesium discs (Figure 40G-L). Formation of slimy matrix around bacteria was clearly 
visible (Figure 40L). To reveal in depth biofilm structures, transmission electron 
microscopy (TEM) was used. TEM of tissue neighboring infected magnesium showed 
matrix encased P. aeruginosa which is typical for biofilm formation (Figure 41A-F). Despite 
immune cell accumulation the bacterial biofilm remained intact (Figure 41A). This shows 
biofilm provide a sheath to bacteria against host defense mechanism. In the surrounding P. 
aeruginosa biofilm, many polymorphonuclear leukocytes (PMNs) were seen engulfing 
single bacteria (Figure 41G-I). Interestingly, white extracellular matrix was only present 
around cluster of bacteria (J). However, single cells were completely lacking such 
structures (Figure 41K, L). These analyses proved that prolonged P. aeruginosa infection 
around magnesium implants was due to biofilm formation. In conclusion, electron 
microscopy analyses clearly revealed that P. aeruginosa forming biofilms directly on 
magnesium as well as in the adjacent tissue. 
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Figure 40: P. aeruginosa establish biofilms in peri-implant tissue. Magnesium discs were implanted 
subcutaneously in mice and then infected with 5µl of suspension with 1x106 CFUs luminescent P. aeruginosa. 
After two weeks, mice were sacrificed and tissue with implants was removed. The samples were fixed with 
5% formaldehyde and 2% glutaraldehyde in HEPES buffer followed by washing in TE buffer and then 
dehydrated with acetone at room temperature. After critical-point drying with CO2 samples were sputter 
coated with palladium-gold and imaged in a field emission scanning electron microscope. P. aeruginosa 
infected implant surfaces (A-L). P. aeruginosa embedded within peri-implant tissue (K and F).  (SEM images 
courtesy by Manfred Rohde, HZI) 
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Figure 41: P. aeruginosa resistance against host immune cells indicative of biofilm formation. Followed 
by two weeks of infection with 5µl of 1x106 CFUs luminescent P. aeruginosa on magnesium, peri-implant 
tissues were removed, fixed, embedded, cut into sections and then examined under transmission electron 
microscope. TEM of tissue near P. aeruginosa infected magnesium (A-L). Polymorphonuclear leukocytes with 
P. aeruginosa (*)(G-I). (SEM images courtesy by Manfred Rohde, HZI) 
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3.4.3.4 P. aeruginosa biofilms show strong inflammatory reaction 
To determine the host inflammatory response against P. aeruginosa histological 
evaluations were performed (Figure 42A-F). Magnesium implants were infected with P. 
aeruginosa immediately after implantation in mice. Magnesium implants without infection 
and infection in sham surgical pouches served as control. After a week, histology of tissues 
surrounding infected magnesium implants showed a severe neutrophilic inflammatory 
infiltrates surrounding the implant (Figure 42A, B; white arrow).  In comparison, there was 
a mild inflammatory response at the site where infection was done with P. aeruginosa alone 
(Figure 42E, F). There was no increased inflammatory response against un-infected 
magnesium implants (Figure 42C, D). Hence, Persistent P. aeruginosa infections on 
magnesium lead to strong inflammatory reactions which can be clearly identified by high 
population of granulocytes.  
 
Figure 42: P. aeruginosa biofilms induce strong inflammatory reactions. 5µl of 1x106 CFUs luminescent 
P. aeruginosa were injected on subcutaneously implanted magnesium discs immediately after implantation 
(A,B) and in sham surgical pouches (E,F). Magnesium discs implanted and left un-infected served as control 
(C,D). After 7 days, infected and un-infected magnesium implants along with infected tissues were removed, 
fixed, paraffin embedded and hematoxylin and eosin (H&E) stained. Peri-implant tissue near P. aeruginosa 
infected magnesium implants (A, B). Peri-implant tissue from un-infected magnesium implants (C, D) and 
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tissue without implant but infected with P. aeruginosa (E, F). The labelled structures are as follows:  e 
(epidermis), a (adipose tissue), m (skeletal muscle) and c (connective tissue). Scale bar corresponds to 50µm. 
(Staining courtesy by mouse pathology, HZI) 
3.4.3.5 P. aeruginosa biofilm matrix composed of exoplysacharide and protein  
To confirm the biofilm formation, Periodic Acid Schiff (PAS) staining specifically targeting 
extracellular polymeric matrix was done (Figure 43A-F). Implants with some surrounding 
tissue were removed after one week post-infection. Biofilm staining of tissues at the site of 
P. aeruginosa infection on magnesium implants showed the presence of polysacharides and 
proteins between immune cells (Figure 43A, B) indicating the presence of biofilm. 
However, such structures were not present in the tissue near un-infected magnesium 
implants (Figure 43C, D) or in tissues which were infected with P. aeruginosa in the 
absence of implants (Figure 43E, F). These results show that P. aeruginosa develop 
prolonged infections due to biofilm formation. 
 
Figure 43: PAS positive biofilm matrix material is detected at the site of infected magnesium implants. 
As mentioned in Figure 42, tissue near magnesium implants infected with P. aeruginosa and stained with 
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Periodic Acid Schiff (PAS). Photographs of infected peri-implant tissue after implant removal (A, B) positive 
for polysacharides and proteins (black arrows), un-infected tissue after implant removal (C, D) and infected 
tissues which were kept un-implanted (E, F). The labelled structures scale bars are same as mentioned in 
figure 42. (Staining courtesy by mouse pathology, HZI) 
3.4.3.6 Immunohistology of P. aeruginosa biofilms 
To detect the distribution of P. aeruginosa from infected tissues immunohistology of tissue 
sections specifically targeting Pseudomonas was done (Figure 44A-F). Immunohistology of 
tissues surrounding magnesium implants infected with P. aeruginosa clearly revealed a 
distinct biofilm enriched with P. aeruginosa surrounded by high numbers of granulocytes 
(Figure 44A,B; black arrow). In the absence of infection tissues near magnesium or P. 
aeruginosa infected tissues without implants; bacteria were not present after 1 week 
(Figure 44C-F). P. aeruginosa in the infected tissues after one week indicates that these 
bacteria can establish persistent biofilms. 
 
Figure 44: High density P. aeruginosa colonization in the tissues near infected magnesium implants. 
Histology was performed as described in Figure 42, samples were removed and Anti-Pseudomonas antibody 
(1:400) staining was performed after heat-mediated-antigen retrieval of the samples. Light-microscopy 
images of immunostained tissue sections near P. aeruginosa infected magnesium implants (A,B) a distinct 
region infiltrated with P. aeruginosa (A; black arrow). Tissue sections containing un-infected magnesium 
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implants (C, D) and tissue sections infected with P. aeruginosa without implantation (E,F). Magnification, 
description of labelled structures and scale bars are as explained in Figure 42. (Staining courtesy by mouse 
pathology, HZI) 
3.4.3.7 P. aeruginosa infections induce prolonged interferon production  
Type I interferon induction is triggered in response to viral and non- viral infections [162]. 
Therefore, the induction of Type I interferon in response to biofilm was also tested using β 
interferon luciferase reporter mice (IFN-β+/Δβ-luc) [155]. Wild- type non-luminescent 
Pseudomonas aeruginosa (PAO1) were injected on subcutaneous magnesium implants 
immediately after implantation. As a control, infection was done at a surgical pouch 
without implant to differentiate the interferon production in response to bacteria alone. A 
localized type I interferon production at the site of magnesium infected with P. aeruginosa 
started within a day post-infection (Figure 45A; a). Later, this localized IFN production 
around infected magnesium became maximum after 1 week of infection and persisted for 
two weeks. In control where bacteria were injected alone interferon was also detected for 
three days (Figure 45A; b). No interferon response could be detected around un-infected 
magnesium implants (Figure 45A; c). 
 
 
Figure 45: Biofilm formation triggers persistent type I interferon production for over two weeks. β 
interferon luciferase reporter (IFN-β+/Δβ-luc) mice were implanted with magnesium and then immediately 
after implantation, 5µl (1x103 CFUs) of wild type P. aeruginosa (PAO1) were injected locally on magnesium 
and in subcutaneous tissues having surgical pouches without implant. Subcutaneously implanted magnesium 
discs without infection were kept as control. Immediately after infection, luciferin (30 mg/ml) was injected 
intraperitonealy (i.p.) and after 15 minutes of injection mice were observed under IVIS.  Luminescence in 
A B
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response to localized type I interferon (A) at site of magnesium infected with bacteria (a), infected sham 
surgical pouch(c), un-infected magnesium (b). Average radiance (B) calculated from infected magnesium 
(filled circles), infected sham surgical pouch (empty squares), from un-infected magnesium (rhombi) or from 
the skin as background (empty circles). 
3.4.3.8 Bacterial RNA isolation from in vivo grown biofilms 
To investigate if intact P. aeruginosa RNA can be isolated from infected tissue for RNA 
sequencing, RNA extraction process was also done. RNA isolated was indeed belonging to 
prokaryotes and found in good shape and integrity (Figure 46). Further, only a small 
amount of the isolated RNA was sequenced to evaluate the libraries. Depending upon 
samples 23 to 53 % of the sequence mapped to Pseudomonas aeruginosa (PAO1) (Table 
15). In summary, the RNA quality is sufficient for whole genomic gene expression analysis. 
The major shortcoming in this approach is the lack of a good control culture. 
 
 
Figure 46: Intact bacterial RNA can be isolated from bacterial biofilms in tissues. Mice bearing 
magnesium infected with bioluminescent P. aeruginosa were euthanized after two weeks and infected tissues 
were removed and shifted in trizole reagent. RNA was isolated by trizole reagent and stored in RNase free 
water. This RNA was then subjected to agilent analaysis. Prokaryotic RNA peaks from four independent 
samples (A-D). RNA Ladder (E). (Agilent analysis in Genome Analytics, HZI ) 
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Table 15: Whole genomic indicates bacterial RNA quality form biofilms suitable for 
gene expression analysis.   
No. 
Total 
reads 
Mapped to 
Psuedomonas 
% mapped to 
Psuedomonas 
mapped to 
mouse 
% 
mapped 
to 
mouse 
% rRNA 
% 
Bacterial 
rRNA 
% Euk. 
rRNA 
1 2,130,866 1,142,265 53.6 871,249 40.9 82.60% 53.08 29.33 
2 1,669,694 800,130 47.9 754,170 45.2 79.70% 47.48 32.1 
3 2,397,579 621,835 25.9 1,578,927 65.9 74.42% 25.84 48.34 
4 2,320,781 543,333 23.4 1,561,115 67.3 67.31% 23.18 44.02 
 
3.4.3.9 P. aeruginosa biofilms induce splenomegaly in mice 
It is assumed that systemic bacterial infections lead to increase in splenic cellularity due to 
recruitment and expansion of leukocytes, this results in splenomegaly in the infected host 
[163]. To see if persistent localized biofilm had any effect on spleen size or on other organs, 
mice bearing infected magnesium implants treated with or without systemic ciprofloxacin 
were sacrificed and their organs were examined. Increases in weight and length of spleens 
from mice bearing magnesium implants with P. aeruginosa biofilms was observed (Figure 
47A-C). Mice treated systemically with ciprofloxacin had comparatively less increase in 
weight and length of spleen as compared to PBS treated (Figure 47B and C). However, no 
gross changes in the shape of other organs could be found. Overall, it indicates that P. 
aeruginosa biofilm leads to the systemic activation of splenic immune cells which cannot 
eliminate biofilm near magnesium implants.  
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Figure 47: P. aeruginosa biofilm infections of implants result in splenomegaly. Mice bearing two weeks 
old biofilms on magnesium which were treated daily with or without systemic ciprofloxacin (2mg/ml).  After 
two weeks of infection, mice were sacrificed to observe morphology of organs. Spleen (black arrow) of a 
mouse bearing infected magnesium implant (A; left) and un-infected mouse (A; right). (B) Spleen sizes of 
infected mice treated daily with intravenous injections of 100 µl of ciprofloxacin (left to right), 200 µl of 
ciprofloxacin, 300 µl of ciprofloxacin and PBS. Spleen of mice bearing magnesium implants but un-infected 
(right). (C) Weight of spleen from the mice as indicated (left) and length of spleen (right).   
3.4.4 P. aeruginosa remain mainly localized within the biofilm 
Bacteria are known to migrate from existing biofilm to new surfaces to establish fresh 
biofilms [164]. To investigate this, magnesium implants were infected with bioluminescent 
P. aeruginosa and in parallel left un-infected with in same mouse. Infection was done 
immediately or 24h after implantation.   P. aeruginosa established prolonged infections on 
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those magnesium which were inoculated immediately or 24h after implantation (Figure 
48A,B). Bacteria did not migrate to the neighboring un-infected magnesium implanted in 
the same mouse as no luminescence could be seen on these implants (Figure 48A,B;Mg1-4). 
P. aeruginosa did not establish infections on any of the titanium implants (Figure 48A,B;Ti). 
This indicated that P. aeruginosa establish localized infections and they do not move in bulk 
into neighboring tissue.  
 
Figure 48: P. aeruginosa establish localized infection on magnesium implants. Four magnesium or four 
titanium discs were implanted subcutaneously in mice. In each mouse, 5µl of approximately 1x106 CFUs 
luminescent P. aeruginosa were injected locally either soon or 24h after implantation on single disc (2) while 
three discs (1, 3 and 4) were left un-infected. Course of infection was observed using in vivo imaging system 
(IVIS). P. aeruginosa luminosity inoculated immediately (A) or 24h after implantation (B) on single implant 
(2) out of subcutaneously implanted four magnesium (Mg) or titanium discs (Ti).  
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3.4.5 Contribution of magnesium corrosion products to prolonged infections  
Magnesium hydroxide and hydrogen gas are major degradation products of magnesium 
corrosion. To assess the contribution of these products in prolonged bacterial infection, 
porous titanium implants were coated with Mg(OH)2 and then implanted into mice. To 
evaluate role of hydrogen gas, magnesium implants coated with phosphate which suppress 
gas formation were used.  Magnesium implants were infected with P. aeruginosa isolated 
from two weeks in vivo grown biofilm to see if these bacteria show any difference from 
freshly grown cultures. Freshly grown P. aeruginosa could be visualized on all implants 
soon after their administration on respective implants (Figure 49A, a, c, d and e). P. 
aeruginosa inoculated from existing biofilm were not visible (Figure 49A, b) even though 
same volume was used. However, this may be due to a reduced metabolic activity or due to 
other reasons. Fresh P. aeruginosa showed increased luminosity and established prolonged 
infections on magnesium (Figure 49B;a). In comparison, these bacteria had decreased 
luminosity and did not establish permanent infection on phosphate coated magnesium 
(Figure 49B, c). Interestingly, fresh bacteria showed high luminescence on Mg(OH)2 coated 
porous titanium discs as compared to un-coated porous titanium (Figure 49B;compare d 
with e). P. aeruginosa (biofilm derived cultures) established prolonged infections on 
magnesium (Figure 49A, b). Overall, these results indicate that magnesium corrosion 
products play an important role in the formation of biofilm on metallic magnesium. 
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Figure 49: Magnesium corrosion products extend in vivo bacterial persistence. Porous titanium discs 
with 7 mm diameter and 2 mm thickness were filled with Mg(OH)2 and then subcutaneously implanted in 
mice. Porous titanium implants without coating were implanted as controls. Phosphate coated magnesium 
discs were also implanted. Immediately after implantation, these discs were infected with 5 µl of 1x106 CFUs 
freshly grown luminescent P. aeruginosa. In parallel, small amount of luminescent P. aeruginosa were derived 
from a two weeks old biofilm established on magnesium in separate mouse. These biofilm extracted bacteria 
were mixed shortly in LB and then 5 µl were injected on subcutaneously implanted magnesium discs. 
Bacterial luminescence over the time (A) measured from mice having three magnesium discs (a), mice 
bearing magnesium discs infected with P. aeruginosa isolated form existing biofilm (b), mice implanted with 
KH2PO4 treated magnesium (c), mice implanted with Mg(OH)2  coated porous titanium (d) and mice having 
un-coated porous titanium (e). Relative radiance calculated from the indicated surfaces over the time (B).  
3.4.6 Role of tissue-air interface in biofilm formation 
Hollow structures such as catheters support bacterial colonization in experimental animal 
models [136].  It was speculated that this could be due to the presence of air liquid 
Results 
 
96 
 
interfaces which prevents immune cells invasion. To confirm this, cylindrical tubes were 
subcutaneously implanted into the mice and then immediately inoculated with 
bioluminescent P. aeruginosa (Figure 50). Bacteria colonized inside tubes for one week 
post-infection however they disappeared at later time points (Figure 50A;a). In addition, 
low bacterial luminosity was detected from infected tubes (Figure 50A;a). Comparatively, 
bacterial luminosity on magnesium implants was high and for extended period of time 
(Figure 50A;b). This suggests that the formation of an air cavity in tissue cannot be the sole 
reason for persistent infections of magnesium implants.  
 
Figure 50: Tubes cannot support bacterial colonization for prolonged time. 5 mm high tubes and 
magnesium discs were subcutaneously implanted into mice and then 5µl of approximately 1x106 CFUs 
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luminescent P. aeruginosa were injected directly into these tubes. Same amount of bacteria were also injected 
subcutaneously in the tissue without implantation as control. Instantly after infection and later at indicated 
time points mice were observed under IVIS. Bacterial luminosity from hollow tubes (a), magnesium discs (b) 
and tissue which was infected without implantation (A). Relative radiance calculated from infected 
magnesium (squares), infected tubes (circles) and infected tissue without implants (rhombi) at the indicated 
time points (B).  
 
3.4.7 Role of quorum sensing in persistent bacterial infection 
 
It is assumed that bacteria use quorum sensing system during biofilm formation. To 
investigate the role of quorum sensing in prolonged infection, a bioluminescent quorum 
sensing deficient Pseudomonas aeruginosa (pqs A) was employed. Bioluminescent P. 
aeruginosa with quorum sensing system served as control. Antibiotic sensitivity of both 
strains was tested using ciprofloxacin. In addition magnesium silver alloy was also infected 
with P. aeruginosa immediately after implantation to see if it was prone to persistent 
infections. P. aeruginosa the quorum sensing mutant strain (pqs A) established persistent 
infections on magnesium implants comparable to wild type P. aeruginosa (PAO1, CTX::lux) 
(Figure 51A; compared d with e). P. aeruginosa also established prolonged infections on 
magnesium silver alloy (Mg6Ag) (Figure 51A; e). Prolonged infections from P. aeruginosa 
(pqs A) and (PA01, CTX::lux) strains on magnesium implants also demonstrated resistance 
against systemic antibiotic treatments (Figure 51A; a,b). These results clearly showed that 
deficiencies in quorum sensing did not impair the biofilm formation of P. aeruginosa on 
magnesium implants. This is consistent with the notion that quorum sensing is mainly 
required for rapid establishment of biofilm [120]. Moreover, magnesium silver alloy was 
susceptible to infection suggesting that the amount of antibacterial silver activity was 
negligible in this assy. 
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Figure 51: Quorum sensing P. aeruginosa mutants can establish prolonged implant infections. 3 
magnesium and magnesium silver alloy discs with 5 mm diameter and 2 mm thickness were subcutaneously 
implanted in mice. Immediately after implantation, 5µl of approximately 1x106 CFUs luminescent P. 
aeruginosa (CTX::Lux) or quorum sensing mutant (PA01, pqsA) were injected on the surface of magnesium 
discs.  Indicated amounts of bioluminescent P. aeruginosa (CTX::Lux) alone were injected on magnesium 
silver discs. After infection and then daily, 200 µl (2mg/ml) of ciprofloxacin was intravenously injected into 
the mice bearing magnesium infected with P. aeruginosa (CTX::Lux) or quorum sensing mutant (PA01, pqsA), 
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while two mice infected were treated with PBS as controls. Bacterial luminescence (A) measured from mice 
having magnesium implants infected with P. aeruginosa (CTX::Lux) (a), quorum sensing mutant (PAO1, pqsA) 
(b) and treated with ciprofloxacin.  Bacterial luminescence from mice having magnesium implants infected 
with P. aeruginosa (CTX::Lux) (c), quorum sensing mutant (PAO1, pqsA) (d) and treated with PBS. Bacterial 
luminescence from mice having magnesium silver implants infected with P. aeruginosa (CTX::Lux)(e). 
Relative radiance (B) calculated from magnesium infected by pqs mutant strain injected daily with 
ciprofloxacin (filled squares) and without ciprofloxacin treatment (empty squares), relative radiance from 
magnesium infected by P. aeruginosa (CTX::Lux) with (filled circles) and without ciprofloxacin (empty circles) 
and from magnesium silver alloy infected with P. aeruginosa (CTX::Lux)(rhombi). 
3.4.8 Role of gas cavity formation and antibiotic treatments in prolonged infection  
The formation of gas cavities due to magnesium degradation seemed to play an important 
role in the formation of P. aeruginosa biofilms around magnesium implants. To confirm it, 
phosphate coated magnesium discs (which eliminate early gas cavity generation) in 
combination with or without ciprofloxacin treatment were subcutaneously implanted and 
then immediately infected with luminescent P. aeruginosa. Previously it was found that 
bacteria on magnesium implants were resistant to systemic administrated antibiotics. To 
see the effect of locally produced antibiotic on P. aeruginosa infection, magnesium discs 
were coated with combination of layered double hydroxide (LDH) as slow drug delivery 
compound and ciprofloxacin.  Magnesium coated with LDH alone served as control. Then 
these discs were implanted subcutaneously and then immediately infected. P. aeruginosa 
injected on the surfaces of phosphate coated magnesium alone and in combination with 
ciprofloxacin did not establish infections and disappeared shortly after infection (Figure 52 
A; a,c). Similarly, bacteria did not survive on magnesium coated with combination of LDH 
and ciprofloxacin (Figure 52A; d). However, P. aeruginosa injected on magnesium implants 
coated with LDH alone (which do not inhibit gas formation) established prolonged 
infections (Figure 52A; b). Over all, this experiment shows that the rapidly degrading 
magnesium is essential for biofilm formation. Local drug delivery system was efficient in 
inhibiting in bacterial colonization around magnesium implants, presumably due to highly 
efficacious local antibiotic concentration. 
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Figure 52: Reduction of magnesium implant corrosion and local antibiotic delivery impede bacterial 
biofilm formation. A phosphate coating was established on magnesium discs alone and in combination with 
250µg of ciprofloxacin. These discs were then implanted subcutaneously in mice and infected with 1x106 
CFUs luminescent P. aeruginosa. Magnesium discs with Layered double hydroxide (LDH) coating alone as well 
as in combination with 250µg ciprofloxacin were subcutaneously implanted in mice and then infected P. 
aeruginosa. Luminescence activity (A) of bacteria injected on magnesium coated with phosphate (a) 
phosphate and ciprofloxacin (c), LDH (b) LDH and ciprofloxacin (d). Relative radiance (B) calculated from 
magnesium coated with phosphate (filled squares), phosphate and ciprofloxacin (empty squares), LDH (filled 
circles), LDH and ciprofloxacin (empty circles). Background radiance calculated from un-infected animal 
(rhombi) as indicated by black line.  
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3.4.9 Gram-positive Staphylococcus aureus can establish prolonged infections on 
magnesium implants  
To investigate if magnesium implants are susceptible to gram positive bacteria, 
bioluminescent S. aureus were employed. Magnesium, titanium and porous glass were 
infected with S. aureus immediately after infection. S. aureus established prolonged 
infections on the surface of magnesium discs which persisted for two weeks (Figure 53A; 
Mg). However, bacterial luminescence disappeared after one day from titanium and porous 
glass (Figure 53A; Ti and Pg). These results clearly indicate that magnesium is susceptible 
to gram negative as well as gram positive bacteria.  
 
Figure 53: Magnesium implants are prone to persistent gram-positive bacterial infections. 3 
magnesium, titanium or porous glass beads were implanted subcutaneously implanted into the mice. 
Immediately after implantation, 1x105 CFUs luminescent S. aureus were injected directly on each implant. 3 
magnesium implants were implanted subcutaneously (Mg) and left un-infected as control (Ctr). Luminescent 
activity of S. aureus at indicated time points from mice bearing magnesium (Mg), titanium discs (Ti), porous 
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glass beads (Pg) implants or mice bearing 3 magnesium discs which were not infected (Ctr). Average 
Radiance calculated from infected magnesium (circles), titanium (squares), porous glass beads (triangles) 
and un-infected magnesium (rhombi) at indicated time points.  
3.4.9.1 Characterization of S. aureus biofilms 
To reveal if S. aureus were establishing biofilms on magnesium implants, electron 
microscopy was used. By scanning electron microscopy (SEM) bacteria could not be seen 
directly on the implants or in peri-implant tissue. However, transmission electron 
microscopy (TEM) of the tissues adjacent to infected implants showed S. aureus embedded 
within a matrix (white arrows) like structure which seemed typical of bacterial biofilm 
(Figure 54A-F).  
 
Figure 54: Staphylococcus aureus biofilms around magnesium implants. Magnesium implants were 
subcutaneously implanted in mice and then infected with 1x105 CFUs luminescent S. aureus. After two weeks, 
peri-implant tissues were removed fixed, embedded by epoxy resin and cut into ultrathin sections and 
examined under transmission electron microscope (A to F). Bacterial biofilms within tissue(A). 
Exopolysaccharide matrix (white arrows) around bacteria (A-F). Inflammatory cells around biofilms (E) 
intracellular bacteria (*). (SEM images courtesy by Manfred Rohde, HZI) 
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3.4.10 Prolonged survival of Salmonella on various implant surfaces  
Even though Salmonella is not a common biomaterial-associated pathogen, to see if 
magnesium were susceptible, bioluminescent S. typhemurium were employed. Bacteria 
injected after implantation on magnesium, titanium discs and porous glass beads persisted 
on all implants for up to two weeks and then started to disappear from magnesium and 
titanium (Figure 55A). Bacteria continued to persist only on porous glass beads for 34 days 
(Figure 55A; Pg). This persistence is therefore not specific for magnesium implants and 
may be related to the nature of bacteria.  
 
Figure 55: S. typhimurium persistence on various implant surfaces. Magnesium, titanium or porous glass 
beads were subcutaneously implanted in mice. Immediately after implantation, 5µl of bioluminescent S. 
typhemurium at OD600=0.1 in LB suspension were directly injected on the surface of each implant and mice 
were observed under IVIS. Luminescent activity of bacteria calculated from magnesium (Mg) and titanium 
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(Ti) and porous glass (Pg). Relative radiance calculated from magnesium (circles), titanium (squares) and 
porous glass beads (triangles). 
3.4.11 Infection by E. coli on implant surfaces  
Escherichia coli is considered most common implant pathogen around urinary catheter. To 
investigate its infection kinetics around magnesium, bioluminescent E. coli were employed 
and injected directly on the surfaces of subcutaneously implanted magnesium, titanium 
and porous glass beads. E. coli remained on all implants during early stages however later 
they disappeared completely from all implants (Figure 56). It could be due to the fact that 
the employed strain was a laboratory adopted strain that is no longer capable of 
establishing infections in vivo. 
 
Figure 56: E. coli infection and absence of survival on various implants. Mice were implanted 
subcutaneously with magnesium, titanium and porous glass beads. Immediately after implantation, 5µl of 
bioluminescent E. coli at OD600=0.1 in LB suspension were injected on the surface of each implant and mice 
were observed by IVIS. Luminescent activity of bacteria observed from magnesium (Mg) and titanium (Ti) 
and porous glass (Pg) implants.  
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4 Discussion  
4.1 Establishment of in vitro corrosion conditions to understand in vivo 
magnesium degradation 
Unpredictable corrosion and evolution of gas have been major limitations towards clinical 
applications of magnesium especially as orthopedic implant. The present study was mainly 
aimed to establish an in vitro model and small animal models to evaluate magnesium for its 
suitability as implant material in humans. Magnesium is corroding and it starts to degrade 
immediately after exposure to moist environments resulting magnesium ions (Mg2+), 
hydroxide (OH-) and hydrogen (H2) as primary corrosion products. During corrosion, 
minerals and elements from the nearby environment accumulate on the surface leading to 
the formation of a protective corrosion layer. With its establishment, the corrosion layer 
delays the ongoing degradation process [60]. For in-depth understanding of magnesium 
degradation, different immersion solutions such as simulated body fluid (SBF), Hank’s 
solution and phosphate buffered saline (PBS) are used [67,31]. However in contrast to 
body fluids, such in vitro solutions are deficient in proteins, and cannot be directly 
compared with the in vivo situation. As described, immediately after implantation, proteins 
from blood and tissue are adsorbed on implant surfaces [165]. To more closely mimic the 
in vivo situation, cell culture solutions were employed as protein containing media [166]. 
These solutions mimic the composition of body fluids but they lack living cells. Different 
murine and human cell lines have previously been cultured with magnesium or its 
degradation products whereby the emphasis was put on the appropriate cellular response 
rather than on the degradation kinetics [67]. Under such in vitro conditions, cells release 
metabolic products that might influence the degradation of magnesium. The present study 
was therefore focused to establish a more reliable in vitro corrosion test would be more 
closely related to the in vivo situations. Therefore, a specific conditioned cell culture 
medium containing cellular secretion products was collected from murine fibroblasts cells 
(spent cell culture medium). Owing to its specific composition, it appears to be more close 
to the in vivo situation. The degradation rate of magnesium can be assessed by the weight 
loss method or by the hydrogen generation [167]. In addition, relative pH changes due to 
hydroxide ions (OH-), a primary corrosion product was also used as degradation 
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assessment strategy [166]. These parameters were evaluated and corrosion in spent cell 
culture medium was compared with various types of solutions under different 
environmental conditions. Conventionally, weight loss due to degradation is determined by 
evaluating the end point after a certain time of incubation [167]. However, in present study, 
weight change in effect to minerals apposition was determined daily under the direct 
influence of corrosion media. Corrosion layer formation and the subsequent weight change 
varied with the composition of immersion solution and the incubation environment. As 
reported in previous studies, cell culture medium had no measureable effect on the weight 
of magnesium even when incubated at different environmental setups [166]. Magnesium 
exhibits fast corrosion at physiological pH 7.4-7.6 under standard cell culture conditions 
[168], which was not the case for cell culture medium DMEM. Given that, proteins and 
amino acids quickly adsorb on implant surfaces this contributes further to the retardation 
of corrosion process [169,170]. Magnesium in spent cell culture medium (pH 7.0-7.2) 
containing cellular excretion products and cellular metabolites showed a more rapid 
weight loss and increased hydrogen evolution when incubated under standard cell culture 
conditions. Interestingly, fast degradation of magnesium in the presence of spent cell 
culture medium was only at standard cell culture conditions. However, magnesium 
immersed in spent medium at temperature (37C) within human physiological range did 
not show any variation in weight. This finding proved that secreted cellular metabolites 
enhanced corrosion in the presence carbon dioxide [171]. Independent of the environment, 
a robust weight gain for magnesium incubated in potassium phosphate solution was 
observed showing that phosphate ions (PO4-) accumulated on corroding magnesium [172]. 
In agreement with previous studies, an increase in the pH of all physiological solutions 
containing magnesium was observed. Such pH increases occurred mainly during the initial 
24h after incubation and became constant at later time points [67]. In the presence of 5% 
CO2, pH increases of all media containing metallic magnesium samples was much lower 
than pH values of same media incubated without CO2. This could be explained by the acidic 
effects of CO2 on aqueous solutions. It is reported that magnesium generally corrodes faster 
under in vitro conditions as compared to in vivo situations [71]. Similarly, in present study, 
pure magnesium wires evidenced weight loss after implantation in soft tissue or tail artery 
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which was less than wires incubated in spent medium. Enhanced weight loss in spent cell 
culture medium became more evident at later time points such that magnesium wires 
degraded completely. Weight loss for magnesium were same in both cases if implantations 
were done subcutaneously or in tail arteries and it was mainly observed after two weeks of 
implantation and remained the same at later stages. Corrosion morphologies of magnesium 
implanted at two mentioned sites were similar suggesting that the tail movement had little 
influence on the degradation of magnesium. Longtime of implantation resulted in cracking 
of  magnesium wires seemingly due to pitting corrosion [77]. Overall, fast corrosion 
properties of biological medium containing cellular products were quite evident. Although, 
there is a need further to investigate the exact composition of spent medium, it can be 
proposed as best immersion solution to investigate the corrosion properties of degradable 
magnesium and its alloys under in vivo-like conditions. 
4.2 Interlocking between corroding magnesium implants and 
surrounding bone in vitro 
Intramedullary bone screws synthesized from titanium or stainless steel are widely used 
for internal fixation of fractured bones. It is expected that stiff fixation of such screws with 
fragmented bones may prevent micro-motion of fracture lines, enhance bone healing [173]. 
Magnesium and its alloys have already shown excellent bone morphogenetic properties in 
small animal models [174,175]. On the basis of these findings, degradable magnesium-
based bone fixation screws were manufactured. After implantation in human, such 
magnesium screws showed promising radio-graphical and clinical properties equivalent to 
standard titanium [176]. Immediately after exposure to biological environments, 
degradation of magnesium starts and precipitates form  a corrosion layer [74]. Calcium and 
phosphorus are major components of this layer and these elements are major constituents 
of natural bone as well. It indicates that magnesium stimulates natural accumulation of 
calcium and phosphorus that could potentiate the bone healing process. In this context, 
magnesium based implants were inserted into bones of small animals and strength of 
internal fixation was assessed using a biomechanical pullout test system [177-179]. 
Biomechanical pullout tests are a widely used and a reliable method to determine the 
strength of implant anchorage with the surrounding bone that is conventionally thought to 
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be due to bone growth. During these studies, increase in bone-implant strength and osseo-
integration was significantly evidenced in the presence of living tissue. However, 
underlying factors responsible for this bone bonding were not previously investigated. It is 
known that magnesium-based implants can stimulate new bone formation and show 
increased bone-bonding [37]. Hence, possible factors for the development of rigid fixation 
between magnesium and bones could either be due to new bone formation or due to the 
formation of a corrosion layer. During the present study, the contribution of magnesium 
corrosion in strengthening bone-bonding was investigated in the complete absence of 
living cells. In the presence of potassium phosphate salt solution, calcium was absent from 
the corrosion layer thereby confirming that precipitation of calcium is exclusively triggered 
in the presence of biological media [180]. The surface morphology of corrosion layer on 
magnesium incubated in biological solutions was different from that incubated in 
potassium phosphate solution [34,181,182].  Thus, it was confirmed that magnesium 
promotes the formation of a corrosion layer as soon as it reacts with the biological aqueous 
solutions. Further, to verify the role of the corrosion layer in promoting the fixation 
between bone and magnesium implant in the complete absence of live cells. Tibia bones 
were isolated from mice and dipped in formalin to eliminate live osteocytes that are 
essential for new bone formation. In the presence of standard cell culture incubation 
conditions, bone-implant bonding strength significantly increased in the complete absence 
of live cells. In comparison, standard titanium could not induce strong bone bonding [178]. 
The interlocking force between magnesium and bone was increasing under the influence 
different corrosion conditions. The strength of pull-out force was incubation time 
dependent. This binding force was smaller during early days post-incubation as compared 
to later time points.  Maximum force was determined after one week of incubation and it 
remained stable thereafter. The elemental composition of the magnesium wires after 
biomechanical testing seemed to be composed from magnesium (Mg), oxygen (O) and 
carbon (C). Whereas, calcium and phosphorous could not be detected and apparently was 
removed due to the mechanical stress. The process of interlocking between magnesium 
and tibia bones seemed to be in agreement with the in vitro corrosion kinetics of 
magnesium which is fast at initial time points and then slows down with the formation of a 
precipitation layer. Hence, formation of corrosion layer plays a dominant role in promoting 
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strong interlocking between magnesium and surrounding bone and is largely independent 
of new bone formation. As a consequence pull-out experiments are not a valid method to 
evaluate bone repair or bone growth in vivo. 
4.3 Preparation and characterization of surface coatings to prevent fast 
degradation of magnesium 
A corrosion resistant coating was established on magnesium which substantially 
circumvented the initial fast corrosion and hydrogen accumulation in tissues. The 
degradation process of magnesium in biological media is a dynamic process. In contact 
with aqueous solutions, magnesium corrosion leads to the generation of (Mg2+) ions and 
hydrogen gas. At the same time, calcium and phosphorus ions from the surrounding 
medium start to accumulate on the surface of magnesium. A corrosion layer mainly 
composed of octacalcium phosphate and hydroxyapatite was established on the surface of 
magnesium which decelerated the corrosion [183]. We reasoned that if magnesium could 
be pre-coated with a similar type of corrosion layer before implantation it could avoid the 
initial rapid corrosion burst. Such coatings would also reduce need for alloying with 
potentially toxic components. In the present study phosphorus was used as main coating 
component. Acidic phosphate ions (PO4-) could stimulate the degradation of magnesium 
and form a sturdy corrosion layer [172]. The acidic pH promoted corrosion and coat 
formation. KH2PO4 appeared most promising and was selected as a coating solution for 
subsequent experiments. KH2PO4 resulted in a densely packed amorphous corrosion layer 
of Newberyite [Mg (HPO4).3H2O] on magnesium [184-187]. Such pre-coated magnesium 
resisted the initial rapid corrosion burst.  Magnesium and its alloys induce the precipitation 
of calcium and phosphorus which may assist the repair of bone tissue. After KH2PO4 
treatment, calcium and phosphorus were still present on magnesium after corrosion assays 
in DMEM, plasma and r-SBF [188,189].  Magnesium corrosion generates (OH-) ions which 
increase the pH of the surrounding liquid. If the local pH reaches 11, magnesium hydroxide 
precipitates on the surface of magnesium and slows down the degradation process [190]. 
Magnesium discs were coated with Mg(OH)2 to investigate if such coatings could prevent 
fast initial corrosion but it had no protective effects. In living tissue, constant blood 
circulation may buffer the high pH due to corroding magnesium implants [191]. Still, 
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alkalization and elevated (Mg2+) ion concentrations may affect cellular and tissue activities 
near magnesium implants [192]. KH2PO4 derived coatings decreased the local 
concentration of (Mg+2) in vitro by reducing magnesium corrosion and also maintained the 
normal pH level of incubation media. It is essential that medical implant coatings must be 
non-toxic cell friendly. Immortalized murine fibroblasts and porcine nasal epithelial cells 
were selected for their potential compatibility with KH2PO4 treated magnesium. After 
implantation, a healing process is triggered to repair the damaged tissue which involves the 
activation of fibroblasts. These cells then adhere to implant surfaces and secrete collagen 
and extracellular matrix proteins together forming fibrous tissue capsule around the 
implants. A direct contact between the test material and cells is critical for the in vitro 
evaluation [193]. Titanium discs were used as standard cell compatible material for 
comparison. The analysis of cell proliferation, size and number showed that plain 
magnesium could not support cell growth but after KH2PO4 treatment of magnesium 
fibroblasts demonstrated excellent proliferation. In addition, viability and expression of  
pro-inflammatory cytokines and chemokines particularly interleukin-8 (IL-8) is another 
criteria to characterize host-implant interaction [194]. Phosphate coated magnesium 
significantly increased the viability of nasal epithelial cells. Magnesium promotes IL-8 
secretion [195]. We detected an increase in the production of IL-8 in response to 
magnesium without coatings. However, IL-8 secretion from the cells incubated with 
phosphate coated magnesium was significantly lower suggesting it has less inflammatory 
potential. Further, a mouse model was established to examine implant-soft tissue 
interaction and measure hydrogen gas evolution at implantation site. Subcutaneous 
implantation allowed the direct observation of gas cavities around implanted discs 
[78,196,60]. We also established a novel method to measure the volume of these gas 
cavities formed around the subcutaneous implants. The mice implanted with plain 
magnesium and Mg(OH)2 coated discs, showed gas pouches about 24h after implantation 
which later decreased wtih time. No gas bubbles developed in the tissue around phosphate 
coated magnesium discs. For comparison, fluoride coated discs were implanted, which also 
diminished the formation of gas cavities. However after one week, small gas cavities 
around fluoride-coated magnesium persisted for a few days and then disappeared. This 
could be explained by a high initial corrosion resistance which is only temporal, followed 
Discussion 
 
111 
 
by the formation of a biological protective corrosion layer. A corrosion layer composed 
from organic compounds and magnesium corrosion products including calcium phosphate 
was detected. The microstructure of phosphate based coatings was still intact after short 
time of implantation. A thick corrosion layer similar in composition was detected on the 
surface of implants after long period of implantation. This information provides solid 
evidence that magnesium based implants are rapidly covered by layer of magnesium 
corrosion products and organic compounds which serves as barrier to slow down the 
corrosion process [170]. This is in agreement with the common notion that magnesium 
based implants quickly develop a passivation layer as soon as they are exposed to aqueous 
environment [184]. It proves that pre-coating process with potassium phosphate generates 
a barrier and protects magnesium form fast corrosion similar to a natural corrosion layer. 
Soft tissue compatibility with the implanted discs was evaluated by histological methods 
[197,65]. Implants were found compatible towards adjacent tissue except with typical 
foreign-body reaction [198,63]. After prolonged implantation, fibrous tissue formation with 
infiltration of some giant cells and granulocytes was detected in response to all implanted 
materials as reported [199]. In addition, a thick corrosion layer was detected around all 
implants. Recruitment of inflammatory cells (mostly granulocytes, with some 
macrophages) seemed slightly more pronounced in tissues near fluoride coated 
magnesium discs indicating an increased inflammatory potential. Phosphate coated 
magnesium discs showed adequate compatibility with contiguous tissues indicating that 
these coatings have equivalent protective effect but are more biocompatible than fluoride 
coatings.  
4.4 Establishment of persistent infections around metallic magnesium 
implants 
Magnesium is antibacterial under in vitro situations due to increased local alkalinity 
resulting from its corrosion [62]. Such inherited antibacterial properties of degradable 
magnesium were further investigated in vivo. In this perspective, a recent study reported 
that pure magnesium intra-medullary nails were antibacterial and anti-biofilm against 
methicillin resistant S. aureus (MRSA) in a rat model of implant related osteomyelitis. 
Antibacterial efficacy was mainly quantified by counting the bacterial load in colony 
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forming units (CFUs) [200,201]. The present study was focused to the antibacterial 
properties of metallic magnesium in vivo. A mouse implant-infection model was established 
whereby metallic discs were inserted subcutaneously and the subsequent infection was 
done by injecting the bacterial inoculum directly on the surfaces of the implanted discs. For 
infection, the bacteria P. aeruginosa and S. aureus (common implant associated pathogens) 
engineered for bioluminescence (lux) were employed. Bacterial luminosity was used as 
indicator to investigate metabolic activity and viability of bacteria in vivo. A sensitive in vivo 
imaging system (IVIS) facilitated the determination of small cultures of bacterial 
luminescence in direct contact with metallic implants beneath the skin of live animals. The 
luminescence detection method is prompt and profound as compared to the conventionally 
used colony counting method which is not only time consuming but is dependent on the 
explanation of samples at each time point after the sacrifice of animals. Overall, in vivo 
imaging allows imaging procedure in single animal at repeated time points. This reduces 
the need for larger number of animals whereby the statistics is improved by the collection 
of multiple data points from same animal and the pathogen load can be quantified without 
exogenous sampling [202]. Surprisingly and in contrast to previous studies, we detected a 
gradual increase in the luminosity of P. aeruginosa and S. aureus specifically on the surfaces 
of subcutaneously implanted metallic magnesium as compared to titanium and porous 
glass beads. Bacterial luminescence as a marker for bacterial load and metabolism on 
metallic magnesium decreased transiently below the initial inoculation during the early 
time points. After that, a gradual increase was seen which lasted for more than two weeks. 
This unexpected outcome revealed that magnesium was bactericidal only in vitro but 
infection prone when implanted in-vivo.  Such stable and prolonged infection occurred on 
magnesium even if very small numbers (100 CFUs) of bacteria were locally injected. 
Infection was also productive when bacteria were injected on subcutaneous magnesium 
implants either immediately after implantation or 24h after implantation. These time 
courses mimic clinical intraoperative or postoperative contaminations [203]. With both 
approaches, magnesium seemed to be highly susceptible to locally injected bacteria. 
However, infections could not be established on magnesium when bacteria were injected 
intravenously neither soon or 24h after implantation.  In some situations, bacterially 
infected tissues may serve as reservoir and bacteria have been proposed to migrate to 
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neighboring healthy tissue to establish new infections [204]. On the other hand, P. 
aeruginosa established a localized infection on magnesium and bacteria did not spread to 
adjacent un-infected magnesium implants in our assays. This may diverge from clinical 
situations however, the bacterial inoculum required for implant colonization is not known. 
4.4.1 Characterization of prolonged infections on magnesium implants 
During chronic infections, bacteria organize themselves to biofilms highly stationary 
cultures surrounded by exoplysacharide matrix. Within biofilms, microbes are held 
together by self- secreted polysaccharides and proteins, become extremely resistant to 
antibiotics and host immune system [205]. Different biological and molecular techniques 
are applied for the detection and visualization of bacterial biofilms. Hence, some of the 
frequently practiced methods were applied to see if the bacteria were making biofilms on 
implanted magnesium discs [206]. Scanning electron microscopy of magnesium discs and 
nearby tissue with P. aeruginosa infection, revealed a high density population of bacterial 
cells inter-connected with filaments of extracellular polymeric (EPS) matrix [207]. P. 
aeruginosa were adhering on the surface of magnesium with well-defined biofilm 
architecture. Bacteria in free-living form can be eliminated by the innate immune system. 
The transition to the biofilm form renders bacteria impervious to host defense mechanisms 
[208]. Transmission electron microscopy was used to detect the infiltration of host immune 
cells. Bacteria on magnesium implants attracted immune cells mainly polymorphonuclear 
leukocytes (PMNs). Even though P. aeruginosa and S. aureus within biofilms were 
surrounded by the immune cells, the biofilms were not visibly affected. Few bacteria which 
were outside of the biofilm could be seen being engulfed by polymorphonuclear leukocytes 
(PMNs) [209]. Moreover, histological findings revealed a strong influx of granulocytes 
towards P. aeruginosa biofilms. These results can be taken as evidence that bacterial 
biofilms formed on magnesium implants exhibit strong resistance against host immune 
system. Bacteria within biofilms are known for their resistance against antimicrobial 
agents [210,211]. This was proved in the current study and a remarkable increase in the 
antibiotic resistance of P. aeruginosa growing on magnesium implants was observed. 
Bacteria are known to communicate with one another through the exchange of chemical 
signal molecules called auto inducers. This process is called quorum-sensing and it plays an 
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important role in biofilm formation [212]. Disabling quorum sensing has been proposed as 
a potential strategy to prevent biofilm formation and chronic infections [213]. In the 
current study, the luminescent quorum sensing mutant P. aeruginosa (pqsA-) showed 
decreased luminescence and antibiotic sensitivity as compared to wild type luminescent 
strain only at early time points after infection. However, at later stages the pqsA- mutant 
strain established prolonged infections on magnesium implants. These results suggest that 
quorum-sensing is not a critical parameter for P. aeruginosa biofilm formation but it may 
affect the kinetics of early steps. Biofilm extracellular matrix is mainly composed from 
proteins, exopolysaccharides and extracellular DNA that together function to facilitate cells 
adherence to surfaces and provide protection [100]. Indeed, proteins and polysaccharides 
were detected in P. aeruginosa infected tissues near magnesium implants with the biofilm 
specific Periodic acid–Schiff (PAS) staining procedure [214,215]. Type I interferon induction 
is triggered in response to viral and bacterial infections [162]. P. aeruginosa biofilm is 
reported to promote strong stimulation of type I interferon in β-interferon luciferase 
reporter mice (IFN-β+/Δβ-luc) [155]. A strong and prolonged production of type I β-
interferon was examined in response to magnesium infected with P. aeruginosa. Taken 
together these findings show that P. aeruginosa and S. aureus establish prolonged 
infections on magnesium implants. Using different biofilm detection methods, we 
determined that these extended infections were mainly based upon biofilm formation.   
4.4.2 Magnesium corrosion products responsible for prolonged implant infections 
When magnesium implants degrade hydroxide ions stimulate the formation of a lowly 
soluble magnesium hydroxide layer with the inclusion of additional organic and inorganic 
molecules [31]. In addition, hydrogen gas is produced resulting in the formation of gas 
cavities. Within these cavities, hydrogen gas is  rapidly exchanged with the surrounding air 
[78]. These observations led us to speculate that these gas cavities could protect bacteria 
from immune cells. As discussed previously, potassium phosphate treated magnesium 
impede the development of gas bubbles on corrosion protected magnesium implants. P. 
aeruginosa disappeared quickly from potassium phosphate treated magnesium and 
infection did not reoccur. This was in agreement with our assumption that magnesium 
implant degradation promoted bacterial survival. It is thought that surgical damaged tissue 
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together with blood clots on implant surface may support bacterial initial adherence and 
biofilm formation [216]. To test the influence of wounding, P. aeruginosa were injected on 
the surface of magnesium after 4 weeks of subcutaneous implantation. Interestingly, 
bacteria were still capable of establishing prolonged infections on the surfaces of 
magnesium discs. It can be assumed that under in vivo situations the buffering from the 
blood circulation stabilizes pH near the tissue-magnesium interface. Nevertheless, the 
elevated pH might be critical to P. aeruginosa survival. To this end, magnesium hydroxide 
coated porous titanium implants were supposed to generate an alkaline environment. P. 
aeruginosa showed a prolonged survival in the presence of magnesium hydroxide loaded 
porous titanium implants. Therefore, sustained bacterial survival was mainly due to high 
pH levels. Overall, mainly pH and possibly to minor degree gas cavities may contribute to 
the initial bacterial survival and immune cell invasion. At later stages, bacteria are 
enveloped within a self-produced extracellular matrix which acts as barrier against host 
defense thereby extending their survival.  
4.5 Proposed mouse model to understand biofilm formation on implant 
surfaces 
Transformation from planktonic bacteria to the biofilm form is different in vitro as 
compared to in vivo [217]. Depending on nutrients supply and surrounding conditions, 
bacteria can make biofilms in vitro. In vivo biofilm formation is more complicated. It is 
thought that bacteria search for suitable substrates like host tissue or inert surfaces like 
medical implants for initial adherence. To adhere on implanted material, bacteria face 
tough competition with fibroblasts which are activated to establish first contact with 
material and completely surround the whole surface. In parallel, bacteria need to cope with 
the host immune defense [204]. Some bacteria manage to establish in vivo biofilms on 
implants. Such implant infections cannot be cured with conventional antimicrobial 
treatments and are major cause of persistent clinical infections [218,219]. Laboratory 
animal models are therefore essential to investigate novel ways to characterize and 
eliminate in vivo biofilms. Such models may provide insight into the molecular mechanisms 
underlying biofilm formation in biological system and further designing certain drugs 
capable of disrupting such microbial consortia. Various animal models have been proposed 
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based on the insertion of pre-colonized solid substrates into animal body [220,221]. A 
major shortcoming with these models is that the bacteria are already in biofilm mode of 
growth and invulnerable to immune system. A catheter tube model is centered upon the 
surgical insertion of small catheter tubes subcutaneously into small animals and then 
administration of bacteria either before or after implantation into tubes [146]. In clinical 
situations, catheters provide suitable conditions for the growth of bacterial biofilm [222]. 
Inside indwelling catheters, bacteria already have no contact with adjacent tissue and 
blood circulation, hence are protected from tissue-resident macrophages and circulating 
neutrophils [223]. Bacteria also proliferate on orthopedic and dental implants [224]. Even 
though, catheter tubes support biofilms they are not perfect models to other types of 
implant infections in patients. Bacterial survival on magnesium implants in mice appears to 
be a better model to investigate effective treatments. Bacteria have been proposed to 
migrate into nearby tissue niches to temporarily hide from the immune attack or from 
antibiotics. Once the situation becomes more favorable, bacteria return back on implants 
and cause persistent biomaterial-associated infections [225]. Similarly, during current 
study, a reduction in bacterial luminosity was monitored at early stages after implantation. 
At later stages, P. aeruginosa and S. aureus biofilms clusters were demonstrated in the 
tissues near magnesium implants. This confirms the notion that bio-material associated 
infections are not limited to the implant interface but bacteria also grow within peri-
implant tissues [226]. It seemed living bacteria within biofilm assemblies were persisting 
in the tissue near infected implants [225]. Magnesium was infected with low numbers of 
planktonic bacteria to improve the clinical relevance. However, this reduced the success 
rate of detectable persistent implant infections.  Magnesium implants accessible to the host 
immune system and polymorphonuclear leukocytes (PMNs) were observed near biofilms. 
Taken together, magnesium based tissue infection model represents a biofilm formation on 
medical implants comparable to hospital conditions. It is the first animal model to our 
knowledge wherein biofilms formation takes place on metallic implants in direct contact 
with host tissue. Thus, this mouse model could be used in the future to identify intrinsic 
mechanisms underlying in vivo biofilm formation and to develop strategies to eradicate 
such infections.  
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5 Conclusion 
A major limitation of permanent metallic implant materials for temporal applications is the 
requirement for secondary surgery for their removal. Medical implants made from 
degradable metals such as magnesium could overcome this difficulty. This study was 
conducted to investigate the properties of magnesium and to provide solutions to problems 
that hinder clinical applications of magnesium-based implants. To understand magnesium 
degradation in vitro, different biological media under various conditions were investigated. 
It was found that magnesium had the potential to develop strong interlocking with bone 
even in the absence of cells, a property which was previously thought to indicate the 
promotion of the healing of fractured bones. Rapid degradation and generation of hydrogen 
gas cavities in tissue were identified as major problems associated with magnesium 
implants. Therefore, a biocompatible phosphate based coating found to render magnesium 
implants corrosion resistant and eliminated the gas cavity formation.   Metallic magnesium 
showed promising antibacterial properties against P. aeruginosa and S. aureus in vitro. 
However, in vivo, magnesium implants were infection prone and it also proved an 
appropriate niche for bacteria to establish resistant biofilms and may therefore be useful as 
in vivo model for implant infections. 
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6 Outlook 
In the present study metallic magnesium implants were investigated. Magnesium showed 
promising degradable properties in vitro and in small animals. It was capable of strong 
bone bonding even in the complete absence of live cells due to the formation of a highly 
biocompatible corrosion layer. However, problems with rapid corrosion and gas cavities in 
the tissue associated with magnesium corrosion were solved by potassium phosphate pre-
treatment. After this treatment, phosphate coatings around magnesium were compatible 
with murine cells and tissue. Accumulation of hydrogen gas in tissue and pitting corrosion 
were completely abrogated for the entire observation period of eight weeks after 
phosphate coating. The promising properties of phosphate coatings warrant further 
investigation in larger animals or in the clinics.    
Metallic magnesium exhibited bactericidal properties in vitro. This property was solely due 
to alkalization produced near magnesium surface. However, in vivo, magnesium was not 
antibacterial but susceptible to persistent bacterial infections. This was quite contrary to 
the expectations. Thus, magnesium alloys and coatings which protect magnesium from 
bacterial colonization need to be established before their clinical applications.  Prolonged 
magnesium infection was clearly due to the formation of biofilms by bacteria which was 
confirmed by various assays. Hence, magnesium infection closely mimics clinical 
biomaterial associated infections thereby this can be used as mouse model to understand 
various aspects of biofilm persistence on medical implants and to test the efficacy of novel 
anti biofilm compounds.  
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8 Appendix 
8.1 List of abbreviations 
Abbreviations   Explanations 
µ     micro; 10-6 
θ     diffraction angle 
ATCC     American type culture collection 
ATP     Adenosine triphosphate 
agr     accessory gene regulator 
AIP     Auto inducing peptide 
AI     auto inducers 
AgNPs     Silver nanoparticles 
AECGM    Airway epithelial cell growth medium 
Al     Aluminum 
Bap      biofilm associated proteins 
Ca     Calcium 
cm     centimeter 
CVC     central venous catheter 
CFSE     Carboxyfluorescein diacetate succinimidyl ester 
CR     corrosion rate 
CFU     colony forming unit 
CTR     control 
CFX     Ciprofloxacin 
DMEM     Dulbecco’s modified Eagle’s medium 
DNA     Deoxyribonucleic acid 
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DMSO     Dimethyl sulfoxide 
DNase     Deoxyribonuclease 
d     day(s) 
ECM     Extra cellular matrix 
EPS     Exopolysaccharide 
eDNA     extracellular DNA  
EDX     Energy-dispersive X-ray spectroscopy 
ELISA     Enzyme-linked immunosorbent assay 
FCS     Fetal calf serum 
FnBPs     fibronectin-binding proteins 
g     gram 
GTP     guanosine triphosphate 
h     hour(s) 
H2     hydrogen 
H&E     hematoxylin and eosin 
HBSS     Hank’s balanced salt solution 
IL     interleukin 
IVC     intravascular venous catheter 
IVIS     in vivo imaging system 
IFN     interferon 
i.p     intraperitoneal 
i.v.     Intravenous 
I     relative X-ray reflection intensity 
Kg     Kilo gram 
K     potassium 
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KH2PO4    Potassium dihydrogen phosphate 
K2HPO4    Potassium monohydrogen phosphate 
LDH     Layered double hydroxide 
LB     Lysogeny broth 
Mg     Magnesium 
ml     milliliter(s) 
mRNA     messenger RNA 
mmol     millimole 
MAGT     Magnesium transporter gene 
MSCRAMMS Microbial surface components recognizing adhesive 
matrix molecules 
M Molar 
min min 
MgF2 Magnesium fluoride 
MRSA methicillin resistant S. aureus 
Na     Sodium 
NK     Natural killer 
NO     Nitric oxide 
N     Newton 
OH     Hydroxide 
OD     Optical density 
PBS     Phosphate buffer saline 
Pg     Porous glass 
PIA     polysaccharide intercellular adhesion 
PJI     prosthetic joint infections 
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PLLA     Poly L lactic acid 
PCR     Polymerase chain reaction 
PNEC     Porcine nasal epithelial cells 
PAS     Periodic acid-Schiff 
PMNs     Polymorphonuclear leukocytes 
QS      quorum sensing 
RNA     Ribonucleic acid 
ROS     Reactive oxygen species 
RNase     Ribonuclease 
RT     Room temperature 
rpm     revolution per minute 
sarA     staphylococcal accessory regulator 
SBF     Simulated body fluid 
Ti     Titanium 
TCR     T-cell receptor 
TIVAP     Totally implantable venous access ports 
w.t.     wild type  
XRD     X-ray diffraction  
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